| Title | Collaboration Type | HHS Participating Agencies | NIH Participating Institutes, Centers, and Offices | Description |
|---|---|---|---|---|
| 2012 International Microbicides Conference Planning Committee | Meeting/ Workshop | CDC, FDA | OD/DPCPSI/OAR, NIAID, NICHD, NIMH, OD | Co-sponser and member of Scientific Program Committee for this international microbicides scientific conference, which is held every 2 years. http://microbicides2012.org/ Test |
| 4th Annual Dissemination and Implementation Research Conference | Meeting/ Workshop | AHRQ, CDC | NIDCR, FIC, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, OD | Multiple NIH institutes and centers participate in planning and implementing an international conference to facilitate the exchange of scientific data related to the dissemination and implementation research. This conference brings together clinical researchers, health services researchers, third-party payers, policy-makers and others to tackle the challenges of moving evidence-based prevention and treatment into community settings in sustainable ways. http://obssr.od.nih.gov/scientific_areas/translation/dissemination_and_implementation/index.aspx |
| 4th National Conference on Genomics and Public Health | Meeting/ Workshop | AHRQ, CDC, HRSA | OD, NCI, NHGRI, NICHD | This conference was held on December 8-10, 2010, and brought together multi-disciplinary professionals from national, state, and other organization to learn about the use of genetics and genomic tools to prevent chronic, pediatric, infectious, environmental, and occupational diseases and provide quality genetic services across the lifespan. https://www.cmpinc.net/2010PHGConference/home.html |
| A Re-Emerging Challenge: New Opportunities for Dengue Research Collaboration | Meeting/ Workshop | CDC, FDA | NIAID | The meeting will provide a forum for exchange of current information on basic and applied dengue research, identify research gaps and priorities, and promote and stimulate research collaborations in the Americas. http://www.niaid.nih.gov/topics/denguefever/pages/default.aspx |
| Accelerating Therapies for Rare Diseases Workshop | Meeting/ Workshop | FDA | NINDS, OD | The 3-day workshop focused on FDA''s regulatory requirements and the clinical trial issues that are especially relevant to rare disease and orphan products research. http://rarediseases.info.nih.gov/Accelerating_Therapies_for_Rare_Diseases_Workshop/ |
| Action for Health in Diabetes (Look AHEAD) | Research Initiative | CDC, IHS | NIDDK, NHLBI | This study is a 16-center, randomized clinical trial investigating the long-term health consequences of weight loss. The Look AHEAD cohort comprises approximately 5,000 overweight or obese participants with type 2 diabetes, aged 45-76. Participants were randomized to one of two interventions: an intensive lifestyle intervention designed to produce and sustain weight loss over the long term or a diabetes support and education arm. Participants will be followed for a total of 11 to 13.5 years from randomization. http://www.lookaheadtrial.org |
| Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study (ACCORDION) -- Health Related Quality of Life and Cost Effectiveness Substudies | Research Initiative | CDC | NHLBI, NIDDK | The ACCORD study was primarily composed of three clinical trials that tested treatment approaches to determine the best ways to decrease the high rate of major CVD events – heart attack, stroke, or death from CVD – among people with type 2 diabetes who are at especially high risk of having a CVD event, like a heart attack or stroke. ACCORDION (the ACCORD Follow-up Study) is a prospective, observational follow-up study of approximately 8000 participants who were treated and followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. It is designed to further elucidate and clarify the long-term effects of the ACCORD treatment strategy and provide additional data on the long-term relationships among various cardiovascular and diabetic risk factors. ACCORD participants had type 2 diabetes and were at high risk for a CVD event. Those who agree to participate in ACCORDION will continue to be followed through clinic and phone visits for an average of 3.5 years in the period 2011 through 2014. Participants will be seen in 76 clinics across the United States and Canada. The CDC is contributing intellectually and financially to the Health Related Quality of Life and Cost Effectiveness substudies of the trial. https://www.accordionstudy.org/public/dspHome.cfm |
| Ad Hoc Interagency Working Group on Climate Change and Human Health | Committee, Work group, Advisory group, or Task Force | CDC, OS | NIEHS, FIC | Developed, wrote, published, and disseminated a white paper on Federal research needs on impacts of climate change, as well as mitigation and adaptation, on human health. Coordinated and participated in Congressional briefings on the paper. http://www.niehs.nih.gov/climatereport |
| Addiction Technology Transfer Center | Public Education Campaign | SAMHSA | NIDA | NIDA initiated a historic partnership with the Center for Substance Abuse Treatment (CSAT), Substance Abuse and Mental Health Services Administration (SAMHSA) to expedite the dissemination of NIDA’s research results into the addiction treatment field. Blending teams composed of NIDA researchers, community treatment providers and trainers from SAMHSA’s Addiction Technology Transfer Centers (ATTC) work closely together to create innovative Blending products. Based on recently tested NIDA research, the Blending Teams design user-friendly products for clinical practitioners to use during treatment. Completed products include training packages composed of informational manuals, PowerPoint presentations, videos, CDs, curricula and annotated bibliographies. http://www.attcnetwork.org/index.asp |
| Adolescent Health Working Group | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | NIDA, NICHD, NIMH, NIMHD | Interagency working group established in January 2010 within the Office of the Assistant Secretary for Health as a forum for HHS agencies to share updates on adolescent health activities and address cross-cutting issues. |
| Adult Questions on Voice, Speech, Swallowing and Language (VSSL) and Children’s Questions on Speech-Language Development and Balance/Dizziness Problems on the 2012 National Health Interview Survey | Health Survey | CDC | NIDCD | The purpose of this agreement is to provide funding for a collaborative effort with the National Center for Health Statistics (NCHS) to develop a Voice, Speech, and Language Supplement to include in the 2012 National Health Interview Survey (NIHS), which is conducted by U.S. Census workers under contractual agreement with the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC). NIDCD funds will support the gathering of current, reliable prevalence data for disorders of voice (+ swallowing), speech, and language (VSL) that have been missing from our national statistics. Questions on balance/dizziness problems experienced by children will also be included. http://www.cdc.gov/nchs/nhis.htm |
| Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me) | Research Initiative | FDA | NHLBI, CC, NCCAM, NIAMS, NICHD | The purpose of this project is to develop, validate and disseminate a patient-reported outcome measurement information system incorporating Patient Outcomes Measurement Information System (PROMIS) methods. The NHLBI contributes funding to the NIH Common Fund for scientific administration of PROMIS and has funded the ASCQ-Me as a sickle cell-specific research tool to be used in conjunction with PROMIS. http://www.nihpromis.org/test |
| Adult to Adult Living Donor Liver Transplant Cohort Study | Research Initiative | HRSA | NIDDK | This study supports nine liver transplant centers with expertise in adult living-donor liver transplantation (LDLT) and a central data coordinating center. The major aims of A2ALL are to (1) Quantify the impact of choosing LDLT on the candidate for transplantation; (2) Characterize the difference between LDLT and deceased donor liver transplant (DDLT) in terms of post-transplant outcomes, including patient and graft survival, surgical morbidity, and resource utilization on the recipient of a transplant; (3) Determine the short- and long-term health and quality of life (QOL) impact of donation, including (a) morbidity after liver donation and (b) long-term health-related QOL of donors; and (4) Standardize and assess the role of "informed consent" in affecting the decision to donate and satisfaction after living liver donation. http://www.nih-a2all.org/ |
| Advanced Anticonvulsant System Interagency Product Team | Committee, Work group, Advisory group, or Task Force | FDA, OS | NINDS, NIAID | The Advanced Anticonvulsant System Interagency Product Team is a Department of Defense-led effort to facilitate activities, both research and regulatory, related to the FDA approval midazolam for use in treating nerve agent exposure. |
| Advancing Regulatory Science Through Novel Research and Science-Based Technologies | Research Initiative | FDA | OD/DPCPSI, NIDDK, NINDS, OD | This regulatory science initiative aims to foster the development, evaluation and availability of new or improved tools, methods, standards, and applied science that support a better understanding and improved evaluation of product safety, quality, effectiveness, and manufacturing throughout the product life cycle. http://nihroadmap.nih.gov/regulatoryscience/ |
| Advising on Human Papillomavirus (HPV) Tests | Other | FDA | NCI | National Cancer Institute (NCI) scientists advised the FDA on testing for human papillomavirus (HPV) infection. |
| Advisory Committee on Childhood Lead Poisoning Prevention | Committee, Work group, Advisory group, or Task Force | CDC | NIEHS | The overall goal of the ACCLPP is to provide advice that will assist the nation in reducing the incidence and prevalence of childhood lead poisoning. http://www.cdc.gov/nceh/lead/ACCLPP/acclpp_main.htm |
| Advisory Committee on HIV and STD Prevention and Treatment | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | OD/DPCPSI/OAR, OD | Chartered committee to advise CDC and HRSA on HIV and STD programs. NIH/OAR participates as an ex-officio member. http://www.cdc.gov/maso/FACM/facmCHACHSPT.htm |
| Advisory Committee on Organ Transplantation | Committee, Work group, Advisory group, or Task Force | HRSA | NIAID | The Advisory Committee on Organ Transplantation (ACOT) was established to assist the HHS Secretary in: Enhancing organ donation, Ensuring that the system of organ transplantation is grounded in the best available medical science, Assuring the public that the system is as effective and equitable as possible, and thereby Increasing public confidence in the integrity and effectiveness of the transplantation system. http://organdonor.gov/legislation/advisory.html |
| Advisory Group for CDC Alcohol-Related Disease Impact (ARDI) Study of Economic Costs of Excessive Alcohol Consumption | Committee, Work group, Advisory group, or Task Force | CDC | NIAAA | This group advises the CDC Alcohol Team on the development and execution of a contract study of the economic costs of excessive alcohol consumption. |
| Agricultural Health Study | Research Initiative | CDC | NCI | A study exploring potential causes of cancer and other diseases among farmers and their families and among commercial pesticide applicators. http://aghealth.nci.nih.gov/index.html |
| Agricultural Health Study: Respiratory Disease Studies | Health Survey | CDC | NIEHS, NCI | Collaboration on respiratory disease analyses from the Agricultural Health Study. The National Institute for Occupational Safety and Health (NIOSH) contributes to survey implementation and provides an American Public Health Association (APHA) fellow to conduct analysis. http://aghealth.nci.nih.gov/ |
| AHRQ Evidence Based Review - Meditation Programs for Stress and Well-being | Resource Development | AHRQ | NCCAM | This is an NIH/AHRQ collaboration driven by a nomination from the Division of Extramural Research of the National Center for Complementary and Alternative Medicine, NIH to review the efficacy of mindfulness-based interventions across the broad range of stress outcomes, as well as develop information related to the understanding of the mechanisms by which these therapies operate. It was submitted through the public domain, and thus does not require NIH funding, but NCCAM is serving in a scientific advisory capacity. http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?search=&topicid=375&pageaction=displaytopic |
| AHRQ Technical Expert | Research Initiative | AHRQ | CC | Serve as a technical expert for AHRQ on an AHRQ healthcare-associated infection contract; the contract is for a systematic review of the literature and a multicenter clinical trial for prevention of surgical site infections with resistant gram-positive organisms. |
| AIDS International Training and Research Program (AITRP) Supplements | Training Initiative | CDC | FIC | The goal of the AITRP program is to build multi-disciplinary biomedical, behavioral, and social science research capacity for the prevention, care, and treatment of HIV/AIDS and HIV-related conditions in adults and children in low-and middle-income countries. Research training will be provided to scientists at institutions in countries defined by the World Bank criteria as low- and middle-income. PEPFAR/CDC-COP funded supplements to parent AITRP awards in Zambia through Vanderbilt; Cote d''Ivoire and Vietnam through Berkeley; Tanzania through Baylor, Dartmouth, and Boston University; and South Africa through Columbia. http://www.fic.nih.gov/Programs/Pages/hiv-aids.aspx |
| AIDS Vaccine 2011 | Meeting/ Workshop | CDC | OD/DPCPSI/OAR, NIAID, OD | AIDS Vaccine 2011 is the premier annual HIV Vaccine Meeting that is held alternately in the U.S. and other countries that are conducting HIV vaccine strategies. http://www.vaccineenterprise.com/conference/2011 |
| AIDSinfo/InfoSIDA | Resource Development | CDC, CMS, FDA, HRSA | NLM, NIAID, OD | These English- and Spanish-language websites assist in the dissemination of the Public Health Service Treatment Guidelines. http://aidsinfo.nih.gov/ |
| Air Force Medical Service CTSA Collaboration Workshop: Opportunities in Translational Science Research | Meeting/ Workshop | AHRQ, FDA, HRSA | NCATS, CC, NCI, NHGRI, NIAID, NIBIB, NICHD, NIDDK, NLM, OD | On May 13, 2011, members of the government (military and civilian), academia, and industry convened a one-day conference at the National Institutes of Health (NIH) to generate collaborative research opportunities and discuss ways to share data resources. Meeting attendees represented the following entities: Air Force Medical Service (AFMS), Clinical and Translational Science Award (CTSA) Consortium, National Institutes of Health (NIH), Veterans’ Administration (VA), Food and Drug Administration (FDA), the Agency for Healthcare Research and Quality (AHRQ), industry, care providers and research investigators. The participants focused specifically on enabling new research for patient centered research including comparative effectiveness research, health economics, and biomedical informatics. http://www.ncrr.nih.gov/publications/most_recent.asp |
| Alaska Native Tumor Registry | Resource Development | CDC, IHS | NCI | In collaboration with CDC and HIS, NCI, with technical assistance from SEER, collects information on cancer cases among Alaskan Native populations residing in Alaska. http://seer.cancer.gov/registries/alaska.html |
| Alcohol Clinical Trial Initiative (ACTIVE) | Committee, Work group, Advisory group, or Task Force | FDA | NIAAA, NIDA | Consortium that includes academia and representatives from the FDA, NIAAA, NIDA and the pharmaceutical industry working together to identify and clarify clinical trials methodology to evaluate medications for treating alcohol dependence. http://isctm.org/Autumn_2011_Alcohol Dependence |
| All-Hazards Playbook | Resource Development | OS | NLM, NIAID, OD | This activity is to develop an interactive tool to assist state and local health departments prepare for and respond to disasters in their regions. |
| All-Ireland NCI Cancer Consortium (AICC) | Committee, Work group, Advisory group, or Task Force | OS | NCI, CC | The goal of the All-Ireland National Cancer Institute (NCI) Cancer Consortium is to reduce the incidence and mortality of cancer on the island of Ireland, which has among the highest rates of cancer in Europe. The Consortium is regarded as a major step toward enhancing diplomatic relations between the United States, Ireland, and Northern Ireland, bringing the governments of the United States and both parts of the island together in the fight against cancer. In order to carry out its mandate of increasing scientific and public health collaborations between Ireland, Northern Ireland, and the United States, the All-Ireland NCI Cancer Consortium has six working groups to provide scientific direction to the Consortium''s many programs and activities. These include prevention, nursing, epidemiology/cancer registries, clinical trials, scholar exchange, and information technology. Initiatives in the area of health economics and cancer policy analysis, biobanking, and palliative care have also been established. The Consortium has trained over 350 scientists, physicians, and other health care professionals since 2000 through its various training programs in prevention, nursing, basic and behavioral sciences. In 2011, the U.S. Department of Health and Human services renewed its MOU with ROI, and NI for five more years. http://www.allirelandnci.org |
| Alzheimer''s Disease Neuroimaging Initiative | Research Initiative | FDA | NIA, NIBIB | To develop biomarkers of Alzheimer’s Disease in elderly subjects. A major goal of the study has been to establish and validate MRI and PET images, cerebral spinal fluid, and blood biomarkers as predictors of the disease. http://adni.loni.ucla.edu/ |
| American Association of Blood Banks (AABB) Interorganizational Biovigilance Network Task Force | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NHLBI | The task force is a collaboration between the American Association of Blood Banks and government and other agencies focused on tracking and analyzing adverse reactions and incidents associated with blood collection and transfusion, as well as organ and cell donation and transplantation. http://www.aabb.org/programs/biovigilance/us/developmenthistory/Pages/default.aspx |
| American Conference for the Treatment of HIV (ACTHIV) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA | OD/DPCPSI/OAR, NCI, NICHD, NIDA, NIMH, OD | Co-sponsor and participate on the Federal Scientific Collaborative Board of the ACTHIV, which is a conference for all frontline clinicians providing HIV care for various population groups, including adults, adolescents, children, and pregnant women. http://acthiv.org/ |
| Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks | Committee, Work group, Advisory group, or Task Force | FDA | NINDS, NCI, NCATS | The mission of the Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership funded by the United States Food and Drug Administration (FDA) is to identify, prioritize, sponsor, coordinate, and promote innovative activities — with a special interest in optimizing clinical trials — that will expedite the discovery and development of improved analgesic treatments for the benefit of the public health. http://www.acttion.org/ |
| Anti-Infective Drugs Advisory Committee | Committee, Work group, Advisory group, or Task Force | FDA | NIAID | Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the FDA for drug approval. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/default.htm |
| Antiretroviral Pregnancy Registry | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NICHD | This is a registry of use of antiretroviral drugs in pregnancy that is sponsored by the various pharmaceutical companies and has a Committee of external experts and government staff from NIH, CDC and FDA. http://www.apregistry.com/ |
| AoA-NIA Partnership | Committee, Work group, Advisory group, or Task Force | AoA | NIA, NHLBI, NIAAA, NIAMS, NIDA, NIDDK, NIMH, NIMHD, NINR | This group is made up representatives from the Administration on Aging and the National Institute on Aging who are working to identify evidence-based interventions that are ready for dissemination and implementation in community programs and to work more collaboratively on their translation into the community. These efforts may also include setting up ways to evaluate the success of these dissemination and implementation efforts. Areas of interest identified to date include Family Caregiving, Exercise/Physical Activity, Nutrition, Elder Mistreatment/Abuse/Financial Fraud, Falls, Driving, Sleep, Medication Management, Depression/Mental Health, Living with Long-Term Disability, and Alzheimer’s Disease. |
| Applied Suicide Intervention Skills Training | Research Initiative | SAMHSA | NIMH | NIMH is collaborating with SAMHSA on a project to evaluate the effectiveness of a new training program for telephone crisis counselors at suicide hotline centers. This project is the first controlled study of how trained crisis counselors assess and refer callers, and will provide the first rigorous analysis of the effectiveness of Applied Suicide Intervention Skills Training (ASIST) gatekeeper program. ASIST involves silent monitoring of calls and follow-up telephone interviews with callers to the hotline, which are used to provide information on the effectiveness of training and the impact of hotline services. The study findings will provide critically needed data to inform policy decisions and plans regarding the optimization of a network of services for imminently suicidal individuals across the United States. |
| Assessment of Validities for Analytical Protocols & Prototypes for Various Dietary Supplements (AOAC) | Research Initiative | FDA | OD | The AOAC provides methods of analysis for which performance characteristics have been determined and tested. |
| Assistance for Orphans and Other Vulnerable Children in Developing Countries Act of 2005 (PL 109-95) Interagency Work Group | Committee, Work group, Advisory group, or Task Force | ACF, CDC, HRSA | NICHD | This congressionally mandated workgroup evaluates efforts on behalf of orphans and underserved children worldwide. http://pdf.usaid.gov/pdf_docs/PDACN600.pdf |
| Asthma Outcomes Workshop | Meeting/ Workshop | AHRQ, CDC, CMS, FDA, HRSA | NHLBI, NIA, NIAID, NICHD, NIEHS, NIMHD, NINR | The NHLBI participated in a workshop, attended by federal agency representatives and asthma clinical researchers, to establish standard definitions and data collection methodologies for validated outcome measures in asthma clinical research. Standard definitions and methods would facilitate comparisons across asthma research studies and clinical trials. A secondary objective of the workshop was to identify promising outcome measures for asthma clinical research and discuss the status of their development and validation. |
| Asthma Supplement to the National Ambulatory Medical Care Survey (NAMCS) | Health Survey | CDC | NICHD, NHLBI, NIAID, NIEHS | The purpose of this Interagency Agreement is to participate in the design and implementation of a national survey of physicians about their opinions and use of the National Asthma Education and Prevention Program (NAEPP) Guidelines for the Diagnosis and Management of Asthma (the Guidelines). http://www.cdc.gov/nchs/ahcd/namcs_participant.htm |
| Audiometric Support for the National Health and Nutrition Examination Survey (NHANES), the Age, Gene/ Environment Susceptibility Study (AGES), and Early Childhood Longitudinal Study – Kindergarten Class of 2010/2011 (ECLS-K:2010/11) | Health Survey | CDC | NIDCD | The purpose of this agreement is to provide funding for the Audiometry (Hearing) components of: (1) the National Health and Nutrition Examination Survey (NHANES), (2) Iceland AGES, and (3) ECLS-K: 2010/11 cohort study. The hearing components consist of: 1) a set of questionnaires relating to hearing, ear infections, noise exposure, and other factors relating to hearing, and 2) audiometric examinations consisting of otoscopy, acoustic immittance (bilateral tympanometry and screening for ipsilateral acoustic reflexes at 1000 and 2000 Hz), and pure-tone, air-conduction audiometry to determine the hearing thresholds in each ear at 500, 1000, 2000, 3000, 4000, 6000, and 8000 Hz. |
| Autism Quality Measure Development Subgroup/Workgroup | Committee, Work group, Advisory group, or Task Force | OS, SAMHSA | NICHD | This is a subgroup of the workgroup that makes recommendations about what is needed for quality measure development of a project for the development of clinical quality measures for behavioral health. The purpose of this project is to facilitate the development and electronic specification of quality measures. Autism is one of the behavioral domains included. |
| Autoimmune Disease Coordinating Committee | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA | NIGMS, CSR, FIC, NCCAM, NCI, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIMH, NINDS, NINR, OD | The purpose of the ADCC is to increase collaboration and facilitate coordination of research among NIH Institutes, Centers, and Offices; other federal agencies; and private organizations and patient advocacy groups with an interest in autoimmune diseases. |
| Avian Influenza Collaborative Project | Research Initiative | CDC, OS | FIC | This multinational research is aimed at modeling the transmission dynamics of Avian Influenza (AI) spill-over from birds to humans using field data from different regions (Asia, Africa, and Latin America). The expected project output is an ecological model for AI spill-over which will help us predict these events as well as inform and focus our global Avian and Pandemic Influenza prevention and response activities. This project, supported through Global Influenza funding from HHS, is one of the few multi-national ecological studies to develop an understanding of the critical elements of spillover and transmission of influenza which integrates diverse fields of expertise (ecologists, geospatial technology experts, modelers, virologists, and epidemiologists) and which is intended to produce a predictive model. It also supports capacity building for collaborating scientists on these three continents. By providing supplements to Fogarty grantees, this activity leverages FIC''s multi-disciplinary network of current grantees, and it promotes sample and data sharing. |
| Bacterial Waterborne and Emerging Infectious Diseases in the MENA Region | Meeting/ Workshop | CDC, FDA | NIAID | The meeting will provide a forum for exchange of current information on basic and applied research on cholera, typhoid, leptospirosis, and brucellosis, and to identify research gaps and priorities, and promote and stimulate research collaborations among scientists in the US, Europe, and MENA region. http://rarediseases.info.nih.gov/files/Agenda%20Cyprus%208-17-2010%20%282%29.pdf |
| Behavioral and Social Sciences in HIV Vaccine Clinical Research | Meeting/ Workshop | CDC | NIAID, NIMH, OD | The purpose of this workshop was to identify how HIV vaccine and Behavioral and Social Science (BSS) researchers, along with relevant communities, could undertake a more collaborative and integrative approach to the area of HIV vaccine clinical research. The workshop sought to identify challenges and opportunities as well as break new ground operationally to advance such an approach. During the 1.5 day workshop, presentations on key BSS topics, methodology, and experiences were presented and discussed. A community panel shared their experiences and insights related to trial participation and community engagement. To formulate concrete recommendations for addressing specific BSS issues in upcoming HIV vaccine clinical research, participants divided into groups to discuss the following topics: social impact, risk assessment, community engagement, informed consent, risk reduction, and special populations. |
| Behavioral Aspects of Pre-Exposure Prophylaxis (PrEP) Counseling for Intermittent Exposure | Research Initiative | CDC | NIMH | This agreement between the CDC''s National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention, and NIMH facilitates the conduct of research for the prevention and treatment of HIV/AIDS.Y1-MH-0315 |
| Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research: Pilot Research (RC4) | Research Initiative | AHRQ | NIA, NCI, NIDA, NIMH, NINDS, NINR | NIH and AHRQ under the American Recovery & Reinvestment Act of 2009 made available funding for applications to study how the principles of behavioral economics could be used to enhance the results of comparative effectiveness research among health care providers in their practice. This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH and AHRQ under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, invites applications to study how the principles of behavioral economics could be used to enhance the uptake of the results of comparative effectiveness research (CER) among health care providers in their practice. (For this FOA, applications should be thought of as large pilot or preliminary studies rather than definitive trials.) This funding opportunity seeks applications that will investigate whether the principles of behavioral economics could be used to enhance the uptake of the results CER among health care providers and also enhance the maintenance of such treatments in patient populations. Research to foster the uptake of CER is seen to be necessary given the surprisingly modest behavioral response of health care providers and health care systems to information concerning treatments or procedures judged to be superior in CER trials. An additional possible benefit is that some behavioral economic interventions to promote the uptake of CER could be far more cost effective than other approaches including some pay for performance schemes (P4P). For the purposes of this FOA, the definition of comparative effectiveness research will adhere to that adopted by the Federal Coordinating Council given at http://www.hhs.gov/recovery/programs/cer/cerannualrpt.pdf. Behavioral economics refers to the interdisciplinary efforts involving cognitive and social psychologists, decision scientists, and other social scientists together with economists to model economic decision-making and consequent actions. The approach is inclusive, since at its heart it tries to take into account what is known about how people actually make behavioral decisions rather than relying on the assumption that economic agents are fundamentally rational in the sense of expected utility theory (see, e.g.,Kahneman and Tversky’s (1979) work on Prospect Theory and Kahneman’s (2003) Nobel lecture). It is hoped that this line of research will lead to significantly greater understanding of the adoption of CER by health care providers and therefore enhance the quality of the nation’s health. Mechanism of Support. This FOA will use the ARRA-specific NIH mechanism RC4. http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-10-002.html |
| Behavioral Health and Electronic Health Records Subcommittee | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, HRSA, IHS, OS, SAMHSA | OD, CC, NCI, NIAAA, NIDA, NIMH, NINR, NLM | Behavioral health and Electronic Health Records subcommittee https://max.omb.gov/community/display/Egov/Behavioral+Health+IT+Interagency+Workgroup |
| Behavioral Health and Primary Care Integration Subgroup of the Behavioral Health Coordinating Committee | Committee, Work group, Advisory group, or Task Force | CDC, CMS, HRSA, IHS, SAMHSA | OD, NIMH | Developing cross-cutting strategies for improving integration of behavioral health care and primary care |
| Bench-to-Bedside (B2B) Program | Research Initiative | FDA | CC, NCI, NCATS, NHGRI, NHLBI, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIGMS, NIMH, NIMHD, NINDS, NINR, OD | An intramural Bench-to-Bedside Program was established in 1999 to integrate the work of basic and clinical scientists on the NIH campus and to foster collaborations across institutes. Since the program’s beginning, more than 500 principal and associate investigators have collaborated on 192 funded projects. The Clinical Center has coordinated the program for the past 13 years. Funding for the program is provided by ICs, the Food & Drug Administration, the NIH Office of Behavioral and Social Sciences Research, the Office of AIDS Research, the Office of Rare Diseases Research, the Office of Research on Women’s Health, the National Center on Minority Health and Health Disparities, the National Center for Research Resources and represents a total investment of approximately $44M. The program expanded in 2006 to encourage partnerships between intramural and extramural investigators. http://clinicalcenter.nih.gov/ccc/btb/index.html |
| Best Pharmaceuticals for Children Act | Research Initiative | FDA | NICHD, NHLBI, NIMH, OD | The Best Pharmaceuticals for Children Act (BPCA) Program is a major activity for the Obstetric and Pediatric Pharmacology Branch (OPPB), a component of the Center for Research for Mothers and Children at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). OPPB is responsible for developing and supporting a comprehensive national research and training effort to increase the knowledge base for understanding how to appropriately treat disease during pregnancy, infancy, and childhood using pharmaceuticals that are appropriately tested within their target populations. NICHD activities related to BPCA are intended to improve pediatric drug therapeutics through preclinical and clinical testing that lead to drug labeling changes. http://bpca.nichd.nih.gov/ |
| Bilateral and Multilateral Health Activities | Research Initiative | OS | NICHD, FIC, NCI, NHLBI, NIAAA, NIAID, NIDA, NIEHS, NIMH, OD | The Bilateral and Multilateral Heath Activities agreement is coordinated by the Office of Global Health Affairs (OGHA). The primary function of Bilateral and Multilateral Activities is for overall policy and coordination of HHS'' International Health issues, social and family policy activities. A committee which consists of high-ranking policy level officials, scientists and international exchange visitors get together periodically and discuss international health and social issues and make policy recommendations/decisions. |
| Bioresource Development, Validation Tools, and Integrating HTS Technology Standards in Probiotics | Research Initiative | CDC, HRSA, SAMHSA | NCCAM, NCI, NCATS, NHLBI, NIAID, NIDDK, NIEHS, OD | Collaborative efforts between the FDA/CBER and the NIH/NCCAM for substantiating health benefit claims for probiotics under INDs were placed in the framework of U01 Cooperative Agreements that began in 2008. The successful evaluation of the initiative has recently developed into an invitation to develop a Memorandum of Understanding to promote resource sharing and exchange of research expertise; development of demonstration project(s); and the initiation of trans-agency research initiatives focused on the integration of advanced molecular technologies that lead to harmonization standards and improved diagnostics for safety and substantiation of the health benefits of probiotic interventions. In 2011 a collaboration with FDA/CFSAN was initiated to expand the validation tool. |
| Board of Scientific Counselors, CDC''s National Center for Injury Prevention and Control | Committee, Work group, Advisory group, or Task Force | CDC | NIA | A member of the NIA staff serves on the Board of Scientific Counselor''s for CDC''s National Center for Injury Prevention and Control. NIA''s staffer brings expertise in behavioral and social science research, research on older adults, and abuse and neglect. http://www.cdc.gov/injury/ |
| Body Mass and Mortality Relationships | Research Initiative | CDC | NCI | A study of the relationships between categories of body mass and mortality in the U.S. population. http://epi.grants.cancer.gov/bmi/ |
| Brain Attack Coalition | Committee, Work group, Advisory group, or Task Force | CDC | NINDS | The Brain Attack Coalition is a group of professional, voluntary and governmental entities dedicated to reducing the occurrence, disabilities and death associated with stroke. The goal of the Coalition is to strengthen and promote the relationships among its member organizations in order to help people who have had a stroke or are at risk for a stroke. http://www.stroke-site.org/index.html |
| C-peptide Standardization Program | Research Initiative | CDC | NIDDK | This program aims to establish reliability in measurements of C-peptide, which is a byproduct of insulin production by beta cells and thus useful as a marker of beta cell function. In people taking insulin as therapy for diabetes, C-peptide is used to assess insulin production from the beta cell. In clinical trials of agents designed to prevent the disease in at-risk persons, or to preserve beta cell function in individuals with new onset type 1 diabetes, C-peptide is being used as the key outcome measure. |
| caBIG® Integrative Cancer Research Nanotechnology Working Group | Committee, Work group, Advisory group, or Task Force | FDA | NCI, NIBIB | The goal of this working group is to develop nanotechnology standards and guide the application of these standards in the caNanoLab nanotechnology resource. This includes developing standards for data sharing as well as standardizing terminology in nanomedicine (ontology). https://wiki.nci.nih.gov/display/ICR/Nanotechnology+Working+Group |
| caNanoLab | Resource Development | FDA | NCI, NIBIB, NIEHS | caNanoLab is a data sharing portal designed to facilitate information sharing in the biomedical nanotechnology research community to expedite and validate the use of nanotechnology in biomedicine. caNanoLab provides support for the annotation of nanomaterial''s with characterizations resulting from physico-chemical and in vitro assays and the sharing of these characterizations and associated nanotechnology protocols in a secure fashion. https://cananolab.nci.nih.gov/caNanoLab/welcome.do |
| Caregivers Survey Supplement for the National Health and Aging Trends Study | Health Survey | OS | NIA | This collaboration is designed to provide funds to support the "Caregivers Survey Supplement" for the National Health and Aging Trends Study (NHATS) U01. NHATS will exam how the daily lives of older adults change as they age. This research will help scientists understand the social and economic consequences of late-life disability for individuals, families, and society. This "supplement" will collect data from the caregivers of the participants in NHATS. http://www.nia.nih.gov/newsroom/2011/04/nih-supported-survey-study-functional-change-older-adults |
| Categorical Diagnosis in Newborn Screening | Meeting/ Workshop | CDC, HRSA | NHLBI | The goal of the workshop was to develop a consensus model to standardize the diagnostic criteria used in newborn screening tests (e.g., a test to screen newborns for cystic fibrosis). This model will facilitate decision making and the ability of states to use similar categorizations when interpreting the results of newborn screening tests. HRSA was the primary sponsor of this workshop which included other Federal Partners (CDC, and NIH) and representatives from academia. http://www.genome.gov/10001755 |
| CDC Chronic Kidney Disease Surveillance | Health Survey | CDC | NIDDK | NIDDK assists CDC in their surveillance program of chronic kidney disease. http://www.cdc.gov/diabetes/projects/kidney.htm |
| CDC Community Guide: Review Various Interventions to Reduce Alcohol-Related Problems | Committee, Work group, Advisory group, or Task Force | CDC, SAMHSA | NIAAA, NIDA | The Community Guide is a free resource to help people choose the most effective programs and policies to improve health and prevent disease in their communities. http://www.thecommunityguide.org/index.html |
| CDC-NIH Lyme Disease Serum Sample Repository | Other | CDC, OS | NIAID | Initiated in 2008, this resource was made available to the scientific community on a broad basis in late 2011. Lyme disease and related serum samples are available upon request for testing and comparison of new and current diagnostic tests with a common serum sample set for standardization. Samples are distributed by the CDC. CDC and NIH both provided support to acquire the samples and continue to work together to ensure the scientific community has access to samples needed for Lyme disease diagnostic test development. |
| Center for Excellence Expert Panel, Substance Abuse and Mental Health Services Administration (SAMHSA) Fetal Alcohol Spectrum Disorders Center for Excellence (FASD CE) | Meeting/ Workshop | SAMHSA | NIAAA | The NIAAA Deputy Director serves on the FASD Center for Excellence Expert Panel which provides advice and guidance to SAMHSA on a range of issues related to FASD and the SAMHSA FASD CE. http://www.fasdcenter.samhsa.gov/ |
| Center for International Blood and Marrow Transplant Research (CIBMTR) Advisory Committee | Committee, Work group, Advisory group, or Task Force | HRSA | NCI, CC, NHLBI, NIAID | Staff from NCI, NHLBI and NIAID serve on the Advisory Committee for the Center for International Blood and Marrow Transplant Research (CIBMTR), to provide oversight of the international bone marrow transplant registry. http://www.cibmtr.org/ |
| Center for Substance Abuse Treatment (CSAT) Hispanic Stakeholders Committee | Committee, Work group, Advisory group, or Task Force | SAMHSA | NIDA | Committee set up by Center for Substance Abuse Treatment (CSAT) to advise CSAT director on issues pertaining to Hispanic drug abuse treatment needs. http://www.nlatinoaddiction.org/index.asp |
| Centers for Medicare & Medicaid Services (CMS) Demonstration Project | Research Initiative | CMS | NICHD, NINDS | Initiative to design Centers for Medicare & Medicaid Services (CMS) demonstration projects to explore new healthcare delivery options and payment strategies as directed by the Patient Protection and Affordable Care Act. This work is currently under development. |
| Chemical Hazards Emergency Medical Management (CHEMM) | Resource Development | ATSDR, CDC, OS | NLM | This activity is to develop a comprehensive web resource: Chemical Hazards Emergency Medical Management (CHEMM) is a tool designed to provide access to comprehensive sets of information about chemical hazards via a user-friendly interface. http://chemm.nlm.nih.gov |
| Child Abuse and Neglect Working Group (CANWG) | Committee, Work group, Advisory group, or Task Force | ACF, HRSA, SAMHSA | NICHD, CSR, NIAAA, NIDA, NIMH, NINDS | The NIH Child Abuse and Neglect Working Group (CANWG) was established in response to a recent directive by the House Committee on Appropriations, which requested that NIH report on current NIH efforts, accomplishments, and future plans for research on child abuse and neglect. The CANWG is co-chaired by program staff from NICHD and NIDA (formally NIMH). The working group is also a subcommittee of the Federal Interagency Workgroup on Child Abuse and Neglect. http://obssr.od.nih.gov/funding_opportunities/requests_for_applications/child_neglect_RFA.aspx |
| Childhood Cancer Among Children with Birth Defects in California | Research Initiative | CDC | NCI | In collaboration with investigators from the Birth Defects Branch, CDC, Stanford University and the Northern California Cancer Center, a registry study has been undertaken that links data from the California Birth Defects Registry and the California State Cancer Registry to quantify risks of total and specific types of pediatric cancer associated with structural birth defects according to phenotype. |
| Children''s Environmental Health Task Force Chemical Exposures Workgroup | Committee, Work group, Advisory group, or Task Force | ATSDR, CDC, FDA, OS | NIEHS, NIAID, NICHD | An interagency collaboration to examine potentially unrecognized health threats to children from environmental exposures |
| Children''s Mental Health | Research Initiative | CDC | NIMH | The purpose of this agreement is to provide funds for continued support by the CDC for data collection, analysis, and dissemination of results from a study on children identified with mental disorders/conditions in the National Survey of Children with Special Health Care Needs. Y1-MH-0301 |
| Chronic Fatigue Syndrome Advisory Committee (CFSAC) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA, OS | OD, NCCAM, NCI, NCATS, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR | The Chronic Fatigue Syndrome Advisory Committee (CFSAC) provides advice and recommendations to the Secretary of Health and Human Services via the Assistant Secretary for Health of the U.S. Department of Health and Human Services on issues related to chronic fatigue syndrome (CFS). These include: 1) factors affecting access and care for persons with CFS; 2) the science and definition of CFS; and 3) broader public health, clinical, research and educational issues related to CFS. http://www.hhs.gov/advcomcfs/ |
| Chronic Toxicity Test for Bisphenol A | Research Initiative | FDA | NIEHS | The FDA will assess BPA toxicity using a two year exposure starting during gestation in SD rats; this will be a GLP ("good laboratory practice") guideline study. The NIEHS has funded twelve researchers who will add specific disease associated endpoints to the standard guideline study. |
| Clinical and Translational Science Awards (CTSA) Comparative Effectiveness Research Key Function Committee | Committee, Work group, Advisory group, or Task Force | AHRQ, HRSA | NCATS, CC, NCCAM, NCI, NHLBI, NIA, NIDDK, NIMH | The Comparative Effectiveness Research (CER) Key Function Committee builds the field of CER for patient centered outcomes research by creating a learning community across Clinical and Translational Science Award (CTSA) institutions, spurring the development of methods, expanding training and education, promoting community and public engagement, and application of CER findings and sharing successes and lessons learned. Through collaborative work products, the CER Key Function Committee facilitates the generation and synthesis of evidence about alternative interventions that results in actionable findings for policymakers, clinicians, patients, and purchasers to use in improving the quality and outcomes of health care. https://www.ctsacentral.org/committee/comparative-effectiveness-research |
| Clinical and Translational Science Awards (CTSA) Education and Career Development Key Function Committee | Committee, Work group, Advisory group, or Task Force | FDA | NCATS, CC, NCCAM, NCI, NHLBI, NIAAA, NIDCR, NIDDK, NIMH, NINR | The CTSA Education and Career Development Key Foundation Committee supports interdisciplinary education, training, and career development in Clinical and Translational Science. The committee provides a forum to discuss novel concepts, methodologies and approaches in curriculum development, program development, clinical research training and recruiting. The annual Translational Science Meetings for scholars provide networking opportunities for junior investigators to interact with the Association for Clinical Research Training, Association of American Medical Colleges, Industry, and federal agencies which share complementary training programs https://www.ctsacentral.org/committee/education-and-career-development |
| Clinical and Translational Science Awards (CTSA) Regulatory Knowledge Key Function Committee | Committee, Work group, Advisory group, or Task Force | FDA | NCATS, CC, NCI, NHGRI, NIAID, NIBIB, NICHD, NIDDK, NLM, OD | The CTSA Regulatory Knowledge Key Function Committee will promote the protection of human subjects and facilitate communicating shared regulatory compliance issues and improvements. Clinical research regulation issues addressed may include the provision of integrated training, services, or tools for protocol and informed consent authoring and translation, adverse event reporting, safety and regulatory management and compliance, etc. CTSAs can disseminate best practices that reduce or remove institutional impediments to clinical and translational research which would enhance inter-institutional collaborations. Regulatory support provided through a CTSA should assist investigators in their regulatory process and documentation requirements. The CTSA Regulatory Knowledge Key Function Committee will also ensure that collaborative clinical and translational research activities are facilitated, whether by procedures or best practices, in developing the Regulatory Support interactions with the IRB and compliance office without loss of participant protections. https://www.ctsacentral.org/committee/regulatory-knowledge-0 |
| Clinical Data Acquisition Standards Harmonization (CDASH) Initiative led by Clinical Data Interchange Standards Consortium (CDISC) | Committee, Work group, Advisory group, or Task Force | FDA | NCI | Harmonization efforts to standardize elements for data capture. http://www.cdisc.org/ |
| Clinical Decision Support (CDS) Federal Collaboratory and Inventory of Federal Clinical Decision Support Activities | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, HRSA, IHS, OS | NLM, CC | A federal community of interest focused on clinical decision support, and a compilation of project summaries describing CDS activities that are either funded by the US Federal government, or that are being executed by agencies of the government. The term Clinical Decision Support (CDS) describes a variety of tools and technologies that are used within electronic clinical information systems to improve the quality, safety, efficiency and effectiveness of patient care. CDS provides clinicians, staff, patients, and other key decision makers with knowledge and person-specific information, intelligently filtered at appropriate times, to enhance health and health care. CDS encompasses computerized alerts and reminders, clinical guidelines, order sets, order entry feedback, patient data reports and dashboards, documentation templates, diagnostic support, and the presentation of contextually relevant reference information within clinical information systems. NLM has submitted to the Collaboratory and Inventory summaries of NLM projects involving Clinical Decision Support. http://healthit.hhs.gov/portal/server.pt/community/healthit_hhs_gov__cds/1218 |
| Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NIAID | Objective: To discuss a range of issues relevant to the development of antiviral drugs for the treatment of influenza. |
| Clinical Islet Transplantation Consortium | Research Initiative | CMS, FDA | NIDDK, NIAID | "The Clinical Islet Transplantation (CIT) Consortium is a network of clinical centers and a data coordinating center established in 2004 to conduct studies of islet transplantation in people with type 1 diabetes. Studies conducted by the CIT Consortium will focus on improving the safety and long-term success of methods for transplanting islets, the insulin-producing cells of the pancreas, in people whose own islets have been destroyed by the autoimmune process that characterizes type 1 diabetes. One clinical trial, in particular, is studying the efficacy of islet transplantation after kidney transplantation. Participants may include Medicare beneficiaries. This study was mandated in the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. " http://www.citisletstudy.org |
| CMS-NIH Collaborations on CMS Innovation Center | Committee, Work group, Advisory group, or Task Force | CMS | OD, CC, NCCAM, NCI, NCATS, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NINR, NLM | The Innovation Center aims to test innovative payment and service delivery models to reduce program expenditures under Medicare, Medicaid and CHIP, while preserving or enhancing the quality of care furnished. CMS and NIH have been discussing potential approaches to NIH collaboration with various Innovation Center Initiatives including the Health Care Innovation Challenge and the State Innovation Program. The Health Care Innovation Challenge, released in November 2011, makes up to $1 billion available, and will be awarded to innovative projects testing creative approaches to delivering high-quality health care services, at lower cost, with priority to projects that hire, train, and deploy new types of health care workers. The State Innovation Program (SIIP) FOA was released in January, 2012, offering States the opportunity to participate directly in multi-payer delivery system strategies, and to design models that achieve the radical shift towards prevention. The program aims to accelerate healthcare system transformation and reduce healthcare cost. The initiative has a five year program life cycle with a total budget of $1.3 billion. NIH has proposed high impact areas and results that could be rapidly implemented on larger scales, including: diabetes (i.e. the Diabetes Prevention Program), schizophrenia (i.e. RAISE trial), stroke, lung cancer (i.e. the National Lung Cancer Spiral CT Screening Trial), and prevention of pre-term birth. Currently, CMS and NIH are collaborating to develop randomized controlled clinical policy trials: novel, low cost practical trials that can drive reform. NIH, in collaboration with CMS is developing a PAR on Large, Inexpensive, Pragmatic Randomized Controlled Policy Trials, as a new way to develop evidence-based policy. This solicitation will represent a first steps to jointly leveraging CMS and NIH strengths. Simple, pragmatic trials, with minimal inclusion and exclusion criteria, will assist NIH and CMS in capturing patients similar to the ones seen in everyday practice, and help capture information on large populations with multiple co-morbidities. |
| CMS-NIH Data Access Committee | Committee, Work group, Advisory group, or Task Force | CMS | OD, CC, NCCAM, NCI, NCATS, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NINR, NLM | Much scientific and policy value could be generated from observational studies which could be based, at least in part, on available CMS data. NIH and CMS established a Data Access Committee to identify and pursue immediate priorities. The Committee has been meeting monthly for the past year. Working Groups are focusing on: a) Identification of data and endpoints in NIH supported trials which would be useful to CMS; b) Identification of types of CMS data and linkages that could prove useful to NIH-supported investigators; c) Design and operation of data enclaves, trusted entities status, and other data security measures; d) Strategies for informing communities of available CMS data, and CMS staff contacts; e) Anticipating natural experiments (e.g. health care reform, geographic variation) Current initiatives include planning a workshop on enclave development and data linkage, aimed at gathering input from researchers who use CMS data; exploring options for jointly establishing a virtual laboratory at Oak Ridge National Labs, and developing an Early Alert System for CMS regarding Anticipated High Impact Clinical Research Findings, using clinicaltrials.gov. |
| CMS-NIH Senior Leadership Forum | Committee, Work group, Advisory group, or Task Force | CMS | OD, NHLBI, NIA | A “CMS-NIH Senior Leadership Forum” comprised of NIH Director Francis Collins, CMS Administrator Don Berwick, and Senior Staff from both agencies, convened quarterly throughout 2011. The Forum aimed to: a) Oversee establishment of joint collaborations to enable rapid translation and implementation of NIH-funded research into clinical practice; b) Stimulate collaboration between NIH and the “CMS Innovation Center” to forge pilot projects; c) Undertake efforts to rapidly identify, design, and execute studies to inform high-priority CMS questions; and d) Enhance research access to CMS data, including making available the establishment of secure CMS data enclaves to qualified NIH investigators. The two agencies look forward to planning a series of important new initiatives. To ensure a successful, longstanding collaboration, a “CMS-NIH Brain Trust” is under development, intended to span NIH ICs and CMS Centers, and to allow for interagency brainstorming. (ATTACHMENT) The Brain Trust will engage in dialogue on CMS needs and NIH research prioritization, and forge joint efforts to develop innovative trials and coverage mechanisms. Working Groups have been/are being, established to focus on data access, health economics, multiple chronic conditions, evaluation, and collaborating with the CMS Innovation Center. |
| Collaboration with SAMHSA on Talk Early, Talk Often, Get Others Involved Underage Drinking Campaign for Parents | Public Education Campaign | SAMHSA | NIAAA | NIAAA collaborated with SAMHSA on its most recent underage drinking prevention ad campaign for parents, providing detailed input on the development and content of the accompanying web site as well as other aspects of the campaign. http://underagedrinking.samhsa.gov/ |
| Collaboration with the Center for Emergency Medical Research | Committee, Work group, Advisory group, or Task Force | OS | NICHD, NINDS | Consultant to Research Subcommittee for needs of children in disasters, surge capacity, and some consultative efforts on specific problems/conditions/diseases in disaster preparedness. http://bolivia.hrsa.gov/emsc/ |
| Collaborative Islet Transplant Registry Ad Hoc Scientific Advisory Committee | Committee, Work group, Advisory group, or Task Force | FDA, HRSA | NIAID, NIDDK | Provides scientific direction to the Registry on an Ad Hoc basis. |
| College and University Drinking and Substance Abuse Workgroup | Committee, Work group, Advisory group, or Task Force | SAMHSA | OD, NIAAA, NIDA | Identifying cross-cutting strategies to reduce alcohol and drug use among college students |
| Combination Biomedical HIV Prevention Modalities: Research Design and Ethical Considerations | Meeting/ Workshop | CDC | NIAID, NIMH, OD | The purpose of this workshop was to review the potential impact of recent successful HIV prevention modalities on the design of subsequent prevention research studies, explore how these prevention modalities might affect the operational and ethical considerations of future prevention research, and identify research gaps and potential collaborations among prevention scientists working in multi-modality HIV prevention research. Potential topics to be discussed include: design of prevention trials (complexity of trials, sample size determinations, and choosing appropriate outcome measures); ethics of prevention trials (informed consent process, recruitment/retention, coercion, and standard of care delivery to trial participants); modeling the impact of multi-modalities on prevention studies; and integrating one or more prevention modalities into future prevention studies. |
| Committee to Develop Guidelines for Preconception Care for HIV-Positive Women | Committee, Work group, Advisory group, or Task Force | CDC | OD/DPCPSI/OAR, NICHD, OD | A multi-disciplinary collaborative committee that designed the national guidelines for preconception care for HIV-infected women |
| Committee Work with HHS Office of the National Coordinator for Health Information Technology (ONC) | Committee, Work group, Advisory group, or Task Force | OS | NLM | NLM is collaborating with OS and HHS Office of the National Coordinator for Health Information Technology (ONC) on developing and disseminating regulatory language related to health information technology, meaningful use and standards and certification criteria related to electronic health records and messaging. http://www.nlm.nih.gov/healthit.html |
| Community Health Worker Initiative | Public Education Campaign | HRSA, IHS | NHLBI | The Community Health Worker (CHW) Initiative supports activities to reduce disparities in cardiovascular risk factors and asthma in African American, Latino, American Indian, and Filipino population groups. The project uses formative research (literature reviews, focus groups, and workshops) to inform the development and implementation of approaches that integrate CHW activities into the broader health workforce to improve cardiovascular health and reduce asthma disparities. http://www.nhlbi.nih.gov/health/pubs/pub_slctpro.htm |
| Community Participation in Research (R01) | Research Initiative | CDC | NICHD, NCI, NHLBI, NIAAA, NIDA, NIDCD, NIDCR, NIEHS, NINR | Solicit grant applications that propose intervention research on health promotion, disease prevention, and health disparities that communities and researchers jointly conduct. http://grants.nih.gov/grants/guide/pa-files/pa-08-074.html |
| Comparative Effectiveness Research Committee | Committee, Work group, Advisory group, or Task Force | AHRQ, CMS, FDA | OD, CC, NCCAM, NCI, NCATS, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NINR, NLM | The NIH Comparative Effectiveness Research Coordinating Committee (CER CC) was established in 2008 at the request of the NIH Director. Its members include NIH Institute and Center (IC) Directors and high level senior staff. Its charge is to coordinate ongoing CER initiatives across the agency, develop a long term research vision for CER, implement collaborative initiatives with sister agencies, determine appropriate definitions, policies and guidance relative to CER, administer the CER funds awarded through ARRA, and track the outcomes of those projects. The CER CC has organized meetings with AHRQ, CMS, VA and FDA to discuss potential strategic collaborations. |
| Comparison of AMD Treatment Trials | Research Initiative | CMS | NEI | Head-to-head Comparative Effectiveness Trial between two chemically related ant-VEGF treatments for Age-related Macular Degeneration http://www.nei.nih.gov/catt/ |
| Computational Toxicology for NIH Medications Discovery | Research Initiative | FDA | NIDA | Through an Inter-Agency Agreement, the FDA provides structure-activity relationship-based toxicity predictions for compounds that are under evaluation in the NIDA Addiction Treatment Discovery Program. On a limited basis, other NIH ICs may utilize this resource by working through NIDA. |
| Computer-aided Diagnosis for Radiology Images | Research Initiative | FDA | CC | The collaboration focuses on the improvement of computer-aided diagnosis for radiology images. Specific applications include computer-aided polyp detection for CT colonography, improvements in the conduct and analysis of observer performance experiments using radiology images and the use and development of advanced machine learning and receiver operating characteristics methods with application to computer-aided diagnosis. http://www.cc.nih.gov/about/SeniorStaff/ronald_summers.html |
| Conducting Comprehensive Toxicological Assessments | Research Initiative | FDA | NIEHS | The purpose of this Agreement is to conduct, at FDA/NCTR, comprehensive toxicological assessments on FDA priority chemicals/agents nominated to the National Toxicology Program. Studies can include range finding sub-chronic and chronic, compound-specific mechanistic studies, and consideration of the use of alternate test systems. This combination of studies is designed to facilitate the interpretation of study results in support of comprehensive quantitative human health risk assessments. The primary goal of this program is to develop a comprehensive scientific data base that can be utilized to reduce the uncertainty in risk assessment/risk benefit analysis for specific chemicals with high FDA impact. |
| Congenital Heart Public Health Consortium | Other | AHRQ, CDC | NHLBI | The Congenital Heart Public Health Consortium (CHPHC) is a group of organizations uniting resources and efforts in public health activities. The CHPHC mission is to prevent the occurrence of congenital heart disease (CHD) and to enhance and prolong the lives of those with CHD through surveillance, population-based research, education, health promotion, advocacy, and policy development. http://www.medicalhomeinfo.org/national/pehdic/chphc.aspx |
| CONNECT EHR (Electronic Health Records) Interoperability Special Interest Group (EHRI SIG) | Committee, Work group, Advisory group, or Task Force | OS | NLM | CONNECT continues to expand and grow in line with the CONNECT Community''s needs and in conjunction with the developments of the Nationwide Health Information Network. To support building out secure and easy-to-implement health information exchange among physicians, patients (personal health record), labs and pharmacies, the CONNECT program created the Electronic Health Record Interoperability Special Interest Group (EHRI SIG). The EHRI SIG was formed to ensure the interoperability requirements for EHR and related solutions are successfully incorporated into CONNECT as it continues to evolve to focus on the end-user experience. Members of the EHRI SIG will work together to achieve interoperability of EHR systems in line with Nationwide Health Information Network standards and specifications using the CONNECT solution. The Director of the NLM Lister Hill National Center for Biomedical Communications serves on the EHRI SIG. http://www.nlm.nih.gov/medlineplus/connect/medlineplusconnecthandout.pdf |
| Consulting on Natural History of Human Papillomavirus (HPV) | Other | CDC | NCI | NCI scientists provided scientific expertise on the natural history of human papillomavirus (HPV). http://www.cdc.gov/hpv/cancer.html |
| Coordinating Committee on Women''s Health (CCWH) | Committee, Work group, Advisory group, or Task Force | ACF, AoA, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | OD | The Coordinating Committee on Women''s Health (CCWH) advises the Assistant Secretary for Health on current and planned activities across HHS that safeguard and improve the physical and mental health of women and girls. http://orwh.od.nih.gov/about/coord.html |
| Council on Emergency Medical Care | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | NINDS, NCATS, NHLBI, NICHD, NIGMS, NIMH | Provides strategic and operational support to the HHS Emergency Care Coordinating Committee (ECCC) through policy-level guidance and interdepartmental and interagency collaboration for ongoing and future Federal efforts that address daily emergency medical care issues in the US. http://www.phe.gov/Preparedness/planning/eccc/Pages/cemc.aspx |
| CounterACT (Countermeasures Against Chemical Threats) | Committee, Work group, Advisory group, or Task Force | OS | NICHD, NHLBI, NIAID, NIAMS, NIEHS, OD | OB-Pediatric representative on the program staff of the CounterACT section of NINDS. Function is to prioritize/fund/manage studies focusing on the development of medical countermeasures (MCMs) for protection against chemical agents. http://www.ninds.nih.gov/research/counterterrorism/counterACT_home.htm |
| Countermeasures Against Chemical Threats (CounterACT) Research Network Annual Symposium | Meeting/ Workshop | CDC, FDA, OS | NINDS, NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, OD | This workshop was organized by NINDS as part of the Countermeasures Against Chemical Threats (CounterACT) Research Network, a group formed to conduct basic, translational, and clinical research aimed at the discovery and/or identification of better therapeutic and diagnostic medical countermeasures against chemical threat agents. The 3-day meeting allowed researchers to share information, encouraged collaboration, and enabled NIH staff to evaluate the group’s progress on themes such as nerve agents, seizure detection technology, cyanide, and sulfur mustard. http://www.edjassociates.com/counterAct2011/home.asp |
| Crafting Integrated Chronic Disease Strategies Using System Dynamics | Training Initiative | ACF, CDC, HRSA, OS, SAMHSA | OD, NHLBI, NICHD, NIDDK, NLM | A one-day educational workshop to provide public health officials with an introduction to system dynamics modeling for research and practice. |
| Creutzfeldt-Jakob Disease Surveillance in Recipients of Human Growth Hormone, National Hormone and Pituitary Program (NHPP) | Resource Development | CDC, FDA | NIDDK | "From 1963 to 1985, the National Hormone and Pituitary Program (NHPP), funded by the U.S. Department of Health and Human Services (HHS), sent hGH (human growth hormone) made from human pituitary glands to hundreds of doctors across the country. As a part of research studies, doctors used the hormone to treat nearly 7,700 children for failure to grow. In 1985, the HHS learned that three people treated with pituitary hGH died of CJD (Creutzfeldt-Jakob Disease), a rare, incurable brain disease. The HHS immediately stopped distributing the hormone and began a national study to learn more about how pituitary hGH treatment may have caused this problem. " http://endocrine.niddk.nih.gov/pubs/creutz/update.htm |
| Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS) | Research Initiative | SAMHSA | NIDA | Research network seeking to determine the best way to integrate evidence-based drug abuse treatment into criminal justice settings including practices related to screening and assessment, HIV intervention, and medication assisted treatment for opioid dependence. http://www.cjdats.org/Wiki%20Pages/Home.aspx |
| DailyMed | Other | FDA | NLM | DailyMed provides high quality information about marketed drugs, including FDA labels (package inserts). The Web site provides health information providers and the public with a standard, comprehensive, up-to-date, look-up and download resource of medication content and labeling as found in medication package inserts. NLM provides this DailyMed a public service, free of advertising. http://dailymed.nlm.nih.gov/dailymed/about.cfm |
| Data Access for Grantees | Resource Development | CMS | NIA | NIA developed this MOU to assist grantees with accessing CMS data. It is anticipated that this initiative will create a more user friendly and more cost efficient means for grantees to access CMS data especially the need to access Part D data. Specifically, this MOU gives CMS''s Privacy Board justification to release Part D data to NIA grantees with Data Use Agreements. Researchers pay for data use. |
| Data Mining on FDA''s 510K Documents for Laboratory Tests | Research Initiative | FDA | NLM | U.S. Food and Drug Administration (FDA) provides a large corpus of text about decision summaries on the applications for in vitro diagnostic (laboratory) products. This corpus of text contains valuable information about the nature of laboratory testing devices and test products such as analyte and specimen names that are tested, unit of measures, and analyte detection limits of the presented devices and products. In this project NLM is trying to recognize and extract this information algorithmically and provide them to the operators who are responsible to collect this information and enter it into the LOINC database manually. |
| Data Sample and CMS Link for the National Health and Aging Trends Study | Research Initiative | CMS | NIA | This collaboration is designed to provide a sample and to link CMS data to participants who consent to participate in the National Health and Aging Trends Study (NHATS). NHATS will exam how the daily lives of older adults change as they age. This research will help scientists understand the social and economic consequences of late-life disability for individuals, families, and society. |
| Defining Appropriate Outcome Measures for Older Persons with Multiple Chronic Conditions | Meeting/ Workshop | AHRQ | NIA | Inter-Agency Agreement between Agency for Healthcare Research & Quality and National Institute on Aging, NIH. The purpose of this Inter-Agency Agreement (IAA) is to authorize the transfer of funds appropriated for the Agency for Healthcare Research and Quality (AHRQ) to the National Institute on Aging (NIA/NIH), in order to support an expert panel meeting, as well as products and activities resulting from this event, that will assess the current state of available metrics for individuals with multiple chronic conditions, prioritize usable measures based upon stakeholder needs, and foster the development or refinement of additional promising outcome measures. The findings from this event should have broad applicability and uptake in research, clinical care, and program evaluation efforts to improve the health of the population burdened by multiple chronic conditions. |
| Demand Reduction Interagency Working Groups | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | NIDA, NIAAA | To encourage greater cross-talk and Agency participation in developing the National Drug Control Strategy, ONDCP reconstituted its demand reduction workgroups focusing on prevention, emerging threats, healthcare delivery, justice systems, military veterans and their families, and performance and accountability measures. NIDA staff have participated in all of these working groups. http://www.whitehouse.gov/open/around/eop/ondcp/plan |
| Detection of Cognitive Impairment: The Search for an Evidence-Based Screening Tool | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS | NIA, NIMH, NINDS, NINR | In January 2011, a New Requirement in the Medicare Annual Wellness Visit is for an Evidence-Based Screening Tool for the Detection of Cognitive Impairment. This new requirement was included in Public Law 111 - 148, the Patient Protection and Affordable Care Act as an additional element under Sec. 4103: Medicare Coverage of Annual Wellness Visit Providing a Personalized Prevention Plan. The Centers for Medicaid and Medicare Services (CMS) noted that in their solicitation for public comments before implementing the new regulation, the definition of cognitive impairment in the statute “was vague and commenters suggested adding a standardized screening tool.” The law only stipulates that providers assess an individual’s cognitive function by “direct observation, with due consideration of information obtained by way of patient report, concerns raised by family members, friends, caretakers, or others.” Most providers routinely use these methods during outpatient visits to assess general well-being and function, but are not always effective in specifically detecting cognitive impairment. Other concerns with this subjective method include false positive findings and questionable, expensive neurological workups. CMS and others, therefore, have identified the need for some standardized instrument or set of tools that could be used by providers. Since the annual wellness visit is scheduled for 45 minutes and has other required elements, the tool would need to be short, with no associated cost, easy to administer, sensitive to change over time, and normed for use in the Medicare beneficiary population. The National Institute on Aging (NIA) at the National Institutes of Health completed a comprehensive review of over 140 published cognitive screening tools to determine the level of evidence to support an instrument or set of instruments that could be used by providers. The review included the critical components identified by CMS as well as other psychometric properties. On October 31, 2011, NIA presented its findings to a large group of researchers, providers, federal policy staff, and other stakeholders for evaluation. Based on the questions raised and input provided by this group, NIA is continuing to add to the information on each tool and will provide additional information as it becomes available. |
| Development of Chemical Emergency Medical Management Website | Committee, Work group, Advisory group, or Task Force | OS | NICHD, NEI, NIA, NIDA | This website is being developed under the auspices of the National Library of Medicine SIS Division. Additional funding is provided by the Biomedical Advanced Research and Development Authority (HHS). NICHD staff is detailed to assist the NLM in its development with primary responsibility for the creation of the medical management guidelines component. |
| Development of In-Vitro Assays to Assess the Potency of Botulinum Neurotoxin Type A | Research Initiative | FDA | NINDS, NIAID | This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop new non-animal-based assays to assess the potency of botulinum neurotoxin type A (BoNT/A) in a Good Manufacturing Practice (GMP) commercial environment. (STTR [R41/R42]) [PA-09-178], (SBIR [R43/R44]) [PA-09-179] http://grants.nih.gov/grants/guide/pa-files/PA-09-179.html |
| Development of Quality Measures for Post-Traumatic Stress Disorder (PTSD) | Other | OS | NIMH | The purpose of the ASPE-NIMH project is to develop a set of at least four validated quality measures for post-traumatic stress disorder (PTSD). These measures will specifically focus on ambulatory care provided to adult PTSD clients and paid for by state Medicaid programs. Since HHS will submit the measures to the National Quality Forum (NQF) for their endorsement, the measures will be in full compliance with the NQF measure evaluation criteria. Y1-MH-1319 |
| DHHS Behavioral Health Coordinating Committee Pharmaceutical Abuse Subcommittee Surveillance Report Team | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS, SAMHSA | NIDA | DHHS Behavioral Health Coordinating Committee formed a Pharmaceutical Abuse Subcommittee in 2010. In March 2011, the subcommittee established a surveillance team with representatives from participating agencies to develop and update a report about the main sources of data including measures of the availability of treatment services, to identify challenges with the databases and to develop strategic plans for improving the databases. |
| DHHS Childhood Overweight and Obesity Prevention Council | Public Education Campaign | ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG | NIDDK | This coordinating committee works with community stakeholders to develop and foster programs that share the goal of providing options for community-based interventions. http://www.surgeongeneral.gov/obesityprevention |
| DHHS Health Care Personnel Influenza Vaccination Task Force | Committee, Work group, Advisory group, or Task Force | OS | CC | This committee is charged with developing strategies to improve the fraction of healthcare professionals who are vaccinated with the influenza vaccine. |
| DHHS Healthcare Infection Control Practices Advisory Committee (HICPAC) | Committee, Work group, Advisory group, or Task Force | OS | CC | This committee serves as the major policy advisory committee in the nation for healthcare epidemiology. |
| DHHS Steering Committee for the Prevention of Healthcare-Associated Infections | Committee, Work group, Advisory group, or Task Force | OS | CC | This committee is charged with developing a national action plan for addressing the important problem of healthcare-associated infections. |
| DHHS Women''s Health and the Environment Interagency Committee | Committee, Work group, Advisory group, or Task Force | ATSDR, CDC, FDA, HRSA, IHS, OS | NIEHS, NCI, NICHD, OD | There is abundant evidence that environmental factors may contribute to a variety of diseases in women, including breast and ovarian cancers, osteoporosis, endometriosis, uterine fibroids and autoimmune diseases. Many Federal agencies and offices are working to address these environmental and often preventable threats to women''s health. The DHHS Office on Women''s Health established the Federal Interagency Working Group on Women''s Health and the Environment (FIWGWHE) in 1994 to coordinate and focus Federal action in this area. |
| Diabetes Autoantibody Standardization Program (DASP) | Research Initiative | CDC | NIDDK | The aim of DASP is to improve the measurements of the autoantibodies predictive of type 1 diabetes, and to decrease laboratory-to-laboratory variation. In combination with genetic screening, autoantibody tests are used to identify individuals at elevated risk of developing type 1 diabetes and to characterize autoimmunity. |
| Diabetes Mellitus Interagency Coordinating Committee (DMICC) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS | NIDCR, CSR, NCCAM, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM, OD | The DMICC facilitates cooperation, communication, and collaboration on diabetes among these government entities. DMICC meetings, held several times a year, help members identify emerging issues and opportunities and develop ways in which different government components can work together and build upon each other’s expertise and resources. This approach helps ensure that federal diabetes activities are coordinated and not duplicated, as well as stimulates collaborations where appropriate. http://www2.niddk.nih.gov/AboutNIDDK/CommitteesAndWorkingGroups/DMICC/ |
| Diabetes Prevention Program (DPP) and Diabetes Prevention Program Outcomes Study (DPPOS) | Research Initiative | CDC, IHS | NIDDK, NCATS, NEI, NHLBI, NIA, NICHD, NIMHD, OD | The DPP showed that lifestyle change or metformin delay the development of type 2 diabetes. The Diabetes Prevention Program Outcomes Study is studying the long term effect of diet and exercise and the diabetes medication, metformin, on the delay of type 2 diabetes in participants of the DPP. http://www.bsc.gwu.edu/dpp/index.html |
| Diabetic Retinopathy Clinical Research Network | Research Initiative | OS | NEI, NIDDK | The Diabetic Retinopathy Clinical Research Network (DRCR.net) is a collaborative network dedicated to facilitating multicenter clinical research of diabetic retinopathy, diabetic macular edema and associated conditions. The DRCR.net supports the identification, design, and implementation of multicenter clinical research initiatives focused on diabetes-induced retinal disorders. Principal emphasis is placed on clinical trials, but epidemiologic outcomes and other research may be supported as well. The network is funded by the NEI, and co-funded by OS, through NIDDK, with the Special Funding Program for Type 1 Diabetes Research. http://drcrnet.jaeb.org/ViewPage.aspx?PageName=Home |
| Dietary Supplements Federal Workgroup | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA, SAMHSA | NCCAM, NCI, NCATS, NHLBI, NIDDK, NIEHS | The ODS Federal Workgroup meets quarterly to review Guidelines for Dietary Supplements (botanics, probiotics/prebiotics; vitamins) reference standards. Collaborative initiatives, state of the science topics, conferences, and workshop are also discussed. http://ods.od.nih.gov/ |
| Dietary Supplements Ingredient Database (DSID) | Resource Development | CDC, FDA | OD, NCI | The database provides statistical estimates—based on chemical analysis—of the nutrient content of selected ingredients in dietary supplements, compared with label-reported ingredient levels. Currently the DSID provides estimated levels of 18 vitamin and mineral ingredients derived from analytical data for 115 representative unspecified adult multivitamin/multimineral supplements (MVMs). Additional dietary supplement ingredients will be included in future releases of the database. http://ods.od.nih.gov/News/DSID_Announcement.aspx |
| Digital Quantitation of Plasma Cells in Marrow Biopsies | Research Initiative | FDA | CC | Collaboration with M Choi, WC Cheng and A Badano from the Imaging Physics Lab, Divison of Imaging and Applied Mathematics Office of Science and Engineering Labs, CDRH, FDA. The project consists of developing software and establish validations for the automated determination of marrow cellularity and enumeration of plasma cells identified by immunohistochemistry (IHC) using a CD138 antibody. This initial effort should serve as proof of principle for a broader plan to utilize IHC-based automated quantitation of different types of cells in bone marrow core biopsies for diagnosis, prognosis and therapy monitoring of marrow disorders. |
| Disconnected Youth and Gangs in the United States | Research Initiative | ACF | NICHD | This Inter-Agency Agreement (IAA) is to provide Fiscal Year 2011 funding to the NIH, NICHD for the award and management of one Phase 1 SBIR grant. The NICHD agrees to perform the grant award and management services for the Administration for Children and Families for this Phase 1 Small Business Innovation Research project entitled, "Disconnected Youth and Gangs in the United States". http://www.researchgrantdatabase.com/g/1R43HD061937-01A2/DISCONNECTED-YOUTH-AND-GANGS-IN-THE-UNITED-STATES/ |
| Domestic Scheduling to Control New Drugs of Abuse, with NIDA-Funded Testing Conducted in Support of Drug Enforcement Administration (DEA) Scheduling Recommendations to the FDA | Research Initiative | FDA, OS | NIDA | HHS depends upon NIDA contracts to generate the in vitro and animal behavioral data that are required to support the domestic scheduling of new street drugs. The long-standing agreement is that DEA provides the drugs (or the funds to cover drug synthesis) to NIDA, and NIDA covers the cost of pharmacological testing. |
| Dominantly Inherited Alzheimer’s Network (DIAN): International Network for the Identification, Evaluation, and Follow up of Families with Early Onset Dominantly Inherited Alzheimer’s Disease | Research Initiative | FDA | NIA | To set up an international network consisting of a consortium of scientific investigators that will have the responsibility to identify, recruit, evaluate, and follow-up individuals from families with early onset dominantly inherited Alzheimer’s disease [i.e., families with the amyloid precursor protein (APP), presenilin 1 (PS1), and presenilin 2 (PS2) mutations or duplications or others still to be discovered]. http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-08-002.html |
| Dr. Andrew Greenberg | Health Survey | ACF | NIEHS, FIC | Test http://www.google.com |
| Drug Induced Liver Injury Network (DILIN) | Committee, Work group, Advisory group, or Task Force | FDA | NIDDK | Both a prospective and retrospective database containing cases of drug-induced liver disease, DILIN is funded by a cooperative agreement and includes eight clinical centers and a central data coordinating center. One of the goals of DILIN is to establish a database of well-characterized cases of drug-induced liver injury along with serum, DNA, and tissue samples that will facilitate research on the mechanisms of hepatic injury due to drugs. Cases of liver injury due to herbal medications are also included. DILIN will develop standardized definitions of drug-induced liver disease and standardization of scoring systems for causality. Three employees of FDA serve as ad hoc members on the committee overseeing the network activities. https://dilin.dcri.duke.edu |
| Dynamics of Health, Aging, and Body Composition (Health ABC) | Research Initiative | CDC | NIA, NCCAM, NIDDK | Major objectives relate to observations that change in body composition in old age, particularly the increase in body fat and the decline in lean mass and bone mineral, represent a common pathway by which multiple diseases contribute to disability. There are many unanswered questions regarding the patterns and health impact of changes in weight and body composition in old age. Weight generally increases over the lifetime until late middle age, and then tends to decrease into old age with changes in muscle, fat and bone. It has been postulated that the accelerated loss of muscle and strength in old age contributes to the onset of disability. Studies of weight and its relationship to mortality in older persons have yielded contradictory findings, leading to controversy regarding public health recommendations for weight in old age. Few studies have examined weight-related morbidity in old age, especially among African-Americans. http://www.nia.nih.gov/research/intramural-research-program/dynamics-health-aging-and-body-composition-health-abc |
| Early Hearing Detection and Intervention | Committee, Work group, Advisory group, or Task Force | CDC | NIDCD | Teleconference sponsored by CDC. http://www.cdc.gov/ncbddd/hearingloss/index.html |
| Elder Justice Interagency Working Group | Committee, Work group, Advisory group, or Task Force | AoA | NIA | The Elder Justice Interagency Working Group was established to protect older adults from abuse including self-neglect. NIA was a founding member of the group along with AoA. The group brings together federal officials responsible for carrying out elder justice activities, including elder abuse prevention, research, grant and program-funding, and prosecutions. Members meet regularly to discuss emerging issues, promising practices, and ways to coordinate their efforts. AoA has also put together a working group to lay the foundation for a study that will determine the prevalence of elder exploitation, and the adequacy of current Federal and State legal protections in this area. http://www.ncea.aoa.gov/main_site/pdf/whatnew/proceedings.pdf |
| Endocrinologic and Metabolic Drugs Advisory Committee | Committee, Work group, Advisory group, or Task Force | FDA | NIAID | Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the FDA for drug approval. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/default.htm |
| Enhanced Comprehensive HIV Prevention Planning (ECHPP)12-Cities Initiatives | Committee, Work group, Advisory group, or Task Force | CDC | NIMH | NIMH staff have participated in workgroups to inform the implementation of the Enhanced Comprehensive HIV Prevention Planning (ECHPP)/HHS Twelve Cities Project. This project is funded by the CDC''s Division of HIV/AIDS Prevention. The project aims to maximize the impact of HIV prevention in the twelve metropolitan areas with the highest AIDS prevalence in the United States. http://www.cdc.gov/hiv/strategy/echpp/index.htm |
| Enhancements to the U.S. Life Table Program | Research Initiative | CDC | NIA | The objectives of this research project are the enhancement and expansion of the U.S. life table program. This will consist of the production of national life tables by detailed race, Hispanic origin, nativity status, and educational status of the U.S. population. |
| Enhancing the National Health Interview Survey (NHIS) | Health Survey | CDC | OD, OD/DPCPSI/OBSSR | FY09 OBSSR funds were used to pay costs associated with the National Health Interview Survey (NHIS). These functions included, but were not limited to: sample design and maintenance; sample selection and listing; questionnaire design and testing; expert consultation, programming and testing of the CAPI instrument; data collection; data analysis; post data collection editing and processing; oversight and management of the operations; data weighting and estimation; preparation and submission of all OMB and IRB clearance packages; preparation of public use data files, data publications, presentations, and analysis; and travel related to any of the above mentioned items. http://www.cdc.gov/nchs/nhis.htm |
| Enhancing Use and Quality of Colorectal Cancer Screening -- Federal Partners Meeting | Meeting/ Workshop | AHRQ, CDC, CMS, HRSA | OD, NCI, OD/DPCPSI/OBSSR | In follow-up to the February 2010 NIH State-of-the-Science Conference: Enhancing Use and Quality of Colorectal Cancer Screening, the NIH hosted a meeting to summarize current Federal agency activities in colorectal cancer screening that address the recommendations presented by the conference panel members. Attendees also discussed research gaps; examined future activities; and Identified and discussed opportunities for new initiatives and/or collaborations to address the panel recommendations, including appropriate potential partners, whether Federal agencies or other organizations. This meeting was held in October 2010. |
| Evaluation of Patient Reported Outcomes Following LASIK Surgery. | Research Initiative | FDA | NEI | This will be a prospective, questionnaire-based study conducted by the U.S. Navy Refractive Surgery Center San Diego in collaboration with the U.S. Food and Drug Administration’s Division of Ophthalmic, Neurological, and Ear, Nose and Throat Devices. The primary purpose is to quantify the satisfaction and health related quality of life of 500 active duty patients over a period of six months following state-of-the-art laser in situ keratomileusis (LASIK). The questionnaire to be used will be a new instrument which, once validated in this study, might be employed in future clinical studies that include civilian refractive surgery centers in the U.S. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ucm186858.htm |
| Evidence Based Review & Report Program | Committee, Work group, Advisory group, or Task Force | AHRQ, FDA | OD, NCCAM | This Congressionally mandated program reviews current scientific evidence on the efficacy and safety of dietary supplements; identifies research needs; and prepares reports of their findings. http://ods.od.nih.gov/Research/Evidence-Based_Review_Program.aspx |
| Evidence Based Review - Probiotic Safety | Other | AHRQ, FDA | NCCAM, OD | In 2008, the ODS, NCCAM and FDA/CFSAN initiated a systematic review through the AHRQ to evaluate the evidence for safety of probiotics. The collaboration has consisted of intellectual exchange of knowledge expertise and appropriate guidance during monthly teleconferences. http://www.ahrq.gov/clinic/tp/probiotictp.htm |
| Family Health History | Health Survey | OSG | NCI, NHGRI | The "My Family Health Portrait" tool is a Web-enabled program that runs on any computer that is connected to the Web and running an up-to-date version of any major Internet browser. The Web-based tool helps users organize family history information and then print it out for presentation to their family doctor. In addition, the tool helps users save their family history information to their own computer and even share family history information with other family members. http://www.hhs.gov/familyhistory/ |
| Family History Initiative | Public Education Campaign | AHRQ, CDC, HRSA, IHS, OS, OSG, SAMHSA | NHGRI, NCI | Collaborative initiative to promote public and health care provider awareness and use of family History as a tool for health care. The activity has also served as a very important driver of work on developing interoperability of health information technology systems and clinical decision support tools. Has included the development and continued enhancement of the U.S. Surgeon General''s My Family Health Portrait family history web tool. https://familyhistory.hhs.gov/fhh-web/home.action |
| Family Smoking Prevention and Tobacco Control Act National Longitudinal Study | Research Initiative | FDA | NIDA, NCI, NHLBI, NICHD, NIEHS, OD | This longitudinal study aims to evaluate the behavioral and health impact of the 2009 Family Smoking Prevention and Tobacco Control Act, which gives the FDA authority to regulate tobacco products. http://www.fda.gov/TobaccoProducts/NewsEvents/ucm173174.htm |
| FDA Blood Products Advisory Committee | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NHLBI, CC | The committee reviews and evaluates available data concerning the safety, effectiveness, and appropriate use of blood, products derived from blood and serum or biotechnology which are intended for use in the diagnosis, prevention, or treatment of human diseases. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/default.htm |
| FDA Cancer Diagnosis Program (CDP) Monthly Meeting | Committee, Work group, Advisory group, or Task Force | FDA | NCI | Participants discuss proposed integral markers and process for regulatory input into integral markers/assays for clinical trials. |
| FDA Center of Drug Evaluation and Research (CDER) Workgroup | Committee, Work group, Advisory group, or Task Force | FDA | CC | The joint CC-CDER collaborative working team is aimed at developing new processes to consider exceptions to existing CDER policies and procedures for extraordinary clinical circumstances. Over the past few years, CC investigators have encountered instances in which regulatory barriers may have precluded novel pharmacological interventions for severely ill patients. Leaders at the FDA CDER became aware of the concern of some NIH intramural investigators and approached CC leadership to understand the issues. |
| FDA Clinical Pharmacology Review Rotation | Training Initiative | FDA | CC | The fellow typically completes a 6 week rotation at the FDA in the Office of Clinical Pharmacology in the Center for Drug Evaluation and Research (CDER). The fellow participates in the review of INDs and supplemental NDAs, including the evaluation of new clinical PK protocols, study reports etc. The fellow will take the lead on 1-2 key assignments, representing clinical pharmacology in interdisciplinary team meetings and writing the final clinical pharmacology report. http://intranet.cc.nih.gov/clinicalresearchtraining/curriculumcert/FDAClinPharm.pdf |
| FDA Substance Registry System Public Interface | Resource Development | FDA | NLM | The National Library of Medicine and the Food and Drug Administration established a collaborative effort to provide an interface for public access to the FDA’s Substance Registration System (SRS). The FDASRS utilizes an existing NLM database backend architecture to provide public search capability for FDA substances and medicinal products. http://fdasis.nlm.nih.gov/srs/srs.jsp |
| FDA/Center for Biologics and Evaluation and Research (CBER) Genomic Biologics | Committee, Work group, Advisory group, or Task Force | FDA | NIAID | --Protect and improve public and individual health in the US and, where feasible, globally --Facilitate development, approval and access to safe and effective products and promising new technologies |
| Federal Interagency Workgroup on Child Abuse | Committee, Work group, Advisory group, or Task Force | ACF, CDC, SAMHSA | NIDA, NIAAA, NICHD, NIMH, NIMHD | Research Subcommittee of NIH Child Abuse and Neglect Working Group''s regular collaborative meetings and communications to facilitate child maltreatment research. http://www.acf.hhs.gov/programs/cb/fediawg/ |
| Federal Collaboration on Rural Health | Meeting/ Workshop | AHRQ, HRSA, SAMHSA | NIMH, NIA, NIDA, NINR | On June 23, 2011, this workshop was held at the National Association for Rural Mental Health (NARMH) and AgriWellness annual meeting. The meeting brought together researchers, persons in recovery, healthcare providers, family members, advocates, and policy makers to learn about effective programs and practices as well as new discoveries. In addition, participants discussed rural behavioral health policy, rural mental health research, and how best to reduce health disparities in rural populations. http://www.narmh.org/conferences/2011/agenda2011.pdf |
| Federal Dietary Reference Intakes Steering Committee | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, OS | NIDDK | This committee serves as an interagency forum to provide oversight on the process used to establish the Dietary Reference Intakes. These values serve as a basis for many federal nutrition programs and policies. |
| Federal Education and Training Interagency Group (FETIG) | Committee, Work group, Advisory group, or Task Force | HRSA | NICHD, NLM | This group''s mission is to overview the development of national standards for disaster preparedness education and training. http://edocket.access.gpo.gov/2008/pdf/E8-4947.pdf |
| Federal HIV/AIDS Web Council (AIDS.gov) | Committee, Work group, Advisory group, or Task Force | CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | OD/DPCPSI/OAR, NCI, NIAID, NIDA, NLM, OD | A trans-agency planning group that manages the activities for AIDS.gov, a web site designed to provide access to Federal HIV/AIDS information through a variety of new media channels, and supports the use of new media tools by Federal and community partners to improve domestic HIV programs serving minority and other communities most at-risk for, or living with, HIV. http://www.aids.gov |
| Federal Interagency Committee on Relationships | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC | NICHD | Interagency group established to improve the information base about children and families. |
| Federal Interagency Forum on Aging Related Statistics | Committee, Work group, Advisory group, or Task Force | AoA, AHRQ, CDC, CMS, OS, SAMHSA | NIA | This Interagency Forum was formed with the goal of bringing together Federal agencies that share a common interest in improving aging-related data. The specific goals of the Forum are to improve both the quality and use of data on the aging population. http://www.agingstats.gov/agingstatsdotnet/Main_Site/About/About_Forum.aspx |
| Federal Interagency Forum on Child and Family Statistics | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, HRSA, OS, SAMHSA | NIDA, NICHD, NIMH | The Federal Interagency Forum on Child and Family Statistics is a collection of 22 Federal government agencies involved in research and activities related to children and families. The Forum''s signature report, America''s Children: Key National Indicators of Well-Being, provides annual updates on the well-being of children and families in the United States across a range of domains. NIDA participates by contributing data from the NIDA-supported Monitoring the Future Survey on drug use and attitudes among 8th, 10th, and 12th graders nationwide. http://www.childstats.gov/forum/ |
| Federal Interagency Traumatic Brain Injury Research (FITBIR) Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA, OS, SAMHSA | NIDA, NCATS, NHLBI, NIA, NIAAA, NIBIB, NICHD, NIDCD, NIGMS, NIMH, NINDS, OD | To encourage greater cross-talk and cross-agency collaboration through enhanced information exchange opportunities on TBI related issues, especially best practices. Specifically, the committee''s charge is fourfold: 1) create and contribute to a centralized online clearinghouse of Federal resources pertaining to TBI; 2) share information regarding upcoming agency events related to TBI; 3) review program strategic plans, materials and funding opportunities to facilitate collaboration, minimize duplication of efforts and fill service gaps; 4) develop and disseminate media to build awareness and promote greater visibility of TBI and associated Federal programs. |
| Federal Interagency Workgroup on Child Abuse and Neglect | Committee, Work group, Advisory group, or Task Force | ACF, AoA, CDC, HRSA, IHS, OS, SAMHSA | OD, NICHD, NIDA, NIMH | Multi-agency workgroup designed to share information hand pool resources on child abuse and neglect http://www.acf.hhs.gov/programs/cb/fediawg |
| Federal Interagency Workgroup on Teen Dating Violence (TDV) | Research Initiative | ACF, CDC, HRSA, OS, SAMHSA | NICHD, NIAAA, NIDA, NIMH, NIMHD, OD | The federal government is coordinating efforts to address the problem of teen dating violence through this workgroup, which serves as a forum for information sharing, cooperation, and collaboration. http://grants.nih.gov/grants/guide/pa-files/PA-09-170.html |
| Federal Interagency Working Group on Vitamin D | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, OS | NEI, NCCAM, NCI, NHLBI, NIA, NIAMS, NICHD, NIDDK, NIEHS, NIMHD, OD | The Federal Working Group on Vitamin D is focused on the development of a comprehensive and forward-looking research agenda for vitamin D. |
| Federal Interagency Working Group on Women''s Health and the Environment | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NICHD, NCI, NIEHS | This committee consists of representatives from various federal agencies and offices. The committee''s three main goals are: (1) to discuss and exchange information on ongoing activities in research, information dissemination and outreach, health care services, training, and public policy related to women''s health and the environment, (2) to ensure cooperation and consolidation of efforts between the various federal agencies and offices that work on the issue of women''s health and the environment, (3) to identify gaps, foster collaborations between agencies, and plan and implement activities that address identified needs. http://www.womenshealth.gov/about-us/who-we-are/groups-committees/environment.cfm |
| Federal Investigator Registry of Biomedical Information Research (FIREBIRD) | Resource Development | FDA | NCI | An agreement has been reached by the FDA and the NCI to manage and share information about clinical investigators using the Federal Investigator Registry of Biomedical Information Research Data, or FIREBIRD, system. Drug makers are encouraged to also submit information about investigators electronically to the new registry. FIREBIRD is the first module of an expected suite of software programs that will comprise a system called the Clinical Research Information Exchange (CRIX). CRIX is intended to support the biomedical and biopharmaceutical research community by streamlining the document and data exchange process. The resulting reduction of paperwork is expected to increase the efficiency and lower the cost of conducting clinical trials. https://cabig.nci.nih.gov/tools/FIREBIRD |
| Federal Liaison Group on Asthma (FLGA) | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, OS | NIAID, NHLBI, NIEHS, NIMH, NINR, NLM | The FLGA is committed to achieving and maintaining effective coordination that respects the unique contributions of individual agencies, facilitates exchange of information to avoid duplication, enables identification of opportunities for collaboration, and ensures that consistent messages about asthma are developed and disseminated. Much coordination of federal asthma activities already exists, and plans for expansion are under way. The FLGA will continue to explore current and planned asthma activities in greater depth in each of the five goal areas and seek new opportunities for interagency coordination and collaboration. http://www.nhlbi.nih.gov/about/naepp/asth01rpt.htm |
| Federal mHealth Collaborative | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA | OD, NCI, NICHD, NIDA | Federal working group of agencies interested in mHealth technology and its potential for enhancing health care http://www.hrsa.gov/healthit/mhealth.html |
| Federal Partners in Bullying Prevention, Intervention, and Recovery | Committee, Work group, Advisory group, or Task Force | ACF, CDC, HRSA, IHS, SAMHSA | NIMH, NIAAA, NICHD, NIDA, OD | This workgroup meets to provide a forum through which staff from relevant Federal agencies can communicate and exchange ideas concerning how to prevent or stop bullying in schools and communities. http://www.findyouthinfo.org/spotlight_bullyingWorkgroup.shtml |
| Federal Partners in the Gulf Long-Term Follow-up (GuLF) Study Working Group | Committee, Work group, Advisory group, or Task Force | ACF, ATSDR, CDC, CMS, FDA, HRSA, OS, SAMHSA | OD/DPCPSI, CIT, NHGRI, NIEHS, NIMH, NLM, OD | The Federal Partners in the Gulf Long-Term Follow-up (GuLF) Study Working Group is an interagency group of Federal agencies responding to potential health effects of the Deepwater Horizon oil spill disaster. The working group was convened to provide input on the design and conduct of the Gulf Long-Term Follow-up (GuLF) study, a longitudinal study of oil spill clean-up workers led by the National Institute of Environmental Health Sciences with support from the NIH Common Fund, NIH OD and BP. Working group members share ideas on ways to maximize interagency efficiency and effectiveness by working collaboratively on areas of common interest and sharing data and samples collected by their agencies, they identify data collection needs that could be met by the GuLF study rather than duplicate surveys to the same population, and they identify agency resources that could be brought together to improve the GuLF study. Scientific oversight for the study is provided by the National Academy of Science''s Institute of Medicine. This helps to facilitate information exchange and coordination among federal agencies with regards to understanding the toxicity and health effects associated with the of Gulf oil spill exposures among workers and affected communities. http://www.niehs.nih.gov/about/od/programs/gulfspill.cfm |
| Federal Partners Senior Workgroup for Mental Health Transformation | Committee, Work group, Advisory group, or Task Force | ACF, AoA, AHRQ, CDC, CMS, FDA, HRSA, SAMHSA | NIDA, NIMH | The workgroup is the direct result of President''s BUSH''s New Freedom Initiative, which included 10 proposals designed to “tear down the barriers that face Americans with disabilities,” This workgroup provides a forum for brainstorming ideas for improving the nation''s mental health. Initiatives are collated, coordinated, streamlined and presented to the interagency steering committee for further discussion and possible implementation. http://store.samhsa.gov/product/SMA05-4060 |
| Federal Working Group on Bone Diseases | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, OS | NIDCR, CSR, NCCAM, NCI, NCATS, NEI, NIA, NIAAA, NIAMS, NIBIB, NICHD, NIDDK, NIEHS, NIMH, NINR, OD | Serves to develop and foster collaborative activities among the government agencies in bone diseases. http://www.niams.nih.gov/About_us/committees/default.asp |
| Federal Working Group on Dietary Supplements (FWGoDS) | Committee, Work group, Advisory group, or Task Force | AoA, AHRQ, CDC, FDA | OD, CC, CSR, FIC, NCCAM, NCI, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM | To facilitate communication and collaboration between NIH and its federal partners in several ways: to co-fund research investigations within the NIH, to expand opportunities for research-investigator training, and to strengthen collaborative efforts involving dietary supplement research, education, and communication. The FWGoDS meets twice a year and serves as a means of communication between the Office of Dietary Supplements (ODS) and its federal partners. http://dpcpsi.nih.gov/collaboration/committees.aspx?TID=2#14 |
| Federal Working Group on International Migration Statistics and Research | Committee, Work group, Advisory group, or Task Force | ACF, CDC, OS | NICHD | This working group brings together agencies from across the Executive Branch to share current work and to collaborate on joint projects to advance the federal government''s contribution in the area of international migration. |
| FedTel: Cross-Federal Work Group on Telehealth | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS | NIBIB, NLM, OD | The goal of this work group is to develop a coordinated view of what the Federal government is undertaking in Telehealth, in an effort to identify possible collaboration mechanisms and share lessons learned across multiple agencies. Current topics of emphasis include Telehealth and HIT; Technology, Innovation and Standards; Public Education of Telehealth; and Access to Health Care. |
| Filovirus Animal Non-Clinical Group (FANG) Team Charter | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NIAID, CC | PURPOSE: The Filovirus Animal Non-Clinical Group (FANG) focuses on the advanced development of Filovirus Medical Countermeasures (MCM), both vaccines and therapeutics. The FANG will focus on the product development tools and other interagency product development (PD) issues relevant to Food and Drug Administration approval of Filovirus MCM. MISSION: The Portfolio Advisory Committee (PAC), as a standing interagency working group, oversees the FANG. The FANG will develop strategies to address broadly applicable and interagency product development issues relevant to licensure of Filovirus MCM. The FANG will develop consensus recommendations to facilitate standardization of reagents, methods and procedures across multiple agencies and laboratories. |
| Fistula First | Committee, Work group, Advisory group, or Task Force | CMS, HRSA | NIDDK | The Fistula First Breakthrough Coalition (FFBI) works together with the entire renal community to ensure that every suitable patient will receive the most optimal form of vascular access, which, in most cases, will be a native arteriovenous fistula (AV fistula). The FFBI also focuses on reducing catheter use and vascular access complications. During FY 2010, the National Kidney Disease Education Program collaborated with Fistula First to produce a series of web-based provider and patient educational videos. http://www.fistulafirst.org |
| Forum on Child and Family Statistics | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, HRSA, SAMHSA | NIMH, NICHD, NIDA | The Federal Interagency Forum on Child and Family Statistics, or the Forum, is a working group of Federal agencies that collect, analyze, and report data on issues related to children and families. The Forum''s signature report, America''s Children: Key National Indicators of Well-Being, provides annual updates on the well-being of children and families in the United States across a range of domains. http://childstats.gov |
| Forum on Global Violence Prevention | Committee, Work group, Advisory group, or Task Force | ACF, CDC, SAMHSA | NIDA, NIAAA | The IOM''s Forum on Global Violence Prevention works to reduce violence worldwide by promoting research on both protective and risk factors and encouraging evidence-based prevention efforts. The Forum aims to facilitate dialogue and exchange by bringing together experts from all areas of violence prevention, including behavioral scientists, policy makers, criminal justice professionals, social service providers, economists, legal experts, journalists, philanthropists, faith-based organizations, corporate social responsibility officers, among others. |
| Frequent Hemodialysis Network (FHN) Clinical Trials | Research Initiative | CMS | NIDDK | The Frequent Hemodialysis Network (FHN) is testing two different approaches to increasing dialysis at Clinical Centers in the U.S. and Canada. The FHN Daily Trial is a randomized controlled trial that randomizes 250 subjects to either conventional hemodialysis delivered for at least 2.5 hours, 3 days per week, or to more frequent hemodialysis delivered for 1.5 – 2.75 hours, 6 days per week. Subjects will be followed for 12 months. The current FHN Nocturnal Trial randomizes 250 subjects to home conventional hemodialysis delivered three days per week or to nocturnal home hemodialysis given six times per week that provides a standardized Kt/V equal to or greater than 4 and treatment equal to or longer than 6.0 hours. Due to the necessity of training for home dialysis, subjects are followed for 14 months. Two outcomes are being assessed in both trials. The first is a composite measure of change in left ventricular mass or death. The second is a composite of change in the physical health composite of the SF36 or death. http://www.clinicaltrials.gov/ct2/show/NCT00264758 |
| Fresh Perspectives in Perinatal Depression Research: Psychosocial Interventions and Mental Health Services | Meeting/ Workshop | CDC | NIMH, OD | On October 5-6, 2010, the NIMH convened a workshop to provide the growing number of early-stage investigators studying psychosocial interventions and mental health services for perinatal depression with the opportunity to discuss research strategies consistent with public health needs and NIMH priorities. NIMH priorities for perinatal depression align with current developments in federal healthcare legislation concerning the mental health of pregnant and post-partum women. With input from the CDC and experts from the broader field of depression research, the workshop incorporated informative and diverse perspective s from outside the immediate field of perinatal mental health. http://www.nimh.nih.gov/research-funding/scientific-meetings/2010/fresh-perspectives-in-perinatal-depression-research-psychosocial-interventions-and-mental-health-services.shtml |
| Gastric Cancer Incidence Trends by Anatomic Subsite | Research Initiative | CDC | NCI | Collaboration on a joint analysis of gastric cancer incidence data for 1976-2007 from the NCI Surveillance, Epidemiology, and End Results (SEER) Program and the CDC National Program of Cancer Registries. http://seer.cancer.gov/statfacts/html/stomach.html |
| Genetics/Genomics Research Coordinating Committee | Committee, Work group, Advisory group, or Task Force | FDA | OD/DPCPSI/OAR, NCI, NCATS, NHGRI, NIAID, NICHD, NIDA, NIGMS, NIMH, OD | Representatives of HHS agencies meet to coordinate and collaborate on HIV and Genetics/Genomics research. |
| Genomic Applications in Practice and Prevention Network (GAPPNet™) | Other | AHRQ, CDC | NCI, NHGRI, NIDDK | The Genomic Applications in Practice and Prevention Network (GAPPNet™) is a collaborative initiative involving partners from across the public health sector who are working together to realize the promise of genomics in healthcare and disease prevention. GAPPNet™ aims to accelerate and streamline effective and responsible use of validated and useful genomic knowledge and applications, such as genetic tests, technologies, and family history, into clinical and public health practice. http://www.gappnet.org |
| Global Change Research Program | Committee, Work group, Advisory group, or Task Force | ACF | NIEHS, FIC | The U.S. Global Change Research Program (USGCRP) coordinates and integrates federal research on changes in the global environment and their implications for society. NIEHS represents HHS as GCRP principal in collaboration with CDC. http://www.globalchange.gov/ |
| Global Collaboration Call | Committee, Work group, Advisory group, or Task Force | AoA, CDC, FDA, HRSA, SAMHSA | NIMH | NIMH participates in a biweekly Global Health Collaboration Call, coordinated by the Office of Global Health Affairs (OGHA). OGHA convenes participants from numerous HHS agencies to share relevant information on global health activities. http://www.hhs.gov/ogha/contact.html |
| Global Health Initiative (GHI) Research Committee | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA, OS | FIC, NIAID, NICHD, OD | The GHI Research Committee, of which Francis Collins is the Chair, was formed to facilitate the integration, synergy, and strategic alignment of USG research and technical guidance in support of reaching the GHI’s targets through identifying and implementing evidence-based interventions. The GHI Research Committee''s purpose is to advance the utilization and application of existing knowledge and integrated coordinated USG research to support GHI Principle #7, “Research and Innovation”, in the implementation and advancement of the GHI’s strategic goals. http://www.fic.nih.gov/programs/research_grants/grip/index.htm |
| Global Health Security Advisory Group | Committee, Work group, Advisory group, or Task Force | CDC, OS | NINDS, NIAID | The Global Health Security Advisory Group (GHSAG) is a committee comprising of high level representatives of the national health authorities for the G-8 block of countries, formed to develop and implement concrete actions to improve global health security and serve as a network for rapid response to biological, chemical, radio-nuclear terrorism (CBRN) crises. http://www.ghsi.ca/english/index.asp |
| Global Strategic Plan to Prevent Harms Associated with Alcohol Misuse | Meeting/ Workshop | CDC, SAMHSA | NIAAA | NIAAA represented HHS at the World Health Organization/Pan American Health Organization Western Hemisphere Meeting to Develop a Global Strategic Plan to Prevent Harms Associated with Alcohol Misuse in Sao Paulo, Brazil, in May 2009. After the meeting, NIAAA officials coordinated with officials at CDC and SAMHSA to review the draft Global Strategic Plan to Prevent Harms Associated with Alcohol Misuse. http://new.paho.org/hq/dmdocuments/2009/Final%20AMRO%20Report%20(Brasil).pdf |
| Glycomics/Glycoscience Needs | Meeting/ Workshop | FDA | NIGMS, NCI, NCATS, NHLBI, NIAID, NIDCR | Meeting held September 19, 2011, on the NIH Campus with NIST, NSF, the FDA, and other NIH Institutes to discuss the field of glycomics and how to work together to meet the needs/challenges for this emerging field, including developing high-throughput assays, standards, and databases. |
| Glycosciences Research Day | Meeting/ Workshop | FDA | NIGMS | The NIH Glycobiology Interest Group, with support from other NIH institutes, The Foundation for NIH, NIST, and the FDA runs a seminar series featuring the findings of an intramural NIH, NIST or FDA investigators working in the glycosciences each month. This SIG also holds a one-day meeting that includes several scientific sessions as well as over 80 poster presentations that explore the breadth of glycoscience research taking place in the intramural NIH, NIST, Naval Medical Research Center, and FDA research programs. This Annual NIH & FDA Research Day promotes communications and interactions among intramural laboratories and often leads to long term collaborations. http://meetings.nigms.nih.gov/?ID=8924 |
| Go4Life | Public Education Campaign | AoA, AHRQ, CDC, OSG | NIA, NCCAM, NHLBI, NIAMS, NIDDK, NIMH, NINDS | Go4Life, is an exercise and physical activity campaign from the National Institute on Aging at NIH, and is designed to help individuals fit exercise and physical activity into their daily life. Motivating older adults to become physically active for the first time, return to exercise after a break in their routines, or build more exercise and physical activity into weekly routines are the essential elements of Go4Life. Go4Life offers exercises, motivational tips, and free resources to help individuals get ready, start exercising, and keep going. The Go4Life campaign includes an evidence-based exercise guide in both English and Spanish, an exercise video, an interactive website, and a national outreach campaign. http://go4life.niapublications.org |
| Grant Writing Workshop for Latin America | Training Initiative | OS | NCI, NHLBI, NIAID, NICHD, NINDS | This initiative results from the US-Colombia Journal of Clinical Microbiology (JCM) Health Section readout as an area of great interest for the Ministry of Health, Colombia. Stemming from these conversations, the NIH‘s NCI in conjunction with the FIC has been gauging interest across the NIH to hold a series of trans-NIH grantsmanship workshops in Latin America, with a pilot to be held in Colombia. The Ministry of Health and Social Protection of Colombia has responded via a letter affirming their participation and support. http://www.cancer.gov/aboutnci/organization/olacpd |
| Guide to Community Preventive Services, Violence Prevention Review | Other | CDC | NIDA, NICHD, NIMH | The Community Guide is a resource for evidence-based recommendations and findings about what works to improve public health and practices for violence prevention. |
| Guidelines for Prevention and Treatment of HIV Related Opportunistic Infections in Adults and Adolescents | Other | CDC, FDA, HRSA | CC | In 1987, CCMD recognized the need for national guidelines on HIV management. The initial guideline focused on prevention and treatment of pneumocystis pneumonia. This was followed by guidelines on mycobacterium avium and then on all opportunistic infections. In 1995 both CDC and the Infectious Diseases Society of America were brought in as partners. Since then these guidelines have been revised many times, widely disseminated in print and on the web, and are the global standard for care. These have been funded by OAR. http://www.cdc.gov/mmwr/pdf/rr/rr5804.pdf |
| Guidelines for Prevention of Mother to Child HIV Transmission; Guidelines for Pediatric Antiretroviral Treatment; Guidelines for Adult Antiretroviral Treatment; Guidelines for Prevention and Treatment of Opportunistic Infections in Adults; Guidelines | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA | NICHD, NIAID | These are separate Working Groups for development of U.S. guidelines related to HIV infection and its treatment. These Working Groups are composed of external experts in the various areas covered as well as federal agency representatives, including CDC, HRSA, and FDA. http://www.aidsinfo.nih.gov/guidelines/ |
| Gulf Oil Spill Interagency Coordination for Issues Involving Toxicology, Health Effects, and Research | Committee, Work group, Advisory group, or Task Force | ATSDR, CDC, CMS, FDA, HRSA, OS, OSG | NIEHS, NIMH, NLM | Facilitate information exchange and coordination among federal agencies with regards to understanding the toxicity and health effects associated with the Gulf oil spill exposures among workers and affected communities. http://www.niehs.nih.gov/about/od/programs/gulfspill/ |
| Harnessing Advanced Health Technologies to Drive Mental Health Improvement | Meeting/ Workshop | AHRQ | NIMH | On November 16-17, 2010, NIMH and AHRQ co-sponsored a workshop, "Mental Health & Health IT Research: The Way Forward." The meeting assembled experts in mental health interventions and services research together with technologists, providers, consumers, and industry representatives to discuss opportunities to leverage emerging technologies toward improved research and service delivery. http://www.nimh.nih.gov/research-funding/grants/concept-clearances/2011/harnessing-advanced-health-technologies-to-drive-mental-health-improvement.shtml |
| Health and Retirement Study (HRS) | Health Survey | CMS | NIA | This survey follows more than 20,000 men and women over 50, offering insight into the changing lives of the older U.S. population. Launched in 1992, this multidisciplinary, longitudinal study has become known as the Nation''s leading resource for data on the combined health and economic conditions of older Americans. http://www.nia.nih.gov/health/publication/growing-older-america-health-and-retirement-study |
| Health Behavior in School-Age Children: NEXT Longitudinal Study 2009-2013 | Research Initiative | HRSA | NIAAA, NCI, NHLBI, NICHD | NEXT is a four-year longitudinal assessment of a representative sample of U.S. school children starting at grade 10. The goals of the U.S. NEXT longitudinal study include: to identify the trajectory of adolescent health status and health behaviors from mid-adolescence through the post high school year; to examine individual predictors of the onset of key adolescent risk behaviors and risk indicators during this period; to identify family, school, and social/environmental factors that promote or sustain positive health behaviors; and to identify transition points in health risk and risk behaviors and changes in family, school, and social/environmental precursors to these transitions. http://clinicaltrials.gov/ct2/show/NCT01031160 |
| Health Behavior in School-Aged Children, 2009-2010 Survey (HBSC) | Health Survey | HRSA | NICHD | This IAA is to fund the 2009/2010 quadrennial survey of the Health Behaviors in School-Aged Children (HBSC) study. This agreement provides needed supplemental funding and HRSA staff experience to conduct the U.S. survey component according to the HBSC study protocol developed in collaboration with the World Health Organization. http://www.nichd.nih.gov/about/org/despr/studies/behavior/HBSC.cfm |
| Health Burden from Indoor Air Pollution on Women and Children in Developing Countries (trans-US Government/international conference) | Committee, Work group, Advisory group, or Task Force | CDC, HRSA, OS | OD, CC, FIC, NCI, NEI, NHLBI, NICHD, NIEHS, NIGMS, NIMH, NINDS | Planning committee with representatives from NIH OPDIVs, other USG departments/OPDIVs (e.g., State, EPA); and international representatives (e.g, First Lady of Peru) http://www.niehs.nih.gov/news/newsletter/2011/june/spotlight-international/index.cfm |
| Health Initiative of the Americas | Public Education Campaign | SAMHSA | NIDA | Provide scientific publications on drug abuse and addiction for teens, parents, and teachers. Publications will be distributed to all Latin American consulates in California. http://hia.berkeley.edu/ |
| Health Literacy Work Group | Committee, Work group, Advisory group, or Task Force | AoA, AHRQ, CDC, FDA, OS | NICHD, NCI, NEI, NHGRI, NHLBI, NIA, NIBIB, NIDA, NIDCR, NIEHS, NIMH, NINR, NLM, OD | This work group meets several times a year and works to promote health literacy within the government for the benefit of the general population. http://www.surgeongeneral.gov/topics/healthliteracy/appxc.htm |
| Health Maintenance Organizations (HMO) Collaboratory | Research Initiative | AHRQ, CDC, FDA | NIDCR, NCCAM, NCI, NCATS, NHGRI, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, OD | "Led by NCAAM - The NIH Common Fund. The Common Fund''s HMO Collaboratory program was created to speed efficiency, generate faster evidence, take advantage of high-throughput technologies and leverage known economies of scale across health care delivery organizations such as health maintenance organizations (HMOs) in order to strengthen methodology for conducting mega-epidemiology studies and clinical trials in real world health care delivery settings. " http://commonfund.nih.gov/hmocollaboratory/ |
| Health Outcomes among Children and Families Living in Rural Communities: Trans-Agency Conference | Meeting/ Workshop | AHRQ, HRSA, IHS | NIDCR, NCI, NHLBI, NICHD, NIDA, NIMH, OD | The NICHD convened a Trans-Agency Working Group to plan a conference focused on the health of children and families living in rural communities. The conference was held on December 1-2, 2011 at the NIH. Collaborators were NIDCR, OBSSR, NINR, NIMH, NIDA, NHLBI, and NCI. The DHHS OMH and OWH, AHRQ, IHS, HRSA, USDA and NRHA were also collaborators. The purpose of the conference was to bring together community members, researchers, health professionals, educators, policy makers, and members of professional organizations to identify gaps in research and address emerging differences between health outcomes for children and families living in rural communities compared to those in urban areas. The conference serves as a catalyst to stimulate collaborative research to fully understand the determinants and health consequences for those living in rural areas. http://www.nichd.nih.gov/about/meetings/2011/120211.cfm |
| Health Services and Technology Assessment Text (HSTAT) | Resource Development | AHRQ, CDC, OSG, SAMHSA | NLM | NLM provides a free, web-based resource of full-text documents that provide information on health-care decision making. http://www.ncbi.nlm.nih.gov/books/NBK16710/ |
| HealthMap: Knowledge Management for Emerging Infectious Disease Intelligence | Research Initiative | OS | NLM | Leveraging previous NLM funded work under the HealthMap project, ASPR and OPEO co-funded an administrative supplement to and NLM/NIH grant to provide funding to Harvard University for a pilot project in which Harvard will develop real-time applications to collect, parse, analyze, and display open source data in order to address the national needs of emergency preparedness and response for hurricanes. http://www.healthmap.org |
| Healthy People 2010 | Committee, Work group, Advisory group, or Task Force | CDC, SAMHSA | NIEHS, CC, CIT, CSR, FIC, NCCAM, NCI, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIGMS, NIMH, NINDS, NINR, NLM, OD | Healthy People 2010 meets to achieve the goals of: 1) promoting health to end preventable death, illness, injury and disability; 2) achieving health equity by eliminating health disparities; and 3) promoting healthy places and environments. http://www.healthypeople.gov/2020/default.aspx |
| Healthy People 2010 - Environmental Health and Respiratory Diseases Chapters | Committee, Work group, Advisory group, or Task Force | ATSDR, CDC | NIEHS, NHLBI, OD | Ongoing maintenance of HP2010 goals/objectives and collection of data. |
| Healthy People 2010 - Kidney Disease | Public Education Campaign | CDC, CMS, FDA, HRSA, OS | NIDDK | The office of the Secretary of HHS leads the Healthy People 2010 initiative. The lead agency for most data activities is the CDC. However, for the kidney area, most of the information is provided by NIDDK through the United States Renal Data System. http://www2.niddk.nih.gov/AboutNIDDK/ReportsAndStrategicPlanning/Healthy_People_2010_Kidney_Disease.htm |
| Healthy People 2010/2020 Partnership | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, HRSA, IHS, OS | NHLBI, NINDS | The Partnership provides the opportunity for several units of the Federal government to work on activities related to the Heart Disease and Stroke (HDS) components of the Healthy People initiative. In particular, the purpose of the activity is to catalyze progress toward achieving the Health People goals through the various phases of prevention, including prevention of the development of risk factors for HDS; detection and treatment of risk factors for HDS; early identification and treatment of HDS especially in the acute phases; and prevention of recurrence and complications of HDS. http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=21 |
| Healthy People 2020 | Committee, Work group, Advisory group, or Task Force | AHRQ, ATSDR, CDC, FDA, HRSA, OS | NIAAA, NCI, NEI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD | Healthy People provides science-based, 10-year national objectives for promoting health and preventing disease. Since 1979, Healthy People has set and monitored national health objectives to meet a broad range of health needs, encourage collaborations across sectors, guide individuals toward making informed health decisions, and measure the impact of our prevention activity. Currently, Healthy People 2020 is leading the way to achieve increased quality and years of healthy life and the elimination of health disparities. http://healthypeople.gov/2020/topicsobjectives2020/default.aspx |
| Healthy People 2020 - Blood Diseases, Disorders, and Safety | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA, OS | NHLBI | The purpose of this agreement is to support development and implementation of survey questions and measures to assess progress made toward the achievement of the Healthy People 2020 national objectives for blood diseases/disorders and safety. http://healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=4 |
| Healthy People 2020 - Environmental Health and Respiratory Disease Topic Areas | Committee, Work group, Advisory group, or Task Force | ATSDR, CDC, OS | NIEHS, NHLBI, OD | Led workgroups, coordinated meetings, developed goals, reported to DHHS, collaborated with other federal agencies. http://www.healthypeople.gov/hp2020/ |
| Healthy People 2020 - Respiratory Diseases | Committee, Work group, Advisory group, or Task Force | CDC | NHLBI, NIAID, NIEHS | The purpose of this agreement is to support development and implementation of survey questions and measures to assess progress made toward the achievement of Healthy People respiratory disease objectives. http://healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=36 |
| Healthy People 2020 - Sleep Health | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, HRSA, OSG | NHLBI, NCCAM, NIA, NICHD, NINDS, NINR | This activity supports the development and implementation of survey questions and measures to assess progress on achieving the Healthy People sleep health objectives. http://healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=38 |
| Healthy People 2020 - Social Determinants of Health Working Group | Committee, Work group, Advisory group, or Task Force | CDC, SAMHSA | NIAAA, NCI, NHLBI, NIAMS, OD | The overarching goals for Healthy People 2020 incorporate a focus on social determinants of health as well as on health outcomes and risk factors. The Working Group intends to develop objectives for the social determinants and methods to ensure their integration across all Healthy People 2020 objectives. http://www.healthypeople.gov/hp2020/Objectives/TopicArea.aspx?id=44&TopicArea=Social+Determinants+of+Health |
| Healthy People 2020 Federal Interagency Special (LGBT) Populations Workgroup | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA, OS, SAMHSA | OD | To make population-specific recommendations to HHS and to create population-specific health information within the online publication http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=25 |
| Healthy People 2020-Dementias, Including Alzheimer''s Disease | Committee, Work group, Advisory group, or Task Force | AoA, CDC | NIA, NIMH, NINDS | This Healthy People 2020 topic will focus on increasing the awareness of the diagnosis of Alzheimer’s disease, and reducing the proportion of preventable hospitalizations in persons with diagnosed Alzheimer’s disease and other dementias. The goal is to reduce the morbidity and costs associated with, and maintain or enhance the quality of life for, persons with dementia, including Alzheimer’s disease. http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=7 |
| Healthy People 2020-Older Adults | Committee, Work group, Advisory group, or Task Force | AoA, CDC | NIA | This Healthy People 2020 topic is designed to develop an understanding of the health and health care needs and implications for older adults. The objectives overall will promote healthy outcomes in this population. The goal of these objectives is to improve the health, function, and quality of life of older adults. http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=31 |
| HEALTHY study | Research Initiative | CDC | NIDDK | "HEALTHY is a 3-year study in 42 middle schools to determine if changes in school food services and physical education classes, along with classroom activities to promote behavior change, lower risk factors for type 2 diabetes in youth at high risk for the disease. Some risk factors for type 2 diabetes are modifiable, such as overweight and obesity, inactivity, high blood pressure, large waist size, and high blood levels of sugar and insulin. Other risk factors are not modifiable, such as family history and race or ethnicity. http://www.healthystudy.org |
| Healthy Vision Month | Public Education Campaign | CDC | NEI | Each May, the NEI sponsors Healthy Vision Month which is national observance designed to elevate eye health as a priority for Americans. NIH worked closely with CDC for the 2010 observance and worked together to create a MMWR article, develop information for their Vision Initiative website and provided online banners and buttons linking to the HVM site and to the NEI for additional information. http://www.nei.nih.gov/nehep/resources/hvm/ |
| Heart Attack, Blood Pressure, and Cholesterol Questions in the 2013 National Health Interview Survey. | Health Survey | CDC | NHLBI | The purpose of the collaborative activity is to support the development by the National Health Interview Survey (NHIS) of measures that can be used to assess progress toward achieving Healthy People 2020 Heart Attack, Blood Pressure, and Cholesterol Objectives. The NIH and the National Center for Health Statistics collaborate on this activity. http://www.cdc.gov/nchs/nhis.htm |
| Hemoglobin A1c (HbA1c) Standardization Program | Research Initiative | CDC | NIDDK | The purpose of the Program is to achieve standardization and reliability in measurement of HbA1c, a component of blood that is a good surrogate measure of long-term blood glucose control and, as such, reflects risk of diabetic complications. http://www.ngsp.org/ |
| Hemoglobinopathy Uniform Medical Language Ontology Project | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA, OS | NHLBI, NIAMS, NICHD, NLM, OD | The purpose of the project is to create a uniform medical language ontology for hemoglobinopathies. The ontology would be a resource for federal programs and extramural communities (e.g., researchers) to use when developing data systems that incorporate data elements related to hemoglobinopathies. |
| HHS Advisory Committee for the Elimination of Tuberculosis | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA, IHS, OS, SAMHSA | NIAID | The Committee advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. http://www.cdc.gov/maso/FACM/facmACET.htm |
| HHS Autism Awareness Month | Committee, Work group, Advisory group, or Task Force | ACF, CDC, CMS, HRSA, OS, SAMHSA | NIMH | NIMH collaborated with the HHS Office of the Assistant Secretary of Health to support activities for the National Autism Awareness Month. These activities included hosting a special seminar on autism that was made available to the public via webcast; releasing the annual Interagency Autism Coordinating Committee Summary of Advances in Autism Spectrum Disorder Research; and hosting a meeting of the Interagency Autism Coordinating Committee (IACC) with guest speakers presenting on HHS autism programs. In addition, the NIMH Director, other NIMH staff experts on autism, and the IACC participated in an Autism Awareness Month Conference at the White House. http://www.hhs.gov/news/press/2010pres/04/20100401a.html |
| HHS Behavioral Health Coordinating Committee | Committee, Work group, Advisory group, or Task Force | ACF, AoA, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | NIAAA, NIDA, NIMH | This is an HHS-wide committee to coordinate and collaborate on behavioral health issues. NIMH and the ASPA are co-leads of the subcommittee for communications. |
| HHS Behavioral Health Coordinating Committee Subcommittee for Communications | Committee, Work group, Advisory group, or Task Force | SAMHSA | OD, NIDA | The communications subcommittee is developing tools to enhance cross-HHS communications on behavioral health with other federal agencies and the public. Initiatives include platforms for data sharing and dissemination across HHS agencies, and establishing common language for behavioral health |
| HHS Biomedical Advanced Research and Development Authority (BARDA) Acute Radiation Syndrome Dosimetry Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NIAID | Interagency Working Group established under BARDA that determines dosimetry requirements for radiological and nuclear contingencies |
| HHS Biomedical Advanced Research and Development Authority (BARDA) Radiological/ Nuclear Integrated Program Team | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NIAID | Interagency Working Group established under BARDA that determines overall radiation countermeasures strategy and priorities. |
| HHS Biomedical Advanced Research and Development Authority (BARDA) Radiological/Nuclear Working Group on Blood and Tissue Products | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NIAID | Working group coordinates requirements, needs, and R&D directions for blood and tissue products for mass casualty treatment after a radiation emergency |
| HHS Biovigilance Committee | Committee, Work group, Advisory group, or Task Force | CDC, CMS, FDA, HRSA, OS | CC, NHLBI | Develop systems for reporting adverse events resulting from blood transfusion or donation. http://ppp.od.nih.gov/pppinfo/docs/PPP_Newsletter_FALL_2011.pdf |
| HHS Blood Safety Committee | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NHLBI | The committee advises the Secretary of the Department of Health and Human Services and the Assistant Secretary for Health on a number of issues related to blood safety including, public health parameters related to the safety and availability of blood and blood products; broad public health, ethical and legal issues related to transfusion and transplantation safety; and the effect of various economic factors on blood safety and availability. http://www.hhs.gov/ash/bloodsafety/advisorycommittee/ |
| HHS Blood, Organ, and Tissue Safety Committee (BOTSEC) | Committee, Work group, Advisory group, or Task Force | CDC, CMS, FDA, HRSA, OS | CC, NHLBI | Advises Asst. Secretary on issues related to blood safety and availability and scientific and policy issues regarding blood safety and organ transplantation. http://www.hhs.gov/ash/bloodsafety/index.html |
| HHS Data Council | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | NIA, NIMH | Coordinates all health and human services data collection and analysis activities of the Department of Health and Human Services, including an integrated data collection strategy, coordination of health data standards and health and human services and privacy policy activities. http://aspe.hhs.gov/datacncl/intro.shtml |
| HHS Dietary Guidance Review Committee | Committee, Work group, Advisory group, or Task Force | ACF, AoA, CDC, FDA, HRSA, IHS, OS | NIDDK | This committee reviews draft nutrition materials developed by all federal agencies and fulfills the legislative mandate (1990 NNMRRA) to ensure that federal dietary guidance is consistent with the Dietary Guidelines for Americans and is scientifically accurate. http://www.cnpp.usda.gov/DGAs2010-DGACReport.htm |
| HHS Federal Partners Sickle Cell Disease Initiative | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, OS | NHLBI | The partnership seeks to enhance coordination and collaboration across HHS agencies to improve the care of people with sickle cell disease by enhancing data on patient populations, facilitating reliable access to quality care and services, fostering innovative new drug development, and conducting biomedical and behavior research. http://minorityhealth.hhs.gov/templates/browse.aspx?lvl=2&lvlid=206 |
| HHS Health Literacy Working Group | Committee, Work group, Advisory group, or Task Force | ACF, AoA, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG | NEI, NCI, NLM, OD | This Workgroup is comprised of various HHS agencies that work towards meeting the Department’s prevention goals and to accomplish the Healthy People 2010 Objective: Improve the health literacy of persons with inadequate or marginal literacy skills |
| HHS HIV/AIDS Management Team | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | OD/DPCPSI/OAR, OD | Leadership of HHS agencies coordinate HIV/AIDS activities across HHS. |
| HHS Incarceration and Reentry Meeting | Meeting/ Workshop | ACF, CDC, CMS, HRSA, OS, SAMHSA | NIMH, NICHD, NIDA | This meeting is sponsored by the Office of the Assistant Secretary for Planning and Evaluation, HHS. The recurring meeting is convened to increase effective and efficient communications across federal agencies on matters pertaining to the health and human service needs of incarcerated individuals and former prisoners who have re-entered local communities. |
| HHS Lyme and Tick Borne Diseases | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NIAID | This group involves members from CDC, FDA, NIH and HHS with the purpose of continued coordination and communication of activities, policy updates, events, agency highlights and other shared interests relating to Lyme Disease and other tick-borne diseases. |
| HHS Meeting on International and Domestic Adoption | Meeting/ Workshop | ACF, CDC, OS, SAMHSA | NIDA, NIMH | The HHS meeting on International and Domestic Adoption focuses on developing policy and research recommendations for this under-researched issue. |
| HHS National Promotores de Salud Initiative | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, HRSA, SAMHSA | NHLBI | Community Health Workers (CHWs) and Promotores de Salud are frontline public health workers who serve as a link between health/social services and communities to facilitate access to services and improve the quality and cultural competence of service delivery. The purpose of the collaborative activity was to establish the National Promotores de Salud Initiative in partnership with HHS agencies to: establish a steering committee, develop a national recognition for Promotores, and develop a HHS Portal for Promotores and a national database system to connect with the Promotores networks. http://minorityhealth.hhs.gov/templates/content.aspx?lvl=2&lvlid=207&ID=8933 |
| HHS Nutrition Policy Board | Committee, Work group, Advisory group, or Task Force | ACF, AoA, CDC, FDA, HRSA, IHS, OS, SAMHSA | NIDDK | This Board coordinates the Department''s nutrition policy development and program implementation and is the principle point of contact with USDA for nutrition policy. http://dnrc.nih.gov/committee-subcommittee.asp |
| HHS Outreach and Messaging Working Group, Part of the HHS Steering Committee for the Prevention of Healthcare-Associated Infections | Committee, Work group, Advisory group, or Task Force | ACF, AoA, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | CC, NIAID, OD | The WG is developing and implementing several promotional activities to raise awareness and improve behaviors to reduce healthcare-associated infections (HAI). Activities include dissemination of HAI prevention information at nation-wide conferences/events during 2011, development of web-based training on HAI prevention. http://www.hhs.gov/ash/initiatives/hai/incentives.html |
| HHS Violence Against Women Steering Committee | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, HRSA, IHS, OS, OSG, SAMHSA | NIMH, OD | NIMH staff have participated in the HHS Violence Against Women Steering Committee, under the leadership of the HHS/Office on Women''s Health, which coordinates the Department''s responses to research needs, program implementation, service provision, and crisis intervention. This committee has proposed and coordinated department-wide budget initiatives, hosted seminars, and proposed actions to address evolving needs in this area. http://womenshealth.gov/violence-against-women/government-in-action/ |
| HHS Viral Hepatitis Interagency Working Group | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | NIDDK, NCI, NIAID | The HHS Viral Hepatitis Interagency Working Group was created by the Office of the Assistant Secretary for Health to address a recent report sponsored by the Institute of Medicine entitled Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. The group meets to discuss collaborations and activities directed at achieving the goals for viral hepatitis research and control highlighted in the IOM report. http://iom.edu/Reports/2010/Hepatitis-and-Liver-Cancer-A-National-Strategy-for-Prevention-and-Control-of-Hepatitis-B-and-C.aspx |
| HIV Prevention Trials Network (HPTN) Steering Committee | Committee, Work group, Advisory group, or Task Force | CDC | OD/DPCPSI/OAR, FIC, NIAAA, NIAID, NICHD, NIDA, NIMH, NINR, OD | Participate on the Steering Committee for the HIV Prevention Trials Network (HPTN), which is administered by NIAID. http://www.hptn.org/index.htm |
| HIV/AIDS Cancer Match Study | Research Initiative | CDC | NCI | Investigators have used data from the NCI HIV/AIDS Cancer Match Study, in conjunction with data from the CDC surveillance program on the number of HIV-infected people in the U.S., to estimate the contribution of the HIV epidemic to the occurrence of Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer. http://hivmatch.cancer.gov/ |
| HIV/AIDS Prevention Research Synthesis (PRS) Project | Committee, Work group, Advisory group, or Task Force | CDC, HRSA | NIMH, NIDA | This collaboration between NIH, CDC, and HRSA involved the development of criteria for identifying evidence-based behavioral interventions for HIV medication adherence. These criteria were finalized in 2010 after a series of consultations with methodologists, HIV prevention researchers, and key federal partners. The revised criteria focus on quality of study design, quality of study implementation and analysis, and strength of evidence of efficacy. http://www.cdc.gov/hiv/topics/research/prs/ma-efficacy-criteria.htm |
| Hospice to Palliative Care: Maximizing Patient Preferences and Cost Savings | Research Initiative | AHRQ | CC | Redesign Medicare Hospice Benefit. The goal of the study is to provide rational, patient-defined, evidence-based recommendations to inform the redesign of the Medicare hospice benefit, transitioning policy from the current hospice benefit to a more patient-centered palliative care model. http://globalhealth.duke.edu/research/project?pid=149&s=105&p=10&t=0&loc=0&rfm=0 |
| HPTN 052A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy Plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 in Serodiscordant Couples | Research Initiative | CDC | NIAID | These Clinical studies are based on data collected in Africa and Thailand. There is a correlation between HIV viral load (blood levels) and HIV transmission. Specifically, the higher the viral load in the blood, the more likely the chance for transmission. Antiretroviral therapy (ART) reduces the viral load in the blood, as well as in genital secretions (for both men and women), and the drugs can be detected in semen and vaginal and cervical secretions. All of this information strongly suggests that ART may make HIV infected people less contagious. HPTN 052 compares the HIV infection rates of two groups of HIV serodiscordant couples. http://www.hptn.org/research_studies/hptn052.asp |
| Human Nutrition Research Information Management (HNRIM) System | Resource Development | CDC, FDA, HRSA | NIDDK | HNRIM is a searchable database of nutrition research and research training activities supported by the federal government and maintained by the NIH Division of Nutrition Research Coordination (DNRC). http://hnrim.nih.gov |
| I Can Do It - You Can Do It Initiative | Research Initiative | OS | NIDDK | The goal of this initiative is to improve the health of the six million American children who have disabilities by encouraging increased physical activity and healthy nutritional behaviors http://www.hhs.gov/od/physicalfitness.html |
| Image-Guided Interventional Therapeutics | Research Initiative | FDA | CC, NCI, NIAID, NIBIB | This collaboration will lead to safer and more effective treatment planning and performance of image-guided interventions and therapeutic drug delivery. The results of all of these studies of image guided interventions and related technologies and the models used to study them will have a direct impact on the effectiveness and consistency of the FDA CDRH’s preclinical review of device applications while meeting the primary research goal of optimizing image guided interventions and pre-clinical modeling of those interventions. Regulatory science and translational therapeutics have overlapping goals when it comes to drugs + devices combination therapies. |
| Image-Guided Tumor Targeted Delivery (IGTD) in Cancer | Committee, Work group, Advisory group, or Task Force | FDA | NCI | Image-Guided Tumor Targeted Delivery (IGTD) in Cancer workshop, Nov 10, 2010 (Bethesda, MD). This one-day workshop brought together molecular imaging and oncology experts from fields related to IGTD, particularly image-guidance/quantitation and targeted delivery of therapeutics and biologics in cancer. In addition to the extramural investigators, participants included scientists from NCI (intramural and extramural) as well as the FDA (Office of the Commissioner, CDER, and CDRH). The workshop included several short presentations followed by break-out sessions, focused on issues related to the use of imaging in guidance and quantitation of targeted delivery in cancer and various stages of translation of innovative solutions to the clinic. |
| Improving Care for Child and Adult Behavioral Health Clients with Suicidal Ideation and Behavior in Emergency Department Settings Conference | Meeting/ Workshop | SAMHSA | NIMH | On July 26-28, 2011, NIMH partnered with SAMHSA, the Institute for Behavioral Healthcare Improvement, and the Department of Veterans Affairs in the planning and coordination of a meeting to discuss suicide prevention in Emergency Department (ED) settings. The conference was held in conjunction with the National Suicide Prevention Center Lifeline Crisis Centers Conference. The goal of the meeting was to review the empirical basis of and consider best practices for the assessment and care of children and adults with suicidal thoughts and behaviors who present to hospital EDs/urgent care settings. http://www.nimh.nih.gov/research-funding/scientific-meetings/2011/improving-care-in-emergency-departments-for-suicide-ideation/index.shtml |
| Improving Technical Standards and Molecular Tools for Probiotics Research and Development | Research Initiative | FDA | NCCAM | In 2008, the USDA Agricultural Service initiated a Memorandum of Understanding (MOU) with NCCAM to exchange expertise in technology development and partner research initiatives to advance the field of probiotic biology and role in human health. The MOU consists of a five year plan defining common mission goals; expected benefits from the exchange of research expertise and resources; and demonstration projects based on NIH/NCCAM funded U01 cooperative agreements. The long-term goal of the MOU is to develop trans-agency networked initiatives. |
| Indian Health Service Interagency Agreement for Health Promotion and Disease Prevention | Public Education Campaign | IHS | NHLBI | The purpose of this collaboration is to implement cardiovascular health/disease prevention strategies in American Indian and Alaskan Native communities. http://www.nhlbi.nih.gov/health/healthdisp/an.htm |
| Indoor Air Pollution Conference | Research Initiative | CDC, OS | NICHD, FIC, NEI, NHLBI, OD | The World Health Organization lists indoor air pollution (IAP) from primitive household cooking fires in developing countries as the fourth leading cause of morbidity and mortality. The poor of the world typically use biomass (wood, crop residues or dung) or coal as fuel to cook and heat their homes resulting in high levels of IAP. Morbidity and mortality from IAP primarily affect poor women and children. For example, IAP is a major cause of acute pneumonia in children under five; in adult non-smoking women, IAP causes diseases as varied as blindness from cataracts to chronic obstructive pulmonary disease to lung and laryngeal cancer. Although there has been decades of efforts to use improved stove technology to reduce IAP, the success of these efforts has been limited due to a lack of awareness of the problem, limited research into the health risks and the logistical challenges of solving a problem that affects almost 3 billion people on the planet. The National Institutes of Health led a 2 day workshop to present the state of the science on the health impacts of indoor air pollution and to determine critical research gaps that if addressed, will permit implementation of effective strategies to reduce the impact of indoor air pollution and to improve human health for poor women and children everywhere. http://www.nichd.nih.gov/news/resources/spotlight/101411-nih-research-impact-indoor-pollution.cfm |
| Influenza Vaccine Manufacturing Improvement Initiative | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NIAID | A research based HHS interagency collaborative program with industry to 1) optimize influenza virus vaccine strains for production yield and 2) develop faster potency and sterility assays. |
| Institute of Medicine (IOM) Youth Concussions Project | Committee, Work group, Advisory group, or Task Force | CDC | NICHD, NINDS | This project began from interest among members of the Institute of Medicine (IOM)/National Research Council (MRC) Board on Children, Youth, and Families (BCYF) in developing a new activity focused on the topic of sports concussions in youth. A series of conference calls were held in early March 2010 focused on the health and educational issues associated with concussions/mild brain trauma among school-ages populations. The IOM first wanted to explore the need for a workshop or study that could identify key research findings, examine current policies and programs, and offer informed guidance for clinical practices, sports management, and educational settings. Congressional staff have also expressed interest in encouraging IOM to conduct a research review in this area, comparable to the 2002 IOM workshop on the consequences of head impact in youth soccer. To date: 1) IOM has secured funds for "planning meeting" towards a workshop; 2) IOM invites NICHD to attend a planning for the planning meeting on October 1, 2010; and 3) IOM in interested is securing funds for workshop. |
| Institute on Systems Science and Health | Training Initiative | CDC | OD, NIBIB, NIDA | This is a week-long training institute for behavioral and social science research investigators to be introduced to systems science methodologies (agent-based modeling, system dynamic modeling, network analysis). http://obssr.od.nih.gov/training_and_education/issh/index.html |
| Inter-American Drug Abuse Control Commission (CICAD) of the Secretariat for Multidimensional Security of the Organization of American States (OAS) | Committee, Work group, Advisory group, or Task Force | SAMHSA | NIDA, NIAID | The Inter-American Drug Abuse Control Commission (CICAD) was established by the General Assembly of the Organization of American States (OAS) in 1986 as the Western Hemisphere''s policy forum on all aspects of the drug problem. http://www.cicad.oas.org/ |
| Interagency Animal Management Committee | Committee, Work group, Advisory group, or Task Force | CDC, FDA | OD/DPCPSI/OAR, NCATS, NHLBI, NIAID, NIMHD | Reviews experimental protocols for use of federally funded chimpanzees. |
| Interagency Artificial Pancreas Working Group | Committee, Work group, Advisory group, or Task Force | FDA | NIDDK, NIBIB, NICHD | The Interagency Artificial Pancreas Working Group is a group of multi-disciplined scientists and clinicians from the FDA and NIH to support the Artificial Pancreas Initiative. The goals of this initiative are to provide infrastructure for narrowing the gap between basic biomedical knowledge and clinical application of novel technologies, and to cross-fertilize and partner with stakeholders in order to identify and overcome the clinical and scientific challenges to the development of an artificial pancreas. Through collaborative efforts, such as workshops, the group strives to develop innovative strategies to achieve their goals. |
| Interagency Autism Coordinating Committee (IACC) | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, HRSA, OS, SAMHSA | NIMH, NCCAM, NIAID, NICHD, NIDCD, NIDCR, NIEHS, NINDS, NINR | The Interagency Autism Coordinating Committee (IACC) is a Federal advisory committee that coordinates all efforts within the Department of Health and Human Services concerning autism spectrum disorder (ASD). The IACC mission is to: (1) provide advice to the Secretary of Health and Human Services regarding Federal activities related to ASD; (2) facilitate the exchange of information on and coordination of ASD activities among the member agencies and organizations; and (3) increase public understanding of the member agencies'' activities, programs, policies, and research by providing a public forum for discussions related to ASD research and services. http://iacc.hhs.gov |
| Interagency Breast Cancer & Environmental Research Coordinating Committee | Committee, Work group, Advisory group, or Task Force | CDC | NIEHS, NCI | The Interagency Breast Cancer and Environmental Research Coordinating Committee is a congressionally mandated body established by the National Institute of Environmental Health Sciences (NIEHS), in collaboration with the National Cancer Institute (NCI). This Committee is comprised of 19 voting members, including representatives of Federal agencies; non-federal scientists, physicians, and other health professionals from clinical, basic, and public health sciences; and advocates for individuals with breast cancer. The IBCERCC is charged with reviewing federal research efforts concerning the environmental and genomic factors related to breast cancer. This review will culminate in a comprehensive report for the Secretary of the U.S. Department of Health and Human Services, summarizing advances and recommendations regarding research gaps and needs. http://www.niehs.nih.gov/about/boards/ibcercc/index.cfm |
| Interagency Chemical Hazards Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NINDS | Working group on chemical hazards led by the Office of Science and Technology Policy (OSTP). |
| Interagency Chemical Risk Assessment Working Group | Committee, Work group, Advisory group, or Task Force | OS | NINDS, NIAID | Department of Homeland Security led effort to determine chemical hazards and development of Chemical Risk Threat Risk Assessment list of priority chemicals. |
| Interagency Collaborative to Advance Research in Epilepsy (ICARE) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA | NIAAA, FIC, NCATS, NHGRI, NHLBI, NIA, NIAMS, NIBIB, NICHD, NIDA, NIGMS, NIMH, NINDS, NINR, OD | This working group aims to help to increase communication and coordination among Institutes and agencies that support epilepsy-related research. Group members also collaborate with epilepsy researchers and voluntary organizations on scientific workshops. http://www.ninds.nih.gov/research/epilepsyweb/researchers/ICARE/ |
| Interagency Committee on Disability Research | Committee, Work group, Advisory group, or Task Force | AoA, AHRQ, CDC | NINDS, NICHD | The Interagency Committee on Disability Research (ICDR) facilitates the effective exchange of information on disability and rehabilitation research activities among its member agencies by coordinating activities that span the areas of assistive technology and universal design; medical rehabilitation; data and statistics; employment; and community participation. http://www.icdr.us |
| Interagency Committee on Drug Control (ICDC) | Committee, Work group, Advisory group, or Task Force | FDA, OS, SAMHSA | NIDA | This committee facilitates communication between USG agencies involved in the drug control process. |
| Interagency Committee on Emergency Medical Services for Children Research (ICER) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA, OS, SAMHSA | NIMH, NHLBI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIGMS, NINDS, NINR | ICER is a federal collaborative effort begun in the mid-1990’s to improve the quality and quantity of Emergency Medical Services for Children (EMSC) research, to foster collaboration between federal agencies in EMSC research, and to reduce barriers to the production of high quality EMSC research. http://www.childrensnational.org/files/PDF/EMSC/NationalActivities/ICER.pdf |
| Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorder (ICCFASD) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, HRSA, IHS, SAMHSA | NIAAA, NICHD | The purpose of this committee is to improve communication, cooperation, and collaboration among disciplines that address health, education, developmental disability, research, justice, and relevant social issues relevant. NICHD is involved in the following working groups of ICCFASD: 1) Education Working Group, 2) Diagnostic Issue Work Group. http://www.niaaa.nih.gov/AboutNIAAA/Interagency/member.htm |
| Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt-Jakob Disease | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NIDDK, NICHD, NINDS | Coordinates federal efforts to understand how pituitary human growth hormone may have led to the development of Creutzfeldt-Jakob Disease in participants of the National Hormone and Pituitary Program. http://www.niddk.nih.gov/federal/planning/hgh/default.htm |
| Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD) | Committee, Work group, Advisory group, or Task Force | ACF, CDC, OSG, SAMHSA | NIDA, NIAAA | The Consolidated Appropriations Act of 2004 directed the Secretary of Health and Human Services (HHS) to establish the Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD) and to issue an annual report summarizing all Federal agency activities related to preventing underage alcohol use. HHS made ICCPUD a standing committee to provide ongoing, high-level leadership on this issue and to serve as a mechanism for coordinating Federal efforts aimed at preventing and reducing underage drinking. The Substance Abuse and Mental Health Services Administration (SAMHSA) serves as the lead ICCPUD agency. https://www.stopalcoholabuse.gov/aboutus/Default.aspx |
| Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) | Research Initiative | ATSDR, CDC, FDA | NIEHS, NCI, NEI, NIAID, NLM, OD | The Interagency Coordinating Committee on the Validation of Alternative Methods is an interagency committee of 15 Federal agencies that carries out specific duties prescribed by the ICCVAM Authorization Act, P.L. 106-545. The ICCVAM is administered by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods ( NICEATM), a component of the NIEHS. NICEATM in collaboration with ICCVAM and its international collaborators in Japan, the EU, and Canada conducts research studies to evaluate the scientific validity of proposed new safety testing methods. NICEATM and ICCVAM also conduct international scientific peer review evaluations of proposed safety methods, and forward recommendations on scientific valid methods to Federal agencies, which must adopt the proposed methods or provide a basis for not adopting it. NICEATM and ICCVAM also organize scientific workshops to evaluate the current state of the science on a wide range of toxicological and other safety endpoints. http://iccvam.niehs.nih.gov/ |
| Interagency Council on Biomedical Imaging in Oncology (ICBIO) | Meeting/ Workshop | AHRQ, CMS, FDA | NCI | Organized by the Cancer Imaging Program of DCTD, ICBIO is a confidential informational meeting for entities, usually small companies, planning product development in cancer. The Interagency Council on Biomedical Imaging (ICBIO) in Oncology brings together technology developers and representatives from the National Cancer Institute (NCI), Food and Drug Administration (FDA), and Centers for Medicare and Medicaid Services (CMS) to expedite the process of bringing new products to market, to provide advice from a multi-agency perspective on the spectrum of scientific, regulatory, and reimbursement issues related to developing imaging devices or technology. http://imaging.cancer.gov/programsandresources/specializedinitiatives/ICBIO/site |
| Interagency Council on Emergency Research | Committee, Work group, Advisory group, or Task Force | AHRQ, HRSA | NICHD, NHLBI, NIGMS | Representation of NICHD and consultation on pediatric acute care research by PCCR Program. |
| Interagency Group on Alzheimer''s Disease and Related Dementias for implementation of the National Alzheimer''s Project Act | Committee, Work group, Advisory group, or Task Force | AoA, AHRQ, CDC, CMS, FDA, HRSA | NIA | This interagency group was established by HHS in response to the Congressional directive to address Alzheimer''s disease. Under the National Alzheimer''s Project Act, HHS created three sub-groups on Research, Long Term Services, and Clinical Services. The Veteran''s Administration, National Science Foundation, and Department of Defense are also involved in this effort. http://aspe.hhs.gov/daltcp/napa/ |
| Interagency Health Team at the US Embassy, Kampala | Committee, Work group, Advisory group, or Task Force | CDC | NIAID | The Interagency Health Team is part of the US Mission to Uganda and composed of senior level individuals from DoD, CDC, USAID, Peace Corps and NIH. This team is chaired by the Deputy Chief of Mission and meets on a monthly basis to discuss policy level issues regarding US Government health development and research activities in Uganda. The goal of the team is to ensure that all agencies are working in a coordinated fashion in meeting the US Mission to Uganda’s strategic goals, one of which is improving health. |
| Interagency Midazolam Product Coordination Team | Committee, Work group, Advisory group, or Task Force | FDA, OS | NINDS, NIAID | HHS led effort to facilitate activities, both research and regulatory, related to the FDA approval midazolam for use in treating nerve agent exposure. |
| Interagency Modeling and Analysis Group | Committee, Work group, Advisory group, or Task Force | FDA | NIBIB, CSR, FIC, NCI, NCATS, NHGRI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NLM, OD | The Interagency Modeling and Analysis Group (IMAG) is comprised of program directors from nine government agencies in the U.S. and Canada, including the National Institutes of Health (NIH), the National Science Foundation (NSF), Department of Energy (DOE), Department of Defense (DOD), the United States Department of Agriculture (USDA), the Canadian federal research network for Mathematics of Information Technology and Complex Systems (MITACS), the National Aeronautics and Space Administration (NASA), the United States Department of Veterans Administration (USDVA), and the Food and Drug Administration (FDA). The purpose of IMAG is to bring together program officers who have a shared interest in supporting modeling and analysis methods in biomedical, biological and behavioral systems. IMAG has promoted and supported a wide variety of modeling over the past six years, notably the multi-scale modeling (MSM) initiative, which was originally a multi-agency FOA and continued on by different IMAG agencies through separate FOAs. http://www.nibib.nih.gov/Research/IMAG |
| Interagency Pain Research Coordinating Committee (IPRCC) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA | NIDCR, NINDS | Charge to the committee includes, 1) develop a summary of major advances in pain care research supported by Federal Agencies relevant to the diagnosis, prevention, and treatment of pain; 2) identify critical gaps and duplications in basic and clinical pain research across Federal Agencies; 3) make recommendations on how best to disseminate information on pain care; and 4) make recommendations on how to expand public-private partnerships to expand collaborative cross-cutting research |
| Interagency Subcommittee on Disability Statistics (ISDS) | Committee, Work group, Advisory group, or Task Force | ACF, AoA, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | NIDCD | A Government-wide group, the Federal Interagency Subcommittee on Disability Statistics (ISDS), meets monthly to discuss the issues related to identifying people with disabilities and coordinate research in this area. http://www.icdr.us/index.php?option=com_content&view=article&id=34&Itemid=62 |
| Interagency Subcommittee on Education (ISED) of the Interagency Committee on Disability Research (ICDR) | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, HRSA | NICHD | The Interagency Committee on Disability Research (ICDR) is mandated to promote interagency coordination, collaboration, and communication. It must identify, assess, and seek to coordinate all Federal programs, activities, and projects, and plans for such programs, activities, and projects with respect to the conduct of research (including assistive technology research and research that incorporates the principles of universal design) related to rehabilitation of individuals with disabilities. The committee facilitates the effective exchange of information on disability and rehabilitation research activities among its member agencies. We coordinate activities that span the areas of assistive technology and universal design; medical rehabilitation; data and statistics; employment; health disparities, and education. The Interagency Subcommittee on Education (ISED), a subcommittee of ICDR, focuses on issues related to the education of persons with disabilities by collecting input from stakeholders to inform planning; identifying emerging research areas; assessing research gaps, synergies and duplications; and making recommendations to inform the federal research agenda. |
| Interagency Subcommittee on Medical Rehabilitation (ISMR) | Committee, Work group, Advisory group, or Task Force | AoA, AHRQ, CDC | NIBIB, NCI, NCATS, NEI, NHLBI, NIAMS, NICHD, NIDA, NIDCD, NIMH, NINDS, NINR | The Interagency Subcommittee on Medical Rehabilitation (ISMR) is composed of representatives from federal agencies involved in disability and related research including rehabilitation research. After receiving input from targeted individuals, the Committee shall identify, assess, and seek to coordinate all Federal programs, activities, and projects, and plans for such programs, activities, and projects with respect to the conduct of research (including assistive technology research and research that incorporates the principles of universal design) related to rehabilitation of individuals with disabilities. |
| Interagency Task Force on the Arts and Human Development | Committee, Work group, Advisory group, or Task Force | ACF, AoA, SAMHSA | OD, NCCAM, NIA, NICHD, NIMH | Jump-start national research into the arts’ role in improving health and education outcomes. http://www.nea.gov/research/convenings.html |
| Interagency Working Group in Preparation for the Annual U.N. Commission on Narcotic Drugs Meeting | Committee, Work group, Advisory group, or Task Force | FDA, OS, SAMHSA | NIDA | This committee, led by the Department of State, is responsible for preparing the U.S. Delegation to the annual meeting of the U.N. Commission on Narcotic Drugs. International drug scheduling issues are a major focus. |
| Interagency Working Group on Dual Use Research Oversight | Committee, Work group, Advisory group, or Task Force | CDC, OS | OD/OSP, NIAID | Develops policy options for USG oversight of dual use research. |
| Interagency Working Group on Hematopoietic Stem Cells | Committee, Work group, Advisory group, or Task Force | CMS, FDA, HRSA | NIAID | The Interagency Working Group on Hematopoietic Stem Cells keeps representatives from relevant HHS agencies with an interest in hematopoietic stem cell research appraised of new developments and programs to maximize collaboration and synergy. |
| Interagency Working Group on Human Stem Cell Transplantation | Resource Development | CDC, FDA, HRSA | NHLBI | The working group provides a forum for the participating agencies to share information about their current activities in human stem cell transplantation. |
| Interagency Working Group on Youth Programs | Committee, Work group, Advisory group, or Task Force | ACF, CDC, OS | NIAAA, NIDA | The Interagency Working Group on Youth Programs is a federal learning exchange examining how different Federal departments and agencies promote and prioritize the development and use of selected evidence-based strategies for youth. http://findyouthinfo.gov/about.shtml |
| Interagency Working Group to Develop White House National HIV/AIDS Strategy | Committee, Work group, Advisory group, or Task Force | ACF, AoA, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | OD/DPCPSI/OAR, NIAID, NIDA, NIMH, OD | OAR participates in the Leadership Group to implement the President''s National HIV/AIDS Strategy. http://www.whitehouse.gov/administration/eop/onap/nhas |
| INTERMACS - Interagency Registry for Mechanically Assisted Circulatory Support | Resource Development | CMS, FDA | NHLBI | INTERMACS is a national registry for patients who are receiving mechanical circulatory support device therapy to treat advanced heart failure. This registry was devised as a joint effort of the National Heart, Lung, and Blood Institute, the Centers for Medicare and Medicaid Services, the U.S. Food and Drug Administration, clinicians, scientists, and industry representatives, in conjunction with the University of Alabama at Birmingham and the United Network for Organ Sharing. http://www.intermacs.org/ |
| International Experience and Technical Assistance Training Program (IETA) | Training Initiative | CDC, FDA, HRSA | NIMH | The International Experience and Technical Assistance (IETA) program is a developmental training program for Federal public health employees offered by the Center for Global Health at the CDC. Specifically, IETA is a professional development/technical assistance program that consists of three workshops and a supervised short-term overseas assignment with an international public health program. http://www.cdc.gov/globalhealth/ieta/ |
| International TB Working Group | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, IHS, OS | NIAID, FIC, NHLBI, NICHD, NIDA | The working group focuses on coordinating TB research, which includes studies to characterize drug resistance; the identification, preclinical development and clinical evaluation of new drugs, diagnostics, and vaccines; and studies of the epidemiology and transmission of TB, including research addressing HIV/TB co-infection and TB in high-risk populations. |
| International Training and Research in Environmental and Occupational Health | Training Initiative | CDC | FIC, NCI, NICHD, NIEHS | FIC, in collaboration with NIEHS and NIOSH/CDC has developed this program in order to train foreign health scientists, clinicians, epidemiologists, toxicologists, engineers, industrial hygienists, chemists and allied health workers from developing countries and emerging democracies in both general environmental health and occupational health. http://www.fic.nih.gov/Programs/Pages/environmental-occupational-health.aspx |
| Intradepartmental Council for Native American Affairs (ICNAA) | Committee, Work group, Advisory group, or Task Force | OS | NIMHD | To support activities of the ICNAA, including tribal consultation sessions, and development of the annual tribal consultation report. http://www.hhs.gov/intergovernmental/tribal/abouticnaa/icnaa_mission.html |
| Investigations of Early Life Determinants of Pediatric and Adult Malignancies in a Population | Research Initiative | CDC | NCI | In collaboration with investigators from the U.S. CDC and the China CDC, NCI is assessing risk of pediatric leukemia and other pediatric cancers in a large population of offspring of mothers enrolled in a community intervention program of periconception folic acid supplementation in China. Pediatric cancer risks will be compared in offspring of mothers treated vs. offspring of mothers not treated with folic acid supplements. |
| IOM Project: A National Surveillance System for Cardiovascular and Select Chronic Diseases | Other | CDC | NHLBI | The NHLBI and the CDC co-sponsored a committee, convened by the Institute of Medicine, to develop a framework for building a nationwide chronic disease surveillance system focused primarily on cardiovascular disease and chronic obstructive pulmonary disease. http://www.iom.edu/Activities/Disease/SurveilCardioChronicDiseases.aspx |
| JANUS | Resource Development | FDA | NCI | Janus is a study data repository component of a common, standards-based infrastructure that is being jointly developed by the FDA and the NCI to support the exchange of clinical research data. This collaborative effort between FDA and NCI has been ongoing and we are now entering Phase 3. FDA and NCI will explore and evaluate uploading of standard data and their required transport layers into the Janus architecture. FDA intends to store all standardized clinical study data submissions in the NCI Janus data warehouse as part of this phase of Janus development. http://gforge.nci.nih.gov/projects/janus-iii |
| Joint Committee and Joint Commission Meetings | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NCI, FIC, NIAID | US State Department establishes collaborative agreements with foreign governments in fields of science and technology. These Joint Committee and Joint Commission Meetings (JCMs) facilitate discussion on selected topics creating cross-talk among the equivalent government agencies leading towards future collaborations. The OS through OGA organizes the DHHS OP/DIVs; FIC facilitates the NIH ICs participation. For FY2011, JCMs were convened for Brazil, Colombia, and Mexico. |
| Joint Fellowship Program | Training Initiative | FDA | NCI | The objective of the NCI-FDA fellowships is to train a cadre of scientists in research and research-related regulatory review, policies, and regulations so that they develop a skill set that bridge the two disparate processes. Fellows will learn to build awareness of regulatory requirements into the early stages of the medical product development process and develop strategies to improve planning throughout research and regulatory review. http://iotftraining.nci.nih.gov/ |
| Kaposi Sarcoma and HHV8 in Sickle Cell and Other Ugandan Populations | Research Initiative | CDC | NCI | Epidemiological studies are being conducted to assess small-area variation of HHV8 and to learn about socio-demographical and environmental risk factors for HHV8 and Kaposi sarcoma in Uganda. http://dceg.cancer.gov/newsletter/Linkage/linkage112011.pdf |
| Kidney Interagency Coordinating Committee (KICC) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS | NIDDK, NHLBI | The KICC Consists of Federal Representatives involved in chronic kidney disease (CKD) programs. KICC''s purpose is to encourage communication and collaboration to shape a more coordinated Federal response to CKD. http://www.nkdep.nih.gov/about/kicc/cdc-matrix.htm |
| Kidney, Urologic, and Hematologic Diseases Interagency Coordinating Committee (KUHICC) | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS | NIAID, CSR, NCI, NCATS, NHLBI, NIA, NIAMS, NIDDK, NINR | The Kidney, Urologic, and Hematologic Diseases Interagency Coordinating Committee (KUHICC) was created in 1987, and continues to meet as subcommittees for kidney, urology, and hematology about four times a year. The committee is chaired by the Director, Division of Kidney, Urologic, and Hematologic Diseases of the National Institute of Diabetes and Digestive and Kidney Diseases and encourages cooperation, communication, and collaboration among all Federal agencies involved in kidney, urology, and hematology research and other activities. The members share information and advice about ongoing, new, and planned activities and identify potential areas of collaboration. http://www2.niddk.nih.gov/AboutNIDDK/CommitteesAndWorkingGroups/KUHDIC/ |
| Know Stroke in the Community | Public Education Campaign | CDC | NINDS | The NINDS developed the Know Stroke campaign to help educate the public about the symptoms of stroke and the importance of getting to the hospital quickly. The campaign includes outreach to consumers and health care professionals using mass media, grassroots outreach, partnerships, and community education. http://stroke.nih.gov/index.htm |
| Lesbians, Gay, Bisexuals, and Transgender (LGBT) Coordinating Committee | Committee, Work group, Advisory group, or Task Force | ACF, AoA, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | NICHD, OD | This committee includes senior representatives from each operating division to ensure coordination of and inclusion for LGBT populations throughout the Department''s activities. |
| Linking Cardiovascular Health Study Data to CMS Data | Resource Development | CMS | NHLBI | The Cardiovascular Health Study is a population-based, longitudinal study of risk factors for development and progression of cardiovascular disease and stroke in elderly adults. Participant data from the NHLBI Cardiovascular Health Study is being linked to Medicare data to allow researchers to investigate the utilization and costs of medical services within the Medicare Program. CMS is providing the Medicare claims data to NHLBI for this purpose at no cost. http://www.chs-nhlbi.org/default.htm |
| Linking Atherosclerosis Risk in Communities (ARIC) Data to CMS Data | Research Initiative | CMS | NHLBI | The ARIC study, which began in 1985, seeks to 1) monitor trends in the incidence and mortality of coronary heart disease and heart failure through a surveillance program in four communities and 2) assess determinants in development and progression of subclinical and clinical cardiovascular disease (CVD) through a cohort follow-up study of 15,796 white and African American persons aged 45-64 at baseline. Since 2005, CMS data has been provided through an interagency agreement. The data is being used to validate and capture all the heart failure cases in persons aged 65 and older in the ARIC cohorts and to validate and capture morbidity and mortality status of these individuals. In addition, CMS data are being used to enhance ARIC CVD outcomes research by enabling researchers to study determinants related to medical care access, quality, cost, and outcomes. Conference calls are conducted among staff of the study, the CMS, and the NHLBI to discuss the data availability, confidentiality, quality, distribution, and to identify research opportunities. http://www.cscc.unc.edu/aric/ |
| Linking Framingham Heart Study Data to CMS Data | Resource Development | CMS | NHLBI | The Framingham Heart study is a longitudinal study of factors influencing the development of cardiovascular disease. Participant data from the NHLBI-funded Framingham Heart Study is being linked to Medicare data to allow researchers to investigate the utilization and costs of medical services within the Medicare program. CMS is providing the Medicare claims data to NHLBI for this purpose at no cost. http://www.framinghamheartstudy.org/about/index.html |
| Linking Jackson Heart Study Data to CMS Data | Resource Development | CMS | NHLBI | The Jackson Heart Study is an epidemiologic study of cardiovascular disease in blacks in Jackson, Mississippi. The purpose of the collaborative activity is to obtain services and expertise in acquisition and use of Medicare claims data for participants enrolled in the Jackson Heart Study (JHS). Combining the detailed clinical and epidemiological data of the JHS with the Medicare claims data will allow (1) assessment of major events (hospitalizations, stroke, MI) for participants lost to follow-up, (2) validation of selected outcomes reported by participants, and (3) expansion of the JHS research agenda to address questions related to resource use among elderly JHS participants that could not be addressed using the JHS data or Medicare claims data alone. http://jhs.jsums.edu/jhsinfo/ |
| Linking Multi-Ethnic Study of Atherosclerosis Data to CMS Data | Resource Development | CMS | NHLBI | The Multi-Ethnic Study of Atherosclerosis (MESA) is investigating the prevalence, correlates, and progression of subclinical cardiovascular disease in a multi-ethnic cohort. Participant data from the MESA cohort is being linked to Medicare data to allow researchers to identify clinical outcomes and to investigate the utilization and costs of medical services within the Medicare Program. http://www.mesa-nhlbi.org |
| Linking Women''s Health Initiative Data to CMS Data | Resource Development | CMS | NHLBI, NCI, NIA, NIAMS, OD | The Women''s Health Initiative was a study of cardiovascular disease, cancer, and osteoporosis in postmenopausal women. Participant data from the NHLBI Women''s Health Initiative cohort is being linked to Medicare data to allow researchers to identify clinical outcomes and to investigate the utilization and costs of medical services within the Medicare Program. http://www.nhlbi.nih.gov/whi |
| Logical Observation Identifiers Names and Codes (LOINC) | Resource Development | AHRQ, CDC, CMS, HRSA, IHS, OS | NLM | This activity supports the maintenance, distribution, and continued development of LOINC®, a set of universal codes and names to identify laboratory and other clinical observations which facilitates the exchange and pooling of clinical results for clinical care, outcomes management, and research. The Regenstrief Institute, Inc., an internationally renowned healthcare and informatics research organization, maintains the LOINC database and supporting documentation, and the RELMA mapping program. http://www.nlm.nih.gov/research/umls/mapping_projects/loinc_to_cpt_map.html |
| Long-term Oxygen Treatment Trial | Research Initiative | CMS | NHLBI | The Long-term Oxygen Treatment Trial is a randomized controlled clinical trial to assess the efficacy of around-the-clock, supplemental oxygen therapy in subjects with chronic obstructive pulmonary disease and moderately severe hypoxemia. NHLBI will administer and oversee the study, and Medicare will cover the costs of items and medical services that are generally available through that program to beneficiaries enrolled in the trial. http://www.nih.gov/news/pr/nov2006/nhlbi-20.htm |
| Lung Cancer and Diesel Exhaust Among Non-Metal Miners (Nested Case-Control Study) | Research Initiative | CDC | NCI | A retrospective cohort mortality and nested case-control study of about 12,315 non-metal miners (278,041 person-years) to investigate risk of lung cancer in relation to quantitative measures of exposure to diesel exhaust. http://clinicaltrials.gov/ct2/show/NCT00342264 |
| Lupus Federal Working Group | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA, OS | NIAMS, NCCAM, NEI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIMHD, NINDS, OD | The Lupus Federal Working Group, established on behalf of the HHS Secretary by the NIH, facilitates collaboration among NIH components, other Federal agencies, voluntary and professional organizations, and industry groups with an interest in lupus. http://www.niams.nih.gov/About_Us/Committees/lupus_fwg.asp |
| Lyme Disease Coordinating Committee | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NIAID, FIC, NCATS, NIA, NIAMS, NIMH, NINDS | This committee reviews the results of current studies and recent advances in Lyme disease research. |
| Maintenance of an Armadillo Colony | Research Initiative | HRSA | NIAID | This contract supports basic research for leprosy. http://www.hrsa.gov/hansensdisease/ |
| Mapping of the SNOMED CT and ICD Clinical Terminology | Other | CDC, OS | NLM | The U.S. Department of Health and Human Services (HHS) has set a goal for the nationwide implementation of an interoperable health information technology infrastructure to improve the quality and efficiency of health care. Achieving this goal will require that key clinical data elements are captured or recorded in detailed, standardized form (using standard vocabularies, codes, and formats) as close to their original sources (patients, health care providers, laboratories, diagnostic devices, etc.) as possible. If these standardized clinical data can also be used to generate HIPAA- compliant billing transactions automatically, this will provide another incentive for adoption of clinical data standards. For automated generation of bills from clinical data to become a reality, robust mappings from standard clinical terminologies to the HIPAA code sets must be created. http://www.nlm.nih.gov/research/umls/mapping_projects/snomedct_to_icd9cm_reimburse.html |
| Medical Expenditure Panel Survey (MEPS) | Health Survey | AHRQ | NCI | The Medical Expenditure Panel Survey (MEPS) is a set of large-scale surveys of families and individuals, their medical providers, and employers across the United States. MEPS is the most complete source of data on the cost and use of health care and health insurance coverage. http://meps.ahrq.gov/mepsweb/ |
| Medicare Benefit Postcards to Promote Treatment for Glaucoma and Diabetic Eye Diseases | Public Education Campaign | CMS | NEI | NEI worked with CMS to develop and disseminate a Medicare benefit card in English and Spanish which describes eligibility for the Medicare benefit for glaucoma and diabetic eye disease. The postcards are distributed to Medicare beneficiaries, the general public, and to health professionals. http://www.nei.nih.gov/nehep/programs/visionandaging/medicare.asp |
| Memorandum of Understanding (MOU) Between the FDA/Center for Biologics Evaluation and Research (FDA/CBER) and NIH | Other | FDA | NINDS | This MOU provides a mechanism for addressing cross-cutting issues related to therapy development for neurological disorders, from bench science to clinical trials and FDA approval and licensure. MOU is between FDA/CBER and NIH/NINDS http://www.fda.gov/AboutFDA/PartnershipsCollaborations/MemorandaofUnderstandingMOUs/DomesticMOUs/ucm114903.htm |
| Mental Health Surveillance Study | Resource Development | SAMHSA | NIMH | This agreement will support expansion of the NIMH research portfolio in population-based mental health studies that build on established federal survey platforms. The purpose of the expanded survey will be to conduct additional calibration work on the survey data; to assess the feasibility of developing a longitudinal component for future surveys; and to produce up to seven reports related to mental health. |
| Meta-Analysis of the Risk of Guillain-Barre Syndrome Following H1N1 Vaccination | Committee, Work group, Advisory group, or Task Force | FDA | NIAID | Statistical expertise is offered in the design and analysis of multiple safety studies to assess the risk of Guillain-Barre Syndrome following H1N1 vaccination |
| Methylphenidate in Male Rhesus Monkeys | Research Initiative | FDA | NICHD | The purpose of this IAA is to utilize a structure approach to evaluate the safety of this frequently used stimulant in a developing animal model in accordance with FDA protocol E0728701. The information from these experiences will enhance our ability to conduct a safety assessment of methylphenidate in humans. |
| mHealth (Mobile Health Technologies) Evidence meeting | Meeting/ Workshop | CMS, FDA, HRSA | OD, NHLBI, NICHD | Meeting designed to identify methodology to enhance mobile health (mHealth) research. The meeting brought together experts from the research, public and private sectors to address the methods in this area. Enhancing utilization of mobile technology should have a significant public health impact. http://obssr.od.nih.gov/scientific_areas/methodology/mhealth/mhealth-workshop.aspx |
| mHealth (Mobile Health Technologies) Summit 2011 | Meeting/ Workshop | FDA, OS, OSG | OD, FIC, NCI, NHLBI, NIBIB, NICHD, NIDA, NIDDK, NIEHS, NINDS, NLM | Multi-sector meeting on mHealth technology, services, research, utilization and policy; convened by FNIH with multiple partners. NIH contributions included abstract solicitation and review, organizing research sessions and networking meetings around specific topics, and interactions with stakeholders representing foundations, NGOs, industry and academia. http://www.mhealthsummit.org |
| Microbicide Trials Network Executive Committee | Committee, Work group, Advisory group, or Task Force | FDA | OD/DPCPSI/OAR, NIAID, NICHD, NIMH, OD | A committee designed to make strategic decisions and prioritize research for the MTN http://www.mtnstopshiv.org |
| Microsystems Team | Committee, Work group, Advisory group, or Task Force | FDA | NIDDK, NINDS, OD | The NIH has identified a critical need for improved model systems to predict efficacy, safety, bioavailability, and toxicology outcomes for candidate therapeutics. This NIH FOA, supported by funds from the NIH Common Fund and participating NIH IC''s, invites applications for projects that will develop accurate cellular and organ microsystems representative of human physiology for the evaluation of drug efficacy and toxicity. By definition, these cellular and organ microsystems will have a multicellular architecture representing the characteristics and functions of the tissue of origin and will demonstrate a reproducible and viable operation under physiological conditions over a long culture period. It is anticipated that these bio-engineered human tissue models could lead to the development and commercialization of microsystems that will enable rapid and high fidelity evaluation of safety and efficacy for candidate therapeutics. http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-11-022.html |
| Million Hearts | Committee, Work group, Advisory group, or Task Force | AoA, AHRQ, CDC, CMS, FDA, HRSA, SAMHSA | NHLBI, NINDS | The NIH provided input via CMS and CDC on the development and implementation of the Million Hearts Initiative. http://millionhearts.hhs.gov/ |
| Modeling Infectious Disease Agent Systems (MIDAS) Committee for Methicillin-Resistant Staph | Research Initiative | AHRQ, CDC | NIGMS | Consultations and committee participation with MIDAS continues on a study of Methicillin-resistant Staphylococcus aureus (MRSA), a virulent bacterial staph infection that is highly resistant to some antibiotics, and spread among health care settings in Orange County California. https://www.epimodels.org/midas/about.do |
| Models of Infectious Disease Agent Study (MIDAS) | Research Initiative | CDC | NIGMS, FIC | Models of Infectious Disease Agent Study (MIDAS) is a collaboration of research and informatics groups to develop computational models of the interactions between infectious agents and their hosts, disease spread, prediction systems and response strategies. The models will be useful to policymakers, public health workers and other researchers who want to better understand and respond to emerging infectious diseases. If a disease outbreak occurs, the MIDAS network may be called upon to develop specific models to aid public officials in their decision-making processes. http://www.nigms.nih.gov/Research/FeaturedPrograms/MIDAS/ |
| Moving Towards a Coordinated HHS Approach to Sustainability: Strategies for Sustainable Change | Committee, Work group, Advisory group, or Task Force | CDC, HRSA, SAMHSA | NHLBI | The purpose of the collaborative activity was to plan a workshop with the HHS Office of Women''s Health entitled "Moving Towards a Coordinated HHS Approach to Sustainability: Strategies for Sustainable Change." |
| Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group | Committee, Work group, Advisory group, or Task Force | CMS, FDA | NHLBI, NIAMS, NIBIB, NICHD, NIDCD, NIDCR | The MATES provides a forum for federal agencies involved in tissue science and engineering to stay informed of each other''s activities and coordinate research efforts. http://www.tissueengineering.gov/ |
| Multinational Influenza Seasonal Mortality Study (MISMS) Research | Research Initiative | OS | FIC, NHLBI, NIAID, NLM | MISMS was originally initiated to analyze national and global mortality patterns associated with influenza virus circulation. The focus of MISMS has since expanded to evaluate the interaction between the epidemiology, ecology, and evolutionary dynamics of influenza, including natural selection, reassortment, migration, and antigenic change. Multinational and bilateral collaborations developed by MISMS collect, analyze, and disseminate research findings through scientific publications, training workshops, and communication tools for investigators and decision-makers. Our research findings inform numerous national governments, multilateral organizations, and research stakeholders on interventions for both pandemic and seasonal influenza. To date, data have been acquired from more than 30 countries (representing ~3.2 billion people), resulting in over 100 publications. http://www.origem.info/misms/index.php |
| Muscular Dystrophy Coordinating Committee (MDCC) | Committee, Work group, Advisory group, or Task Force | ACF, CDC, FDA, HRSA | NIAMS, NHLBI, NICHD, NINDS | Coordinate activities across NIH and with other Federal health programs and activities relevant to the various forms of muscular dystrophy. http://www.ninds.nih.gov/find_people/groups/mdcc/index.htm |
| Nanotechnology Characterization Laboratory | Research Initiative | FDA | NCI, NIEHS | The Nanotechnology Characterization Laboratory (NCL) performs and standardizes the preclinical characterization of nanomaterials intended for cancer therapeutics and diagnostics developed by researchers from academia, government, and industry. The NCL serves as a national resource and knowledge base for cancer researchers and facilitates the development and translation of nanoscale particles and devices for clinical applications. http://ncl.cancer.gov/ |
| National Academies Workshop: Emerging Technologies for Measuring Individual Exposomes | Meeting/ Workshop | ATSDR, CDC, FDA | OD, NICHD, NIEHS | This workshop will take a close look at emerging technologies that can be used to gather individual exposure information based upon external and internal measurements. Presentations and discussions will explore which of the technologies are “ready now” and which are still “emerging” for use in environmental health research. Particular attention will be paid to the relative advantages and disadvantages of external and internal measurements for characterizing individual exposomes and for performing EWAS (Environment-Wide Association Study). Exposomes are the measure of total exposures of an individual in a lifetime and how those exposures relate to heatlh. Recent proof-of-concept studies will be highlighted and bioinformatic tools will be discussed. This synthesis should inform researchers and policy makers about the critical roles that the exposome concept and new technologies can play in understanding the origins of human diseases. http://nas-sites.org/emergingscience/workshops/individual-exposomes/ |
| National Action Alliance for Suicide Prevention (NAASP) | Committee, Work group, Advisory group, or Task Force | AoA, CDC, HRSA, IHS, OS, OSG, SAMHSA | NIMH | The National Action Alliance for Suicide Prevention (NAASP) is a public-private partnership for advancing the National Strategy for Suicide Prevention. The mission of the NAASP is to champion suicide prevention as a national priority; to catalyze efforts to implement high priority objectives of the NAASP; and to cultivate the resources needed to sustain progress. The NIMH Director is an ex officio member of the NAASP Executive Committee and Co-Chair of the NAASP Research Task Force. Additional NIMH staff serve on task forces pertaining to LGBT Youth, Military and Veterans, Youth in Justice Settings, and American Indian/Alaska Natives. http://actionallianceforsuicideprevention.org/ |
| National Advisory Board for Medical Rehabilitation Research | Committee, Work group, Advisory group, or Task Force | CDC, CMS | NICHD, CSR, NCI, NCATS, NHLBI, NIA, NIAMS, NIBIB, NIDCR, NINDS, NINR | The Board meets twice a year to advise the directors of NIH, NICHD, and NCMRR on matters and policies relating to the Center''s programs. The Board comprises 12 members representing health and scientific disciplines related to medical rehabilitation and 6 members representing persons with disabilities. http://www.nichd.nih.gov/about/overview/advisory/nmrrab/ |
| National African-American Youth Initiative (NAAYI) | Training Initiative | OS | NEI, NCATS, NIAAA, NIMH, NIMHD | The NAAYI allows qualified African-American students nationwide to learn about careers in biomedical research and other professional opportunities within the government and the private sector. Y1-MD-4002 http://www.anmanet.org/index.php?option=com_content&view=article&id=5&Itemid=7 |
| National Alcohol and Drug Addiction Recovery Month Planning | Public Education Campaign | SAMHSA | NIAAA, NIDA | For more than 20 years, the National Alcohol and Drug Addiction Recovery Month campaign has joined together millions of people to celebrate recovery and educate communities about addiction. Supported by the efforts of the Planning Partners, Recovery Month is a fundamental part of raising awareness outside the treatment and recovery community of the potential for recovery from alcohol and drug addiction. http://www.recoverymonth.gov/ |
| National Ambulatory Medical Care Survey Asthma Supplement - Interagency Agreement with CDC/National Center for Health Statistics (NCHS) | Health Survey | AHRQ, CDC | NIEHS, NHLBI, NIAID, NICHD | Developed a survey of a national sample of primary care health providers and specialists likely to see asthma patients to gauge implementation of the NHLBI Guidelines for the Diagnosis and Management of Asthma. http://www.cdc.gov/namcs/ |
| National Asthma Control Initiative/National Asthma Education and Prevention Program | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NHLBI, NIAID, NIEHS | The National Asthma Control Initiative (NACI) is a national effort to facilitate implementation of the National Asthma Education and Prevention Program (NAEPP) Expert Panel Report-3 Asthma Guidelines implementation panel report. The NAEPP, which was initiated in 1989, seeks to enhance the quality of life for patients with asthma and decrease asthma-related morbidity and mortality by improving asthma awareness, diagnosis, and treatment. http://www.nhlbi.nih.gov/health/prof/lung/asthma/naci/ |
| National Asthma Education and Prevention Program Federal Liaison Group on Asthma (FLGA) | Committee, Work group, Advisory group, or Task Force | AHRQ, ATSDR, CDC, CMS, FDA, HRSA, OS | NIAID, NHLBI, NIA, NICHD, NIEHS, NIMHD, NINR | The Federal Liaison Group on Asthma is a subcommittee of the National Asthma Education and Prevention Program that is charged with addressing ways to strengthen and improve the coordination of asthma-related activities across agencies of the Federal Government. The group provides a forum for federal agencies with major interest in asthma to exchange ideas and explore collaborative activities. http://www.nhlbi.nih.gov/about/naepp/naep_pd.htm |
| National Birth Defects Prevention Network (NBDPN) - Expanded Collaboration Possibilities | Meeting/ Workshop | CDC | NIDCR, NICHD | Meeting of NIH staff, CDC staff, and investigators from the National Birth Defects Prevention Network to discuss ongoing projects, challenges, and possibilities for expanded collaboration. As a follow-on, a Birth Defects Genetics Workshop is scheduled for November 2, 2010 (FY2011). http://www.nbdpn.org |
| National Children''s Study | Research Initiative | CDC | NICHD | The NICHD leads a consortium of federal agencies in conducting the National Children''s Study (NSC). This study is a large longitudinal study on the environmental effects of children''s health. This IAA is an agreement between CDC and NICHD in supporting the NCS. CDC will prescreen biological sample collection supplies for environmental contaminants and conduct laboratory analysis of biological samples. http://www.nationalchildrensstudy.gov/Pages/default.aspx |
| National Children''s Study Interagency Coordinating Committee | Committee, Work group, Advisory group, or Task Force | CDC | NICHD, NIEHS | Initiated in 2000-2001, the NCS Interagency Coordinating Committee represents the lead agencies for the Study and oversees broad Study issues and ensures interagency collaboration. The representatives assure that at a high level, the mission and goals of the National Children''s Study are maintained over time and that they reflect the scientific priorities of the Study''s four lead agencies. The committee is made up of staff from the U.S. Department of Health and Human Services (including the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Environmental Health Sciences, of the National Institutes of Health, and the Centers for Disease Control and Prevention), and the U.S. Environmental Protection Agency. http://www.nationalchildrensstudy.gov/about/organization/icc/Pages/default.aspx |
| National Coalition for Health Professional Education in Genetics/(NCHPEG) | Public Education Campaign | HRSA | NHGRI, NCI, NEI, NICHD | Independent umbrella organization promoting education of health professionals regarding genetics and genomics. Also conducts relevant research activities. http://www.nchpeg.org/ |
| National Collaborative on Childhood Obesity Research (NCCOR) | Research Initiative | CDC | NIDDK, NCI, NHLBI, NICHD, OD | The mission of the National Collaborative on Childhood Obesity Research (NCCOR) is to improve the efficiency, effectiveness and application of childhood obesity research and to halt—and reverse—the current childhood obesity trend through enhanced coordination and collaboration. NCCOR accelerates progress to reduce childhood obesity in the United States by maximizing outcomes from research, building the capacity for research and surveillance, creating and supporting the mechanisms and infrastructure needed for research translation and dissemination and supporting evaluations. http://www.nccor.org/index.html |
| National Conversation on Chemical Exposures and Public Health | Committee, Work group, Advisory group, or Task Force | ATSDR, CDC | NIEHS | A collaboration between government staff and public stakeholders to develop an action agenda — clear, achievable recommendations — that can help government agencies and other organizations strengthen their efforts to protect the public from harmful chemical exposures. http://www.atsdr.cdc.gov/nationalconversation/ |
| National Diabetes Education Program (NDEP) | Public Education Campaign | CDC | NIDDK | "Established in 1997, the National Diabetes Education Program is a federally-funded program sponsored by the U.S. Department of Health and Human Services’ National Institutes of Health and the Centers for Disease Control and Prevention and includes over 200 partners at the federal, state and local levels, working together to improve the treatment and outcomes for people with diabetes, promote early diagnosis, and prevent or delay the onset of type 2 diabetes. " http://www.ndep.nih.gov |
| National Drug Facts Week | Public Education Campaign | SAMHSA | NIDA, NIAAA | NIDA launched this new national health awareness week in November 2010 to bring together teens and scientific experts to discuss the facts about drug abuse. The observance is being supported by offices in multiple federal agencies that share an interest in preventing teen drug abuse: ONDCP, US Department of Education, US Department of Transportation, US Department of Justice, and US Department of Defense. http://www.drugfactsweek.drugabuse.gov |
| National Emphysema Treatment Trial | Committee, Work group, Advisory group, or Task Force | AHRQ, CMS | NHLBI | NETT was a landmark randomized clinical study to evaluate lung volume reduction surgery. The study researchers continue to disseminate results. http://www.nhlbi.nih.gov/health/prof/lung/nett/lvrsweb.htm |
| National Evaluation of the Maternal, Infant and Early Childhood Evidence-Based Home Visiting Programs to Prevent Child Maltreatment (EBHV) | Research Initiative | ACF, HRSA | OD | NIH is contributing funds to support the planning and implementation of the national evaluation of the Supporting Evidence-Based Home Visiting Programs to Prevent Child Maltreatment (EBHV) initiative. ACF has funded Mathematica Policy Research and Chapin Hall at the University of Chicago to conduct a cross-site evaluation of the grantees'' programs. The primary purpose of the cross-site evaluation is to identify successful strategies for adopting, implementing, and sustaining high-quality home visiting programs to prevent child maltreatment. |
| National Forum for Heart Disease and Stroke Prevention | Committee, Work group, Advisory group, or Task Force | CDC | NHLBI, NHGRI, NINDS | The Forum was founded to implement a public health action plan to prevent heart disease and stroke. http://hearthealthystrokefree.org/ |
| National Health and Nutrition Examination Survey (NHANES) | Health Survey | ACF, CDC, FDA, OS | NIA, NCI, NHLBI, NIDDK, OD | A program of studies designed to assess the health and nutritional status of adults and children in the United States. The survey is unique in that it combines interviews and physical examinations. http://www.cdc.gov/nchs/nhanes.htm |
| National Health and Nutrition Examination Survey (NHANES) Components | Research Initiative | CDC | NCI, NHLBI, NIA, NIDDK, OD | For NHANES 2011-14, NCI proposed and coordinated funding from multiple NIH institutes and the Department of Defense for two components: a new technology physical activity monitor to be worn on the wrist and measurement of muscle strength using a hand-grip dynamometer. The wrist-worn accelerometer will provide the first objective measurement of sleep duration in a nationally representative sample, in addition to measuring physical activity movement. The muscle-strength measure will provide an indicator of total body strength for children, adults, and older adults who are NHANES participants. http://riskfactor.cancer.gov/studies/nhanes/ |
| National Health and Nutrition Examination Survey (NHANES): Hearing Component | Health Survey | CDC | NIDCD | To provide support to the National Center for Health Statistics (NCHS), CDC for audiometry testing and related questions on hearing loss and noise exposure in adults ages 20 to 69 years in the National Health and Nutrition Examination Survey (NHANES), including hearing thresholds in each ear at 500, 1000, 2000, 3000, 4000, 6000, and 8000 Hz. http://www.cdc.gov/nchs/nhis.htm |
| National Health and Nutrition Examination Survey 2010-2012: Chemosenses Component | Health Survey | CDC | NIDCD | The purpose of this agreement is to provide funding for a collaborative effort with the National Center for Health Statistics (NCHS) to pilot test the chemosenses component in persons age 40 and older, and implement in the survey pending a successful pilot. The chemosenses component will consist of 1) household interview questions to define the prevalence of self-reported taste and smell disorders, and to identify risk factors and confounders for the analysis of the taste and smell exam data; 2) smell testing using two modified Pocket Smell Identification Tests, a "scratch and sniff'' test with 8 odorants; and 3) taste testing performed using small amounts of liquids that can be spit out afterwards. For Taste testing, the respondent will be asked both to identify and to rate the intensity of the stimulus. http://www.cdc.gov/nchs/nhis.htm |
| National Health and Nutrition Examination Survey Oral Health Component: | Health Survey | CDC | NIDCR | Periodic oral health component of National Health and Nutrition Examination Survey (NHANES); enamel fluorosis imaging study for inclusion in future NHANES http://www.cdc.gov/nchs/nhanes.htm |
| National Health Interview Survey (NHIS) | Health Survey | CDC | NCI | The National Health Interview Survey (NHIS) - started in 1957 - is a continuous, nationwide in-person survey of approximately 35,000 households, or about 87,500 persons, in the civilian non-institutionalized population. The NHIS over samples African-American and Hispanic respondents. NCI periodically sponsors a Cancer Control Supplement (CCS) which is administered to a randomly selected sample of 39,000 adults. http://appliedresearch.cancer.gov/surveys/nhis/ |
| National Health Interview Survey (NHIS): Complementary and Alternative Medicine (CAM) Data Collection | Health Survey | CDC | NCCAM, NHLBI, NIA, NIMH, NINDS, OD | The National Health Interview Survey (NHIS), carried out by the CDC, is a national survey that annually monitors the Nation’s health through personal interviews of a representative sample of the civilian, non-institutionalized U.S. population. Complementary and Alternative Medicine (CAM) related questions are posed to about 30,000 randomly selected NHIS participants every 5 years. The data from the survey provides many fascinating insights into the types of CAM people use, the reasons for which they turn to CAM, and changes that have occurred since the last time CAM questions were included in the survey. http://www.cdc.gov/nchs/nhis.htm |
| National Health Interview Survey (NHIS): Diabetes Components | Health Survey | CDC | NIDDK | NIDDK provides support for the development of the diabetes interview components and funding for collection of data. http://www.cdc.gov/nchs/nhis.htm |
| National Hispanic Science Network (NHSN) | Committee, Work group, Advisory group, or Task Force | SAMHSA | NIDA, NIAAA, NIAID, NIMH | Serve as a federal liaison that provides critical knowledge and guidance to NHSN''s national network of research scientist and graduate student members. http://nhsn.med.miami.edu/x44.xml |
| National Hispanic Youth Initiative (NHYI) | Training Initiative | OS | NEI, NCATS, NIAAA, NIGMS, NIMH, NIMHD | The NHYI allows qualified Hispanic students nationwide to learn about careers in biomedical research and other professional opportunities within the government and the private sector. Y1-MD-1002 http://www.icps.org/Default.aspx?tabid=2078 |
| National HIV Prevention Conference | Committee, Work group, Advisory group, or Task Force | CDC, HRSA, OS, SAMHSA | OD/DPCPSI/OAR, NIDA, NIMH, OD | Planning Committee for national conference on HIV prevention that is held every other year. http://www.2011nhpc.org/ |
| National Institutes on Deafness and Other Communication Disorders (NIDCD) Resources Directory | Resource Development | AHRQ, CDC, CMS | NIDCD | The NIDCD Resources Directory is designed to encourage networking among individuals and organizations with an interest in the diseases and disorders of human communication. The directory is maintained in an online database as well as published biannually in booklet form. The NIDCD pays to maintain and publish the directory, however several HHS agencies are featured in it. http://www.nidcd.nih.gov/directory/ |
| National Kidney Disease Education Program | Public Education Campaign | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS | NIDDK, NHLBI | "NKDEP is an initiative of the National Institutes of Health, designed to reduce the morbidity and mortality caused by kidney disease and its complications. NKDEP aims to improve early detection of chronic kidney disease (CKD), facilitate identification of patients at greatest risk for progression to kidney failure, promote evidence-based interventions to slow progression of CKD, and support the coordination of Federal responses to CKD. http://www.nkdep.nih.gov |
| National Longitudinal Mortality Study | Resource Development | CDC | NIA, NCI, NHLBI | A national, longitudinal, mortality study to study the effects of differentials in demographic and socio-economic characteristics on mortality. http://www.census.gov/did/www/nlms/ |
| National Native American Youth Initiative (NNAYI) | Training Initiative | OS | NEI, NCATS, NIAAA, NIGMS, NIMH, NIMHD | The NNAYI allows qualified Native American students nationwide to learn about careers in biomedical research and other professional opportunities within the government and the private sector. Y1-MD-1011 http://www.aaip.org/?page=NNAYI |
| National Obesity Action Forum and Other Follow up Meetings to the Surgeon General''s Call to Action to Prevent and Decrease Overweight and Obesity | Committee, Work group, Advisory group, or Task Force | AoA, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG | NIDDK | The objective is to stimulate and share the outcomes of grassroot efforts at the state and local community level to address the public health problem of overweight and obesity. |
| National Partnership for Action to End Health Disparities (NPA): Federal Interagency Health Equity Team (FIHET) | Committee, Work group, Advisory group, or Task Force | ACF, AoA, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | NIMH, NCI, NCATS, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMHD, NINR, OD | The National Partnership for Action to End Health Disparities (NPA) is sponsored by the Office of Minority Health, HHS. The Federal Interagency Health Equity Team (FIHET) was established to foster communications and activities of the NPA within federal agencies and their partners; and to increase the efficiencies and effectiveness of related policies and programs at the national, state, tribal, and local levels. NIMH staff serve on the FIHET, including co-chairing the Leadership Subcommittee and participating on the Data, Research, and Evaluation Subcommittee. http://www.minorityhealth.hhs.gov/npa/ |
| National Prevention Strategy | Committee, Work group, Advisory group, or Task Force | AoA, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | NHLBI, NCI, NIDDK, OD | The NIH provided input via an HHS committee on the development and implementation of the National Prevention Strategy. http://www.healthcare.gov/prevention/nphpphc/strategy/index.html |
| National Robotics Initiative | Research Initiative | FDA | NIBIB, NCATS, NIA, NICHD, NINDS, NINR | The Office of Science and Technology Policy (OSTP) is creating a "National Robotics Initiative" to promote research in a variety of robot-related topics. NIH has been asked to join as a major civilian aspect of this coordinated inter-agency plan which will incorporate agencies from the Departments of Defense, Education, Health and Human Services, and Commerce. The National Center for Medical Rehabilitation Research would like to issue a Program Announcement focusing on the human/machine interaction aspect of incorporating robots into the healthcare and rehabilitation system, with particular emphasis on the needs of people with disabilities. The goal is not to develop robotic technologies, but to understand the human factors required for successful integration. http://grants.nih.gov/grants/guide/notice-files/NOT-EB-11-006.html |
| National Science Advisory Board for Biosecurity (NSABB) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | OD/OSP, NIAID | Advises USG on oversight of dual use life sciences research. http://oba.od.nih.gov/biosecurity/biosecurity.html |
| National Survey of Family Growth | Health Survey | ACF, CDC | NICHD | The National Survey of Family Growth (NSFG) gathers information on family life, marriage and divorce, pregnancy, infertility, use of contraception, and men''s and women''s health. The survey results are used by the U.S. Department of Health and Human Services and others to plan health services and education programs, and to do statistical studies of families, fertility, and health. http://www.cdc.gov/nchs/nsfg.htm |
| National Women''s Health Week | Other | ACF, AoA, AHRQ, CDC, CMS, FDA, HRSA, SAMHSA | OD, CC, CIT, CSR, FIC, NCCAM, NCI, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM | This is a weeklong health observance to empower women to make their health a top priority and encourages women to take simple steps for a longer, healthier, and happier life. This nationwide initiative is collaboration between federal departments, agencies, state and local governments and the general public. |
| Native American Research Center for Health (NARCH) | Research Initiative | AHRQ, HRSA, IHS, OS | NIGMS, CSR, NCCAM, NCI, NCATS, NHGRI, NHLBI, NIAAA, NIAID, NIAMS, NIDA, NIDCR, NIDDK, NIMH, NIMHD | This NIH-wide program supports partnerships between American Indian (AI), Alaska Native (AN), or Tribally-based organizations and institutions that conduct intensive academic-level biomedical, behavioral and health services research in an effort to build a research infrastructure of core components for capacity building and to reduce health disparities in AI/AN communities. Y1-MH-8221 http://www.ihs.gov/Research/index.cfm?module=narch |
| Native American Research Centers for Health (NARCH) V program at the National Congress of American Indians Policy Research Center (NCAIPRC), Univ. of New Mexico and Univ. of Washington | Research Initiative | IHS | OD, NIGMS | The objectives of the supported project are to conduct research on community-based participatory research (CBPR) processes in various contexts, and relationships between processes and outcomes; develop a national Community of Practice to advance the science of CBPR; and examine outcomes focusing on system change and capacity change in communities to reduce health disparities and improve health status. http://narch.ncaiprc.org |
| Natural Experiments and Effectiveness Studies in the Prevention and Control of Diabetes | Research Initiative | CDC | NIDDK | This project will focus on population-targeted interventions that health systems, communities, and governments can undertake to reduce the incidence of diabetes and its complications. This project will also strengthen the capacity of CDC and NIDDK to conduct vital health services and health policy research related to diabetes prevention and care. |
| NEI/FDA Endpoints Symposium: Use of Functional Vision Endpoints in Visual Prostheses Product Development | Meeting/ Workshop | FDA | NEI | Conference aims were to obtain recommendations for measuring specific tasks of mobility and daily living activities as well as how they will be analyzed and correlated with objective measures of visual acuity and contrast sensitivity in the clinical trial. http://www.arvo.org/eweb/startpage.aspx?site=epoints11 |
| Network for Improvement of Access to Treatment (NIATx) | Research Initiative | SAMHSA | NIDA | Research grant focused on helping drug abuse treatment organizations develop practice improvement procedures to get patients enrolled in treatment. http://www.niatx.net |
| Network for Translational Research (NTR): Optical Imaging in Multimodality Platforms | Research Initiative | FDA | NCI | NTR is a U54 research network. The goals are to develop and validate the next generation of imaging platforms that address the cancer problem. The network structure is designed to develop a consensus on their validation with an overall aim to accelerate the FDA approval of these imaging platforms http://imaging.cancer.gov/programsandresources/specializedinitiatives/ntroi |
| Neural Interfaces Conference | Meeting/ Workshop | FDA | NIBIB, CSR, NEI, NIA, NICHD, NIDCD, NINDS, OD | The Neural Interfaces research community consists of investigators, supported by grants or contracts, who are working in areas that include functional neuromuscular/electrical stimulation, auditory prosthesis, cortical prosthesis, neuromodulation, microelectrode array technology, brain computer/machine interfaces and other related areas. This conference was held in June of 2010. NIH Program Officers reviewed abstracts. http://www.ninds.nih.gov/research/npp/ |
| Newborn Screening Coding and Terminology Guide | Resource Development | CDC, HRSA, OS | NLM, NHGRI, NICHD | This ongoing collaboration develops, supplements and publicizes a free online resource with guidance to help promote efficient electronic exchange of standardized newborn screening data. Related efforts include: studying the screening process for diseases including severe combined immunodeficiency (SCID), lysosomal storage disorders (LSDs), and critical congenital heart disease (CCHD), and developing standard codes for ordering and reporting the results of newborn screening for SCID, CCHD, and other conditions added to the Uniform Recommended Screening Panel by the Secretary''s Advisory Committee on Heritable Disorders in Newborns and Children. http://newbornscreeningcodes.nlm.nih.gov/ |
| Newborn Screening Committee | Committee, Work group, Advisory group, or Task Force | CDC, HRSA | NICHD, NHLBI, NLM | The NIH, HRSA, CDC, the American College of Medical Genetics and the Genetic Alliance meet monthly, in person or online, to discuss and coordinate current activities and initiatives in newborn screening. Topics include the activities of the Newborn Screening Translational Research Network Coordinating Center, the Clearinghouse for Newborn Screening information, Sickle Cell Screening Programs, the CDC Quality Control program for Newborn Screening, and the Regional Newborn Screening Collaboratives. http://www.nichd.nih.gov/news/resources/spotlight/101309-newborn-screening.cfm |
| NIDA Consultative Assistance to the FDA Regarding Domestic Scheduling of New Medications | Other | FDA | NIDA | Subsequent to the filing of a New Drug Application by a pharmaceutical company, the FDA prepares an “8-factor analysis” of abuse liability and prepares a draft scheduling recommendation. NIDA reviews the draft documents and provides advice regarding potential revisions. |
| NIH American Association for Clinical Chemistry (AACC) Statistics and Experimental Design Workshop | Meeting/ Workshop | FDA | NCI, NHLBI | Stakeholders in the disease biomarker community gathered to discuss statistical design of biomarker discovery experiments and verification experiments. |
| NIH Consensus Development Conference: Diagnosing Gestational Diabetes Mellitus | Meeting/ Workshop | AHRQ, CDC | OD, NICHD, NIDDK, NINR | Gestational diabetes mellitus (GDM) is a condition in which women without previously diagnosed diabetes exhibit high blood glucose levels during pregnancy (especially during the third trimester of pregnancy). GDM is estimated to occur in 1-14% of U.S. pregnancies, affecting more than 200,000 women annually. It is one of the most common disorders in pregnancy and is associated with an increased risk of complications for the mother and child. Debate continues regarding the choice of tests and the effectiveness of treatment, especially in women with mild to moderate glucose intolerance. To better understand the benefits and risks of various GDM screening and diagnostic approaches, the NIH engaged in a rigorous assessment of the available scientific evidence. An evidence report on GDM will be prepared, and a Consensus Development Conference will be held on October 29–31, 2012 http://consensus.nih.gov/2012/gdm.htm |
| NIH Consensus Development Conference: Inhaled Nitric Oxide Therapy for Premature Infants | Meeting/ Workshop | AHRQ, CDC | OD, NHLBI, NICHD | The final product of an NIH Consensus Conference is a written statement on a controversial medical topic prepared by an independent panel of health professionals free from conflicts of interest on the basis of the results of a systematic literature review, presentations by experts in the field, and public comments and questions. Inhaled nitric oxide therapy was approved by the U.S. Food and Drug Administration in 2000 to treat term and near-term infants with respiratory failure. Since its approval, researchers have examined expanding the use of inhaled nitric oxide therapy to treat premature babies born at less than 34 weeks gestation. Studies to evaluate its safety and efficacy for these infants have had mixed results in terms of key outcomes. The goal of this conference was to clarify the role of inhaled nitric oxide in this population. The meeting was held on October 27-29, 2010. http://consensus.nih.gov/2010/ino.htm |
| NIH Recombinant DNA Advisory Committee | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | OD/OSP, NCI, NHGRI, NIAID, NINDS | Advises NIH on the safe and ethical conduct of basic and clinical research involving recombinant DNA. http://oba.od.nih.gov/rdna_rac/rac_about.html |
| NIH State-of-the-Science Conference: Role of Active Surveillance in the Management of Men With Localized Prostate Cancer | Meeting/ Workshop | AHRQ, CDC | OD, NCI | Prostate cancer is the second leading cause of cancer-related deaths among men in the United States. It is estimated that in 2010, approximately 32,000 American men died of prostate cancer and 218,000 were newly diagnosed with the disease. Most prostate cancers are detected by a blood test that measures prostate-specific antigen (PSA), a tumor marker. More than half of cancers detected with PSA screening are localized (confined to the prostate), not aggressive at diagnosis, and unlikely to become life-threatening. However, 90 percent of patients receive immediate treatment for prostate cancer, such as surgery or radiation therapy. In many patients, these treatments have substantial short- and long-term side effects without any clinical benefit. Appropriate management of screen-detected, early-stage, low-risk prostate cancer is an important public health issue given the number of men affected and the risk for adverse outcomes, such as diminished sexual function and loss of urinary control. To better understand the benefits and risks of active surveillance and other observational management strategies for PSA-screening-detected, low-grade, localized prostate cancer, the NIH engaged in a rigorous assessment of the available scientific evidence. After weighing the evidence, an unbiased, independent panel prepared and presented a statement addressing the key questions. The conference was held December 5-7, 2011. http://consensus.nih.gov/2011/prostate.htm |
| NIH Translational Research Interest Group | Committee, Work group, Advisory group, or Task Force | FDA | NCI, CC, CIT, CSR, NCCAM, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD | As Chair of the NIH Translational Research Interest Group (TRIG), the NCI staff has coordinated Forums, Workshops, NIH Bench-to-Bedside Awardees’ Lecture Series, and Monthly Seminar Series to help bridge the gap between laboratory research and clinical applications; suggestions of topics and speakers for the Annual NIH Research Festivals; and nominations of speakers for the NIH Wednesday Afternoon Lecture Series and the NIH Director’s Lecture Series. The NCI staff has informed the TRIG members of scientific events coordinated with other NIH Scientific Interest Groups and Working Groups. http://sigs.nih.gov/trig/ |
| NIH/CMS Coordinating Committee for Trials and Data Sharing | Committee, Work group, Advisory group, or Task Force | CMS | NIDDK, NCI, NCATS, NIA | NIH and CMS meet periodically to discuss areas of common interest with respect to both clinical trials and research data. The lead for NIH is NCRR. |
| NIH/CMS Interagency Committee | Committee, Work group, Advisory group, or Task Force | CMS | NHLBI, NCI, NCATS, NEI, NIA, NIDDK | The NIH-CMS Committee is a trans-NIH committee that fosters collaboration between NIH and CMS to fulfill their respective missions. |
| NIH/FDA Interagency Clinical Outcome Assessments Working Group | Committee, Work group, Advisory group, or Task Force | FDA | NIA, CC, NCCAM, NCI, NHLBI, NIAMS, NICHD, NIDDK, NIMH, NINDS, OD | The NIH-FDA Interagency Clinical Outcome Assessments Working Group is a chartered group. The purpose of the group is for the two agencies to work together strategically to foster science and processes related to the development and application of Clinical Outcome Assessments for use in medical product development and clinical and translational research to support regulatory science. http://outcomes.cancer.gov/networks/fdanih/ |
| NIH/FDA Joint Leadership Council | Committee, Work group, Advisory group, or Task Force | FDA | OD/OSP, NCI, NHLBI, NIAID, NIDDK, NIGMS, NIMH, NINDS, OD | The Joint Leadership Council will work together to help ensure that regulatory considerations form an integral component of biomedical research planning, and that the latest science is integrated into the regulatory review process. Such collaboration and integration will advance the development of new products for the treatment, diagnosis and prevention of common and rare diseases and enhance the safety, quality, and efficiency of the clinical research and medical product approval enterprise. The formation of the Leadership Council represents a commitment on the part of both agencies to forge a new partnership and to leverage the strengths of each agency toward this common goal. http://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm201654.htm |
| NIH/FDA Leadership Council Working Group Drug Rescue & Repurposing Committee | Committee, Work group, Advisory group, or Task Force | FDA | NIAID, OD | NIH has been working with the FDA to create the NIH-FDA Joint Leadership Council, through which senior leaders from both agencies will address ways to facilitate new processes, such as FDA review of combination therapies and its consideration of rare disease trials with fewer patients enrolled. Medicines that have been developed and approved for one indication are sometimes useful for the treatment of other diseases, leading to enormous savings in development time and costs. |
| NIH/FDA Tobacco Science Working Group | Committee, Work group, Advisory group, or Task Force | FDA | NIGMS, NCI | NIH Funding Opportunities: Research Relevant to FDA Regulatory Authority (relevant to Family Smoking Prevention and Tobacco Control Act) http://cancercontrol.cancer.gov/nih-fda |
| Northwest Portland Tribal Registry Project | Resource Development | IHS | NCI | Over the past 10 years, health care delivery for Northwest American Indians and Alaska Natives has evolved from a centralized system maintained by the Indian Health Service (IHS) to a diverse and complex environment. The Northwest Tribal Registry Project was developed in January 1999 by the Northwest Tribal Epidemiology Center, a tribally operated program located at the Northwest Portland Area Indian Health Board (NPAIHB) in Portland, Oregon. http://surveillance.cancer.gov/disparities/native/portland.html |
| Nutrition Coordinating Committee (NCC) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA, IHS, OS | NIDDK, CC, CIT, CSR, FIC, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD | Nutrition Coordinating Committee (NCC) operates as an NIH-wide forum to review, stimulate, and encourage the support of nutrition research and training to better define the role of nutrition in the promotion and maintenance of health and in the prevention and treatment of disease. The NCC also plays a key role in the development of nutrition research policy at the NIH. http://dnrc.nih.gov/ |
| Obesity and the Built Environment Program | Research Initiative | CDC | NIEHS, NCI, NIDCD, OD | To begin understanding the wide variety of issues relating to the built environment and obesity, the NIEHS released RFA-ES-04-003, Obesity and the Built Environment, in August, 2004. Research proposals were to examine two specific areas related to the built environment and obesity: understanding the role of the built environment in causing/exacerbating obesity and related co-morbidities; and developing, implementing, and evaluating prevention/intervention strategies that influence parameters of the built environment in order to reduce the prevalence of overweight, obesity and co-morbidities. Participating NIH institutes included NCI, NICHD, and OBSSR, and two Centers within the CDC. http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-04-003.html |
| Offices of National Drug Control Policy (ONDCP): Colleges and Universities | Resource Development | CDC, SAMHSA | NIAAA | ONDCP supports keeping college and university students healthy through prevention, intervention, treatment, and recovery plans that effectively address the negative consequences of high risk drinking, underage drinking, and drug use on our Nation’s college and university campuses. http://www.whitehouse.gov/ondcp/college-and-universities |
| Oral Health, Cancer Care, and You | Public Education Campaign | CDC | NIDCR | A series of publications to inform health care providers and patients about steps they can take before, during, and after cancer treatment to reduce the risk and impact of these often painful side effects. http://www.nidcr.nih.gov/OralHealth/Topics/CancerTreatment/ |
| Osteoporosis and Related Bone Diseases—National Resource Center | Resource Development | OS, OSG | NIAMS, NIA, NICHD, NIDCR, NIDDK, OD | Provides patients, health professionals, and the public with an important link to resources and information on metabolic bone diseases, including osteoporosis, Paget’s disease of the bone, and osteogenesis imperfecta. http://www.bones.nih.gov |
| Package and Distribution of Nutritional Biochemistry for AREDS 2 | Research Initiative | OS | NEI | AREDS2 is a multi-center randomized trial designed to assess the effects of oral supplementation of high doses of macular xanthophylls (lutein and zeaxanthin) and/or omega-3 LCPUFAs (DHA and EPA) for the treatment of AMD and cataract. The primary objective of AREDS2 is to evaluate the effect of dietary xanthophylls (lutein/zeaxanthin) and/or omega-3 LCPUFAs (DHA and EPA) on progression to advanced AMD. This objective will be accomplished by collecting and assessing the data on approximately 4,000 AREDS2 participants aged 50 to 85 years, who at the time of enrollment have either: 1) bilateral large drusen or 2) large drusen in one eye and advanced AMD (neovascular AMD or central geographic atrophy) in the fellow eye. https://web.emmes.com/study/areds2/resources/areds2_mop.pdf |
| PACT (Production Assistance for Cellular Therapies) Workshop - Cell Therapy for Pediatric Diseases: A Growing Frontier | Committee, Work group, Advisory group, or Task Force | FDA | NHLBI | The purpose of the workshop is to discuss strategies for overcoming barriers that impede the development and delivery of cell-based therapies for pediatric patients, in particular those with rare and life-threatening diseases. The participants will consider clinical applications of cellular therapies and regenerative medicine, including ethical considerations and models of clinical trial design. http://www.pactgroup.net/ |
| Partners in Information Access for the Public Health Workforce | Resource Development | AHRQ, CDC, HRSA, OS | NLM | Partners in Information Access for the Public Health Workforce is a collaboration of U.S. government agencies, public health organizations, and health sciences libraries which provides timely, convenient access to selected public health resources on the Internet. http://phpartners.org/ |
| Partnerships to Address Cardiovascular Health Disparities | Training Initiative | HRSA | NHLBI | This partnership was established to test prevention strategies to address cardiovascular disease using community health workers. http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-04-002.html |
| Pathways of Diagnosis, Treatment, and Medical Service Utilization in Medicare and Medicaid Population | Research Initiative | CMS | CC | CMS and NIH CC/RMD agree to collaborate in data-sharing for research the results of which may be helpful to improve medical-service quality, utilization, and effectiveness for Medicare and Medicaid beneficiaries. CMS will provide electronic data to NIH CC/RMD who will perform analyses that are agreed to by both parties. |
| Patient-Reported Outcomes Measurement Information System (PROMIS) | Research Initiative | FDA | NICHD, NCCAM, NCI, NHLBI, NIAID, NIAMS, NIDA, NIDDK, NIGMS, NIMH, NINDS, OD | The Patient-Reported Outcomes Measurement Information System (PROMIS) is a network of NIH-funded primary research sites and coordinating centers working collaboratively to develop a series of dynamic tools to reliably and validly measure patient-reported outcomes (PROs). PROMIS provides an opportunity to improve healthcare outcomes by giving decision makers hard data on how healthcare affects what patients are able to do and how they feel. The FDA has been invited to contribute to the scientific steering committee meetings as an interested partner. http://www.nihpromis.org/default.aspx |
| Pediatric Emergency Care Applied Research Network (PECARN) | Research Initiative | HRSA | NICHD | Study of resuscitation practice and relationship to fulminant cerebral edema. PCCR program director is program official for the trial. This is a multisite clinical trial. The application was received as part of PAR HD 08-261/Emergency Medical Services for Children (EMSC). http://www.pecarn.org/ |
| Pediatric Formulations Platform | Committee, Work group, Advisory group, or Task Force | FDA | NICHD, NINR | This IAA is a collaboration between NICHD and the Center for Drug Evaluation and Research, FDA. The purpose is to create an open-source, publicly available oral pediatric formulations platform. This platform will designate specific formulation technologies, given the molecular and chemical properties of the drug and specific desired properties of the dosage form. The ideal pediatric dosage form would be an orally dissolvable solid; tasteless; in an appropriate dose amount that would be appropriate for infants; contain minimal amounts of safe excipients; stable in light, humidity, and heat; and have the necessary release characteristics, as applicable. http://bpca.nichd.nih.gov/collaborativeefforts/initiatives/index.cfm |
| Peripheral and Central Nervous System Drugs Advisory Committee | Committee, Work group, Advisory group, or Task Force | FDA | CC | Ad hoc member of the Committee. January 20 2011, meeting to consider an NDA for Florbetapir F 18 injection for use in PET imaging of beta-amyloid in the brain. |
| Personal Motion Technologies for Healthy Independent Living | Meeting/ Workshop | CMS, FDA | NIBIB, NCATS, NIA, NICHD, NINDS, OD | Support the development and translation of high-impact home-based technology systems for health. This includes viable integrated systems using standards and common platforms for diagnosis, monitoring, screening, and intervention as well as studies to prove the effectiveness/efficacy of personal health technologies for people with disabilities, aging adults, and people with chronic disease. http://www.nibib.nih.gov/nibib/file/NewsandEvents/PreviousSymposiaandWorkshops/22June2010/2010_June_Personal_Motion_Summary_Report-%20rev%208-2-10.pdf |
| Pharmacist Education in the Era of Genomic Medicine Meeting | Meeting/ Workshop | CDC, HRSA | NHGRI, NCI | The Genomic Healthcare Branch, NHGRI, hosted a meeting of all the major U.S. pharmacy organizations in Rockville, Md., to discuss the current landscape of pharmacist education in genomics and determine priorities for genomics education of the profession. |
| Phenylketonuria (PKU) Scientific Workshop | Meeting/ Workshop | AHRQ, FDA, HRSA | OD, NHGRI, NICHD, NIDDK, NINDS, NINR | In October 2000, the NIH published a Consensus Development Conference Statement for screening and management of PKU. Since then, new treatments, including pharmacological, have emerged. To assist clinicians in making treatment decisions, NIH has revisited the guidelines. Five working groups were convened to explore an expanded body of literature and address important questions regarding treatment of PKU. These working groups will present their findings during the conference on February 22-23, 2012. https://www.team-share.net/phenylketonuria_scientific_review_conference/Overview.aspx |
| Pillbox | Resource Development | FDA | NLM | The National Library of Medicine and the Food and Drug Administration have established a collaborative relationship to enhance patient safety through the linking of digital images of prescription solid dosage form medications to the Structured Product Labeling (SPL) files and the substance information of those pharmaceuticals. http://pillbox.nlm.nih.gov/ |
| Pilot Workshop on Behavioral and Social Sciences Research: Engaging Patients and Providers in Patient-Centered Primary Care | Meeting/ Workshop | CMS | OD | This co-sponsored research workshop provided an opportunity for CMS staff to learn about patient-provider communications and the impact of incentives in patient and provider behavior from NIH-funded research on these topics. Three researchers discussed their work and its implications within the context of CMS demonstrations related to the patient-centered medical home, but their findings have broad applicability to other demonstrations and initiatives aimed at engaging providers and patients in specific behaviors. |
| Planning Committee for the Annual Conference of the African American Healthy Marriage Initiative (AHMI) - Planning Committee for the Annual Conference | Meeting/ Workshop | ACF, SAMHSA | NIDA, NIMH | The mission of the African American Healthy Marriage Initiative (AAHMI) is to promote and strengthen the institution of healthy marriage in the African American community. The Administration for Children and Families has partnered with national, civic and community organizations to develop a strategy directed toward increasing child well-being and strengthening families by promoting healthy marriages. http://www.acf.hhs.gov/healthymarriage/aa_hmi/AAHMI.html |
| Planning Committee to Outline Guidelines for the Conduct of Biomedical Prevention Intervention Research During Pregnancy | Committee, Work group, Advisory group, or Task Force | CDC, FDA | OD/DPCPSI/OAR, NIAID, NICHD, OD | A collaborative group that planned meetings and developed guidelines to outline a safe step-wise approach to conducting biomedical prevention intervention research during pregnancy. http://www.mtnstopshiv.org/ |
| Pluripotent Stem Cells in Translation: Early Decisions | Meeting/ Workshop | FDA | NINDS, CC, NCI, NHLBI, NIAID, NIAMS, NIBIB, NIDCR, OD | The National Institutes of Health (NIH) and the Food and Drug Administration (FDA) are organizing a series of workshops that will engage the broader research community regarding requirements necessary for translation of pluripotent stem cell-derived products into the clinic. The first workshop, held March 2011, focused on establishment of stem cell lines and banks, covering safety and regulatory issues related to how the original cell line derivation is done in the case of embryonic stem cells, and how the cells are reprogrammed in the case of iPS cells. The second workshop, to be held July 10-11, 2012, will focus on preclinical safety and proof of concept testing, including, among other topics, clinical relevance of the animal models, selection of cell dose levels, impact of host microenvironment, and cell fate post-administration. A third, and final, workshop is expected to focus on clinical trial design including safety monitoring, immunogenicity, immunosuppressant use and immune monitoring. http://www.fda.gov/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/ucm241380.htm |
| Polyhalogenated Aromatic Hydrocarbons (PHAH) and Thyroid Cancer | Research Initiative | CDC | NCI | PHAHs are being measured in banked serum/plasma samples from cohort studies to evaluate the association with thyroid cancer incidence. |
| Practical Oral Care for People with Developmental Disabilities | Public Education Campaign | CDC | NIDCR | A series of publications designed to equip dental professionals in the community with the information they need to deliver quality oral health care to people with special needs. http://www.nidcr.nih.gov/OralHealth/Topics/DevelopmentalDisabilities |
| President’s Emergency Plan for AIDS Relief (PEPFAR) Implementation Science and Public Health Evaluation Activities | Research Initiative | CDC, HRSA, SAMHSA | NIAID, FIC, NCI, NIAAA, NICHD, NIDA, NIMH, OD | PEFPAR is governed by intra-agency groups, including NIH, CDC, and HRSA for HHS. CDC has a large role as an implementing partner for PEPFAR, while NIH has limited their activities to providing technical expertise on issues related to safety and efficacy of elements for PEPFAR programs, and to facilitating evaluation of PEPFAR through NIH funded investigators. The Agencies work together to set research and evaluation priorities for PEPFAR. In previous years, this was done through the PHE process, and in FY10 a specific funding announcement was made with supplement awards through NIH Institutes and Centers. NIH takes an active role in reviewing and making recommendations for the PHE process, CDC and HRSA were actively involved in the review process for the NIH supplement applications. http://www.pepfar.gov/ |
| Prevention Research Centers | Research Initiative | CDC | NCI | The PRC program funds community-based research projects at 37 academic research centers across the United States; 5 developmental and 32 comprehensive centers. These centers: • Conduct research projects that promote health and prevent disease • Build research teams of multidisciplinary faculty • Seek solutions, strategies, and policies that address public health problems • Participate in research networks that address priority health issues, such as healthy aging, cancer prevention & control, and obesity prevention • Build long-term relationships for engaging communities as partners in research • Conduct research in directions guided by advisory boards of community leaders • Develop and deliver trainings that enhance the public health workforce • Conduct additional research funded by other federal agencies, foundations, and nonprofit organizations http://www.cdc.gov/prc/ |
| Prevention Research Coordinating Committee | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, OS | NIDCR, CC, FIC, NCCAM, NCI, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD | The Prevention Research Coordinating Committee promotes prevention research designed to yield results directly applicable to identifying and assessing risk, and to developing interventions for preventing or ameliorating high-risk behaviors and exposures, the occurrence of disease/disorder/injury, or the progression of detectable but asymptomatic disease. Prevention research also includes research studies to develop and evaluate disease prevention and health promotion recommendations and public health programs. http://prevention.nih.gov/prcc.aspx |
| Prevention Scientists Promoting Global Health: Emerging Visions for Today and Tomorrow | Meeting/ Workshop | CDC | NIAAA, NCI, NHLBI, NICHD, NIDA, NIMH | The Society for Prevention Research envisions a wellness-oriented society in which evidenced-based programs and policies are continuously applied to improve the health and well-being of its citizens. The SPR Annual Meeting provides unique opportunities to advance this vision by providing an integrated forum for: the exchange of new concepts, methods, and results from prevention and public health-related research; and communication between scientists, public policy leaders and practitioners concerning the implementation of evidence-based preventive interventions. http://www.preventionresearch.org/2011-annual-meeting/ |
| Prevention with Positives Intervention at HIV Clinics Y1-MH-1318 | Other | CDC | NIMH | NIMH is collaborating with the CDC to conduct an HIV clinic-based comparison of a comprehensive prevention program for people living with HIV. The study targets multiple health behaviors (sexual risk, medication adherence, clinic attendance) and health outcomes (viral load, retention in care). |
| Principles of Community Engagement (Second Edition) | Committee, Work group, Advisory group, or Task Force | AHRQ, ATSDR, CDC, SAMHSA | NCATS, NCCAM, NCI, OD | This new research resource was developed in partnership with the Centers for Disease Control and Prevention, National Institutes of Health, Health Resources and Services Administration, other federal agencies, academic institutions, community partners and individuals who are committed to advancing community engagement and to overcoming the challenges. Through hands-on advice and success stories, Principles of Community Engagement (Second Edition) can provide public health professionals, health care providers, researchers and community-based leaders and organizations with both the theoretical framework and practical guidance for engaging partners in projects to advance health science and benefit communities nationwide. The first edition of Principles of Community Engagement was published in 1997 by the CDC and the Agency for Toxic Substances and Disease Registry (ATSDR). Since then, the body of knowledge supporting community engagement principals and initiatives has grown. Principles of Community Engagement (Second Edition) provides new tools for those who are leading efforts to improve population health through community engagement. It also can serve as a guide for understanding the principles of community engagement for those who are developing or implementing a community engagement plan, and by faculty and students who want to teach and learn more. https://www.ctsacentral.org/ |
| Procurement of Biotechnology Services, Including GFP Cell Sorting and Analysis | Research Initiative | FDA | NICHD | The purpose of this agreement is to provide funding from the NICHD to the FDA to purchase various biotechnology services, including GFP cell sorting and analysis. FDA will administer this funding and will keep the NICHD informed of the results through the delivery of data reports. |
| Proteomics (NCI/FDA Memorandum of Understanding) | Research Initiative | FDA | NCI | The purpose of this MOU is to create a framework to foster scientific and programmatic collaborations. The collaborations envisioned by this MOU involve proteomics science and technology applications such as instrument/technology validation, informatics, biological sample preparation, diagnostics, and discovery and validation of biomarkers for cancer development, therapeutics, and response. This MOU sets forth the basic principles under which the agencies intend to work together to foster partnership in: research and education; the exchange of ideas, information, and data; the development and use of proteomics technologies that may be used by the NCI and other sponsors in clinical applications. |
| Public Health and Infertility National Action Plan-Research Working group | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | This research working group is part of strategic plan of CDC in the development of a National Action Plan for Public Health and Infertility. CDC''s goal is to reduce infertility. Working groups will be formed that address research, environment and occupational exposures, fertility preservation, infectious disease, male infertility, policy, and surveillance. Topics to be addressed by the research working group include: epidemiology of infertility; advancing the knowledge base to better prevent, diagnose and treat infertility; and capacity building between Federal agencies and outside partners. http://www.cdc.gov/reproductivehealth/Infertility/PublicHealth.htm |
| Public Health Dimensions of Epilepsy | Other | ACF, CDC, FDA, OS | NINDS, NIA, NICHD, NIMH | The Institute of Medicine will convene an ad hoc committee to recommend priorities in public health, healthcare and human services, and health literacy and public awareness for the epilepsies and to propose strategies to address these priorities. http://iom.edu/Activities/Disease/Epilepsy.aspx |
| Public Health Emergency Management Countermeasures Enterprise (PHEMCE) | Committee, Work group, Advisory group, or Task Force | ACF, CDC, FDA, OS, SAMHSA | NICHD, NIAID, NIAMS, NINDS, NLM | The NICHD representative is a regular member of the chemical working group and provides PRN assistance to the Infectious Disease and Radiation Working Groups. These groups determine medical countermeasures (MCM) requirements, reviews available and up and coming MCMs, makes advanced R&D study recommendations, funds recommended studies, funds some of the MCMs for the strategic national stockpile. The NICHD representative provides pediatric/OB input regarding MCM gaps, study needs, prioritization. https://www.medicalcountermeasures.gov/barda/phemce-management.aspx |
| Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Chemical Requirements Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NINDS, NIAID, NICHD, NIEHS | The HHS Public Health Emergency Medical Countermeasures Enterprise (HHS PHEMCE) leads the mission to develop and acquire medical countermeasures that will improve public health emergency preparedness as well as prevent and mitigate the adverse health consequences associated with chemical, biological, radiological and nuclear (CBRN), and naturally occurring threats. https://www.medicalcountermeasures.gov/ |
| Public Health Information Network (PHIN) | Committee, Work group, Advisory group, or Task Force | CDC | NCI | The CDC Public Health Information Network (PHIN) is a national initiative to improve the capacity of public health to use and exchange information electronically by promoting the use of standards and defining functional and technical requirements. http://www.cdc.gov/phin/ |
| Public Health Pesticide Consortium (PHPC) | Committee, Work group, Advisory group, or Task Force | CDC | NIAID | This group involves members from CDC and NIH as well as other federal US agencies ( USDA, EPA, DoD, USAID, HUD, and USFWS) with the purpose of learning about new programs and activities relating to the development and approval of pesticides for public health. |
| Public Health Prevention of HIV Risk Behaviors Technical Working Group | Committee, Work group, Advisory group, or Task Force | CDC, SAMHSA | NIAAA, NIDA | Collaboration with the Office of Global AIDS Coordination (OGAC), CDC to identify and implement effective HIV prevention and treatment interventions among alcohol abusing and dependent populations. http://www.aids.gov/ |
| Public Health Service (PHS) Biovigilance Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NHLBI | The working group was formed to develop an operational proposal for enhancing safety monitoring for blood products, cell and tissue products, and solid organs. http://www.hhs.gov/ash/bloodsafety/ |
| Public Health Service (PHS) Blood XMRV Scientific Research Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NHLBI | The working group is charged with designing and coordinating research studies to evaluate whether xenotropic murine leukemia virus-related virus (XMRV) poses a threat to blood safety. The group is led by the NHLBI and includes representatives from the PHS, the FDA, and the CDC, as well as experts in research on transfusion medicine, blood banking, retrovirology, and myalgic encephalopathy/chronic fatigue syndrome. http://www.nih.gov/news/health/sep2011/nhlbi-22.htm |
| Public Health Service (PHS) MSM Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NHLBI | The working group is developing guidelines and strategies to improve HIV/STD programs for men who have sex with men (MSM). |
| Public Health Service (PHS) Pathogen Reduction Taskforce | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NHLBI | As a part of the HHS strategic plan for blood and tissue safety, the taskforce is charged with reviewing the potential of pathogen reduction technologies that are designed inactivate pathogens in blood supply. Current surveillance systems detect threats, but the lag between detection and action continues to place recipients at risk. The taskforce seeks to address questions and challenges in transfusion safety, barriers to technological advancement, safety gaps related to pathogen reduction. |
| Quality Review of ClinicalTrials.gov | Resource Development | AHRQ, FDA | NLM, CC, NCCAM, NCI, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, OD | ClinicalTrials.gov is an NLM-operated database of summary protocol and results information from publicly and privately funded clinical research. As of October 2010, the database included over 96,000 studies conducted in 174 countries with over 2,300 summary results. NLM is collaborating with FDA and other parts of NIH to implement the statutory requirements of the Food and Drug Administration Amendments Act of 2007 and working together on a project with CTTI (Clinical Trials Transformation Initiative) to create a ClinicalTrials.gov Analysis Data Set. NLM and AHRQ are collaborating on conducting quality reviews (e.g., evaluate for internal consistency, meaningful entries, formatting) of summary results information. http://www.clinicaltrials.gov/ |
| Racial and Ethnic Approaches to Community Health Across the U. S. (REACH US) | Research Initiative | CDC | NIMHD | The purpose of the REACH U.S. Program is for organizations serving racial and ethnic minority populations at increased risk for infant mortality, diabetes, cardiovascular diseases, Asthma, Hepatitis B, deficits in breast and cervical screening and management, deficits in child and/or adult immunization rates to develop, implement, and evaluate innovative community level intervention demonstrations which could be effective in eliminating health disparities. The racial and ethnic groups targeted by REACH U.S. include: African-Americans, Asian-Americans, Hawaiian Pacific Islanders, Hispanic-Americans, and American Indians or Alaskan Native populations. http://www.cdc.gov/reach/ |
| Racial Disparities in Prostate Cancer Incidence Rates by Census Division in the United States, 1999-2008 | Research Initiative | CDC | NCI | An analysis of the National Program of Cancer Registries database to assess census division differences by race (white, black) in trends of prostate cancer. |
| Radiation Emergency Medical Management (REMM) | Resource Development | CDC, OS | NLM, NCI | This activity is to develop a comprehensive web resource. REMM is a mechanism to collect, evaluate, collate, store and make available electronically to health care professionals immediate, up-to-date, evidence-based clinical information they would use to treat civilian patients and others affected by radiation incidents. http://www.remm.nlm.gov/ |
| Randomized Intervention in Children with Vesicoureteral Reflux (RIVUR) | Research Initiative | OS | NIDDK | The multicenter, randomized, double-blind, placebo-controlled RIVUR trial is designed to determine whether daily antimicrobial prophylaxis is superior to placebo in preventing recurrence of UTI in children with VUR. The study is designed to recruit 600 children (approximately 300 in each treatment group) over an 18-24 month period. The primary endpoint is recurrence of UTI. Quality of life, compliance, safety parameters, utilization of health resources, and change in VUR will be assessed periodically throughout the study. http://www.rivur.net |
| Reciprocal Educational and Training Partnerships between FDA/CDER and the NIH Clinical Center | Training Initiative | FDA | CC, NCI, NIAID | This activity is sponsored by the Clinical Pharmacology Program, Office of Clinical Research Training and Medical Education (OCRTME) at the NIH Clinical Center and it consists of elective rotations at the Office of Clinical Pharmacology (OCP) and the Office of New Drugs (OND)- FDA/CDER for NIH staff with a primary focus on clinical fellows and research fellows who expressed an interest in learning more about FDA regulatory sciences applicable to drug development research. Rotating fellows are mentored by FDA staff on the required elements of an Investigational New Drug (IND) application and the key elements of the FDA review process from a regulatory perspective. This program also established a mechanism for FDA scientific reviewers at the OCP to rotate at the NIH Clinical Center and to interact with members of a clinical research team, thus acquiring a better perspective on clinical research protocol implementation and the requirements of an Institutional Review Board (IRB) at the NIH. http://intranet.cc.nih.gov/clinicalresearchtraining/curriculumcert/FDAClinPharm.pdf |
| Recovery Act Limited Competition: Building Sustainable Community-Linked Infrastructure to Enable Health Science Research (RC4) | Research Initiative | AoA | NIA, NCI, NCATS, NEI, NHGRI, NHLBI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OBSSR | To develop or expand needed infrastructures that will fundamentally transform collaboration and communication between academic health centers and local communities. Such collaborative infrastructures are essential to advance the health science research enterprise while ensuring that important research findings are effectively disseminated and implemented to improve public health and advance health care delivery. http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-09-010.html |
| REGARDS Study - Occupational Supplement | Health Survey | CDC | NINDS | The goal of this study is to identify the extent to which occupational exposure contributes to cardiovascular disease in a racially diverse, population-based sample, with emphasis on health disparities secondary to racial/ethnic characteristics. http://www.regardsstudy.org/ |
| Registry and Surveillance System in Hemoglobinopathies (RuSH) | Resource Development | CDC, HRSA, OS | NHLBI, NICHD, NIDDK | RuSH is a system to collect information on people living with hemoglobinopathies (sickle cell disease and thalassemia) in six states. http://www.nhlbi.nih.gov/about/directorscorner/legislativeinformation/budget-testimony/fiscal-year-2011-budget-request.html |
| Registry of Patient Registries | Resource Development | AHRQ | NLM | This project aims to develop a central source for accessing multiple levels of information related to patient registries. http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=690 |
| Registry of Patient Registries (RoPR) Project | Committee, Work group, Advisory group, or Task Force | AHRQ | NIDDK, NLM | The Agency for Healthcare Research and Quality (AHRQ) is working to design and deploy Registry of Patient Registries (RoPR), which will create a searchable central listing of patient registries in the United States that will be integrated with ClinicalTrials.gov. as part of this project, broad consultations were carried out with relevant groups. NIDDK staff participated extensively in these consultations. http://www.outcome.com/ropr.htm |
| Research in Diabetes Mellitus, its Complications, and Obesity | Research Initiative | IHS | NIDDK | The objectives are to identify the determinants and understand the progression of type 2 diabetes, obesity, and other chronic diseases in Pima Indians. http://diabetes.niddk.nih.gov/dm/pubs/pima/ |
| Research on Research Integrity Program | Research Initiative | OS | NIEHS, NIDCR | Handle the administrative responsibilities for soliciting, reviewing, funding, and managing the RRI program in collaboration with the DHHS Office of Research Integrity (ORI) http://ori.hhs.gov/rri-program |
| Research on the Comparative Management of Uterine Fibroid Disease | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA | NICHD, NCCAM, NIEHS, OD | The primary purpose of the project is to develop a protocol to study the clinical effectiveness and/or comparative effectiveness of uterine fibroid diagnosis, management, care coordination and treatment, and to disseminate the findings. |
| Research-Tested Intervention Program Database (RTIPs) | Resource Development | SAMHSA | NCI | RTIPs is a searchable database of cancer control interventions and program materials and is designed to provide program planners and public health practitioners easy and immediate access to research-tested materials. http://rtips.cancer.gov/rtips/index.do |
| Respiratory/Asthma Question in the 2013 National Health Interview Survey | Health Survey | CDC | NHLBI | The purpose of the collaborative activity is support development and implementation by the National Health Interview Survey (NHIS) of measures that could be used to assess progress towards achieving Healthy People 2020 respiratory/asthma objectives. The NHLBI and the National Center for Health Statistics collaborate on this activity. http://www.cdc.gov/nchs/nhis.htm |
| Restructuring Services for Drug Abusing Temporary Aid to Needy Families (TANF) Women | Research Initiative | ACF, IHS | NIDA, NIMHD | Jointly funded research intended to determine the best way to structure and deliver drug abuse, mental health, and other treatment services to women receiving TANF support. http://www.acf.hhs.gov/programs/opre/welfare_employ/nj_subst_abuse/reports/barriers_employ/barriers_employ.pdf |
| Revision of CDC Guidelines | Other | CDC | CC | The collaboration serves to revise guidelines for managing occupational exposures to HIV and managing healthcare workers infected with hepatitis B. |
| Ruth L. Kirschstein National Research Service Award Program | Training Initiative | AHRQ, HRSA | NIBIB, NCCAM, NCI, NCATS, NEI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, OD | Predoctoral and postdoctoral research training. http://www.ahrq.gov/fund/training/trainix.htm |
| RxNorm | Other | FDA | NLM | RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software. By providing links between these vocabularies, RxNorm can mediate messages between systems not using the same software and vocabulary. http://www.nlm.nih.gov/research/umls/rxnorm/ |
| Sabbatical in Clinical Research Management Program | Training Initiative | FDA, OS | CC, FIC, NCATS, NEI, NIAID, NLM, OD | Experienced investigators come to the NIH to learn about management of a clinical research enterprise, including topics such as planning and budget development, protocol writing and tracking and scientific review. Sabbaticals are self-directed, meaning that the participant chooses from a list of electives and helps determine how much time to spend studying each topic. The electives are offered by leaders at the NIH and other HHS agencies with the NIH Clinical Center being the most heavily involved. http://www.cc.nih.gov/training/sabbatical/index.html |
| Safety and Efficacy Evaluations of Topical Microbicide (TM)/Biomedical Prevention (BP) Products in the Repeat Low-Dose Macaque SIV/SHIV Infection Model | Research Initiative | CDC | NIAID | The NIAID and CDC recognize the need to perform preclinical safety and efficacy evaluations of candidate products in the repeat low-dose (RLD) macaque SIV/SHIV infection model that has been established by CDC. NIAID established an interagency agreement with CDC in order to: 1) conduct safety and efficacy evaluations of TM/BP products in the RLD macaque model -- including pharmacokinetic/pharmacodynamic analyses of candidate biomedical prevention products; 2) utilize relevant macaque species, virus strains, and routes of infection to accomplish the proposed evaluations; and 3) perform other macaque studies as needed. http://projectreporter.nih.gov/project_info_description.cfm?projectnumber=Y1AI0681-2-0-1 |
| Safety Reporting Portal | Resource Development | FDA | OD/OSP | Development of a portal to streamline the process of reporting pre- and post-market safety data to the FDA and NIH and to serve as a prototype for a federal-wide system. The Portal is an important policy innovation and major step forward in the effort to eliminate unnecessary complexities and inefficiencies associated with the current system of reporting adverse events. The Portal uses a harmonized set of terms, the Basal Adverse Event Report, to provide a single, web-based interface for standardized electronic reporting of adverse events and unanticipated problems to NIH and FDA and also enables the transmission of reports to local oversight bodies such as IRBs and DSMBs. https://www.safetyreporting.hhs.gov |
| Science without Borders | Training Initiative | OS | NCI, NHLBI, NIAID, NICHD, NINDS, OD | Collaboration with the Brazil Ministry of Science and Technology and the National Council for Scientific and Technological Development (CNPq) “Science without Borders” Program - The focus of the CNPq/MCT program is to collaborate with select institutions (both in US and Brazil) to advance both infrastructure and human resources in areas of science, technology and innovation. CNPq priorities under the "Science without Borders" program are to train 75,000 Brazilians in areas of science and technology over the next 4-5 years, particularly in the health sciences and engineering. Training could be both short-term (workshops/conferences) and long term/capacity building (collaborations/joint programs). CNPq would focus on top level Brazilian research institutions to select post-docs for support, but would consider applications from smaller institutions. A Letter of Understanding was established by the CNPq of Brazil and NIH (DHHS) as of September 2011. |
| Scientific Advisory Committee on Alternative Toxicological Methods (SACATM) | Committee, Work group, Advisory group, or Task Force | ATSDR, CDC, FDA | NCI, NIEHS, NLM, OD | To establish criteria for validation of testing methods to reduce, refine, or replace animals in toxicity testing. http://ntp.niehs.nih.gov/?objectid=7201756D-BDB7-CEBA-FD6377A9354BA3F6 |
| Screening and Brief Intervention Models to Address Unhealthy Drug Use (SBIRT) | Research Initiative | SAMHSA | NIDA | Randomized controlled trial 3 arm to determine efficacy of SBIRT using the SAMHSA funded SBIRT program in Massachusetts. http://www.samhsa.gov/samhsanewsletter/Volume_17_Number_6/SBIRT.aspx |
| SEARCH for Diabetes in Youth | Research Initiative | CDC | NIDDK | SEARCH is a multi-center study that identifies cases of diabetes in children/youth 20 years of agin in six geographically dispersed populations that encompass the ethnic diversity of the United States. http://www.searchfordiabetes.org |
| Secretary''s Committee on Blood Safety and Availability (BSAC) | Committee, Work group, Advisory group, or Task Force | CDC, CMS, FDA, OS | CC, NHLBI | Oversees national status of blood safety and availability, investigates problems and proposes action. http://www.hhs.gov/ash/bloodsafety/advisorycommittee/index.html |
| Senate Staff Delegation visit to India and Cambodia | Other | CDC | NIAID, FIC, NHLBI, NIBIB | A delegation of 4 bipartisan staffers from the Senate Appropriations Committee traveled in August 2011 to India (Aug 8-12) and Cambodia (Aug 13-17) to view research sites that are receiving NIH funds and possibly collaborating with US researchers and/or NIH or CDC. Research collaborations were both basic and/or applied (including clinical) with either direct funding to in-country researchers or indirect funding through collaborations with U.S. researchers. |
| Sex Differences in Esophageal Cancer Incidence Rates by Census Region in the United States, 1999-2008 | Research Initiative | CDC | NCI | An analysis of the National Program of Cancer Registries database to assess census region sex differences in trends of esophageal squamous cell carcinoma and esophageal adenocarcinoma. |
| Sleep Disorders Research Advisory Board | Committee, Work group, Advisory group, or Task Force | CDC | NHLBI, NCCAM, NCI, NCATS, NIA, NIAAA, NICHD, NIDA, NIDDK, NIMH, NINDS, NINR, OD | The Board consults with and makes recommendations to the Director of the National Institutes of Health, through the Director of the National Heart, Lung, and Blood Institute, and the Director of the National Center on Sleep Disorders Research, about scientific activities and coordination with other Federal agencies, public entities, and nonprofit organizations. http://www.nhlbi.nih.gov/meetings/sdrab/index.htm |
| Smokefree.gov | Other | CDC | NCI, OD | Smokefree.gov is intended to help individuals quit smoking. Different people need different resources as they try to quit. The information and professional assistance available on this Web site can help to support both immediate and long-term needs as individuals become, and remain, a nonsmoker. Smokefree.gov allows individuals to choose the help that best fits their needs, including immediate assistance in the form of: • A step-by-step quit smoking guide • Information about a wide range of topics related to smoking and quitting • An interactive U.S. map highlighting smoking information in your state • LiveHelp, National Cancer Institute''s instant messaging service • National Cancer Institute''s telephone quitline, 1-877-44U-QUIT • Local and state telephone quitlines, 1-800-QUIT-NOW • Publications to download, print, or order http://smokefree.gov/ |
| SNOMED (Systematized Nomenclature of Medicine) International and Support Services | Other | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | NLM | This activity provides support for SNOMED CT (Systematized Nomenclature of Medicine -- Clinical Terms), a systematically organized computer processable collection of medical terminology covering most areas of clinical information such as diseases, findings, procedures, microorganisms, pharmaceuticals etc. It allows a consistent way to index, store, retrieve, and aggregate clinical data across specialties and sites of care. It also helps organizing the content of medical records, reducing the variability in the way data is captured, encoded and used for clinical care of patients and research. http://www.nlm.nih.gov/research/umls/Snomed/snomed_main.html |
| Specialized Centers of Research (SCOR) on Sex and Gender Factors Affecting Women''s Health | Research Initiative | FDA | OD, NIAMS, NICHD, NIDA, NIDDK, NIMH | The SCOR programs are large Center Programs (P50) that consist of 11 Centers that conduct interdisciplinary research focused on health issues that affect women and examine sex/gender contributions to health and disease. The currently funded SCORs are interdepartmental, intercollegiate, interinstitutional and focus on sex differences in pregnancy, substance abuse, reproductive health, urinary tract, and pain. The SCOR mechanism promotes collaborative research among scientists with varied expertise in order to achieve research objectives that are less likely to occur through other grant mechanisms. http://orwh.od.nih.gov/interdisciplinary/SCORs.html |
| Standard Based Clinical Data Forms for Post-Acute Care | Research Initiative | CMS | NLM | NLM is contributing to a CMS effort to develop a standardized form used to collect clinical information as patients are discharged from various care settings. NLM is creating and updating the RxTerms drug database resource, initially used to support the CARE assessment tool used by CMS. http://wwwcf.nlm.nih.gov/umlslicense/rxtermApp/rxTerm.cfm |
| Standards for Genetic Testing Report | Research Initiative | AHRQ, CDC, OS | NLM, NHGRI | This activity aims to develop a standard reporting format, using LOINC and HL7, for NLM''s Personal Health Record Project and activities of the Office of the Secretary. |
| State Cancer Profiles | Resource Development | CDC | NCI | The objective of the State Cancer Profiles Web site is to provide a system to characterize the cancer burden in a standardized manner in order to motivate action, integrate surveillance into cancer control planning, characterize areas and demographic groups, and expose health disparities. The focus is on cancer sites for which there are evidence based control interventions. Interactive graphics and maps provide visual support for deciding where to focus cancer control efforts. http://statecancerprofiles.cancer.gov/ |
| Strategic Multisite Initiative for the Identification, Linkage and Engagement in Care of Youth with Undiagnosed HIV Infection (SMILE in CARING for YOUTH) | Research Initiative | CDC | NICHD, NIDA, NIMH | The Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) was awarded grant money to expand their project of increasing availability of HIV testing for adolescents 12-24 and the provision of adolescent-focused healthcare services for those adolescents who are diagnosed with HIV infection. The project''s expansion includes all the ATN sites across the US and Puerto Rico. NICHD is collecting data to evaluate the effectiveness of adolescent oriented linkage to care services for the HIV infected adolescents. This collaboration has the potential to improve the health of American youth, both by identifying those with undiagnosed HIV and bringing them into adolescent-friendly treatment programs and by reducing the chances of them further spreading the virus to others. http://main.uab.edu/Sites/MediaRelations/articles/70737/ |
| Strategic Prevention Framework | Research Initiative | SAMHSA | NIDA | Provide support for the cross-site evaluation of the Strategic Prevention Framework (SPF) State Incentive Grant (SIG) program. http://www.samhsa.gov/prevention/spf.aspx |
| Strong Heart Study | Research Initiative | IHS | NHLBI | Originally, the Strong Heart Study (SHS) the study attempted to look at differences in CVD and CVD risk factors among three geographically diverse groups of American Indians comprising 4,549 men and women ages 45-74. Three exams were completed on the original cohort, which continues to be followed for morbidity and mortality. Following a successful pilot study, the focus of the last two examinations has been on evaluating genetic and environmental contributors to CVD in a cohort of extended families. Two exams have been completed to date on this cohort of 3,768 individuals from about 120 families. The SHS collaborates with the Indian Health Service on access to health records, development of research goals, and communication with the Tribal Communities. http://strongheart.ouhsc.edu/ |
| Study of a Unique Hepatitis C Virus Strain JFH-1 in Chimpanzees | Research Initiative | CDC | NIDDK | To understand the biological behavior of this unique hepatitis C virus JFH-1 strain, NIDDK is studying its infection in chimpanzees by performing various virologic, immunologic, and genetic analyses. http://data.nidb.nih.gov/search/searchreport.taf?ipid=59495 |
| Study of Cancer Among United States Firefighters | Research Initiative | CDC | NCI | A retrospective cohort study to evaluate the relationship between occupational exposures of firefighters and cancer risk. |
| Study on Prevalence of Autism in Somali Children in Minneapolis Community | Research Initiative | CDC | NIEHS, NICHD, NIDCR, NIMH, NIMHD, NINDS | This activity supports a study to determine the administrative prevalence of autism among Somali and non-Somali children in the Minneapolis Minnesota community. http://www.nimh.nih.gov/science-news/2011/nimh-teams-up-to-study-asd-rates-in-somali-american-children.shtml |
| Subcommittee on Nanoscale Science, Engineering, and Technology | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NCI, NHGRI, NIBIB, OD | This subcommittee of the National Science and Technology Council''s Committee on Technology is responsible for coordinating the National Nanotechnology Initiative (NNI). The NNI was established in 2001 to coordinate federal research and development in nanotechnology by providing a vision of the long-term benefits and opportunities offered by nanotechnology and acting as a locus for communication, cooperation, and collaboration between federal agencies involved in nanotechnology research and development. In 2011, the NSET developed a strategic plan that encompasses a comprehensive nanotechnology R&D initiative built on shared goals, priorities, and strategies that complement agency-specific missions and activities. http://www.nano.gov/nset |
| Subcommittee on Social, Behavioral and Economic Sciences, Committee on Science, National Science and Technology Council, Office of Science and Technology Policy | Committee, Work group, Advisory group, or Task Force | CDC | OD, OD/DPCPSI/OBSSR | The purpose of the Subcommittee on Social, Behavioral and Economic Sciences is to advise, assist and respond to inquiries from the Committee on Science (CS) and the NSTC on U.S. SBE science policies, on procedures and plans that relate basic and applied research and development (R&D) efforts to national priority areas, and on the use of SBE research knowledge for the benefit of all Americans. http://www.whitehouse.gov/administration/eop/ostp/nstc/committees/cos |
| Subpopulations and Intermediate Outcome Measures in Chronic Obstructive Pulmonary Disease (COPD) | Research Initiative | FDA | NHLBI | SPIROMICS (SubPopulations and Intermediate Outcome Measures In Chronic Obstructive Pulmonary Disease Study) is an observational study of COPD that seeks to identify practical intermediate outcome measures and mechanistically homogeneous subgroups of patients with the disease. The study was developed in cooperation with the FDA and will be implemented with industrial partners. http://grants.nih.gov/grants/guide/notice-files/NOT-HL-06-132.html |
| Suicide Research Consortium | Committee, Work group, Advisory group, or Task Force | CDC, IHS, SAMHSA | NIAAA, NIMH | The consortium coordinates program development in suicide research, stimulates extramural research on suicide, and disseminates science-based information on suicidology. |
| Superfund Research Program/NIOSH Interagency Regarding Funds for Hazardous Substance Training | Training Initiative | CDC | NIEHS | Provides NIOSH with funds for two training programs: One in continuing education in hazardous substances and one for graduate academic training to meet the needs of professional working in hazardous substance training. http://www.niehs.nih.gov/research/supported/srp/about/index.cfm |
| Support for the Federal Interagency Forum on Child and Family Statistics | Other | ACF, AHRQ, CDC, HRSA, OS | NICHD, NIMH | The purpose of this IAA is to provide funds to support the work of the Federal Interagency Forum on Child and Family Statistics (Forum). The purpose of the Forum is to foster collaboration among Federal agencies that produce or use statistical data on children and families and seeks to improve both the quality and use of data on children and families. http://childstats.gov/ |
| Surgeon General''s Call to Action to Prevent Prescription Drug Abuse in Youth: The Dangers of Improper Use of Controlled Medications | Public Education Campaign | CDC, FDA, OS, OSG, SAMHSA | NIDA, NIAAA | A multi-agency federal workgroup was formed to inform the development of a Surgeon General’s document on prescription drug abuse. An expert panel meeting was held in 2011 to receive input from researchers, public health officials, clinicians, military and law enforcement personnel on the magnitude of the problem and effective interventions to address it. As a result, the federal workgroup is now developing a Call to Action to Prevent Prescription Drug Abuse Among Youth. |
| Surveillance, Epidemiology, and End Results (SEER) Program | Resource Development | CDC | NCI | SEER is the premier source for cancer statistics in the United States. It collects information on incidence, prevalence and survival from specific geographic areas representing 26 percent of the US population. Through SEER, we develop reports on all of these information areas plus cancer mortality for the entire country. The site is intended for anyone interested in US cancer statistics or cancer surveillance methods. http://seer.cancer.gov/ |
| Systematic Review Data Repository (SRDR) | Resource Development | AHRQ | NLM | NLM is collaborating with AHRQ on the Evidence-based Practice Center (EPC) at Tufts Medical Center to construct a Web-based electronic repository of systematic review data. As envisioned, this resource would serve as both an archive and data extraction tool, enabling the creation of a central database of systematic review findings, which would be made available to a range of audiences in an effort to facilitate evidence reviews and thus improve and speed policy-making with regards to healthcare. http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=591 |
| Systems Dynamics Modeling: Prevention and Management of Heart Disease and Stroke in Two Communities | Meeting/ Workshop | CDC | OD, NHLBI | Working meeting to help develop a system dynamics model of upstream factors contributing to first time cardiovascular events. A second purpose of the model was to use it to evaluate policy interventions in a local community in terms of cost, CVD first time event incidence/mortality, and risk factor prevalence. http://www.cdc.gov/pcd/issues/2008/apr/07_0230.htm |
| Task Force on Environmental Health Risks and Safety Risks to Children: Coordinated Federal Action Plan to Reduce Racial and Ethnic Asthma Disparities | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, OSG | NHLBI, NIAID, NICHD, NIEHS, NIMHD, NINR | The Action Plan to Reduce Asthma Disparities is an effort to promote collaboration and coordination among federal agencies to leverage existing resources and program capabilities, and emphasize activities with the greatest potential to combat the multi-leveled causes of asthma disparities. The Action Plan outlines four key strategies to improve the quality of care for children who have asthma and promote community programs and resources to support clinicians, children, and their families in following best practices for asthma management. |
| TB Trials Consortium Study 26/ACTG 5259: A Study of the Effectiveness and Tolerability of Weekly Rifapentine/Isoniazid for Three Months Versus Daily Isoniazid for Nine Months for the Treatment of Latent Tuberculosis Infection | Research Initiative | CDC | NIAID | Phase III clinical trial to compare the effectiveness of a three-month (12-dose) regimen of weekly rifapentine and isoniazid (3RPT/INH) and a nine-month (270-dose) regimen of daily isoniazid (9INH). Trial conducted among high-risk tuberculin skin-test reactors, including children and HIV-infected persons, who require treatment of latent infection to prevent tuberculosis. The 3RPT/INH regimen will be given under direct observation and the 9INH regimen will be primarily self-administered. http://clinicaltrials.gov/ct2/show/NCT00023452 |
| Technical Advisory Group | Other | ACF | NICHD | Advise ACF on contract with Mathematica that is evaluating selected comprehensive sexuality education interventions. |
| Technical and Clinical Consultation to Indian Health Service in Kidney Disease. | Public Education Campaign | IHS | NIDDK | NIDDK senior staff member serves as Chief Clinical Consultant for Nephrology for the Indian Health Service. http://www.nkdep.nih.gov/news/mailinglistarchive/053106_update.htm |
| Terminology Resources | Resource Development | FDA | NCI | In 2004, FDA and the National Cancer Institute (NCI) signed a Memorandum of Understanding (MOU) whereby NCI agreed to provide terminology development and maintenance services to all FDA Centers. Under this MOU, CDRH''s Office of Surveillance and Biometrics (OSB) convened a cross-Center workgroup and collaborated with staff at NCI Enterprise Vocabulary Service (EVS) to streamline the Patient and Device Problem Codes and integrate them into the NCI Thesaurus and Meta-Thesaurus. |
| Text 4 Baby Program Evaluation Technical Advisory Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA, OS, SAMHSA | NICHD | Formal program evaluation of the Text 4 Baby initiative, which provides health info to pregnant women and young mothers via text message. http://www.womenshealth.gov/about-us/government-in-action/text4baby.cfm |
| The Behavioral Health Workforce Subgroup of the Behavioral Health Coordinating Committee | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, HRSA, IHS, OS, SAMHSA | OD, CSR, NIAAA, NIDA, NIMH | Identifying gaps in federal efforts to develop a sufficient behavioral health workforce to accommodate the increased demand that is expected to result from implementation of the Affordable Care Ace and developing a cross-cutting strategic plan. |
| The CDC Dental, Oral, and Craniofacial Data Resource Center (DRC) | Resource Development | CDC | NIDCR | Publicly accessible database, query system, and survey catalog for population-based oral health surveys http://drc.hhs.gov |
| The Environmental Determinants of Diabetes in the Young (TEDDY) | Research Initiative | CDC | NIDDK, NIAID, NICHD, NIEHS | This consortium is organizing international efforts to identify infectious agents, dietary factors, or other environmental factors that trigger type 1 diabetes in genetically susceptible people. The study enrolled over 8,000 newborns and is following them for 15 years to identify environmental triggers of type 1 diabetes. http://www.teddystudy.org |
| The Federal TB Task Force | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | NIAID, FIC, NCATS, NHLBI, NIAAA, NICHD, NIDA | The Federal Tuberculosis (TB) Task Force is a coalition composed of the federal agencies and organizations involved in U.S. TB control efforts. Established in 1991, it facilitates coordination of activities between federal agencies. It was created by the Director of the Center for Disease Control and Prevention (CDC) to address the outbreaks of multidrug-resistant (MDR) TB occurring during 1985-1992 surge in TB cases. http://www.cdc.gov/tb/about/taskforce.htm |
| The Foundation for the NIH Biomarkers Consortium | Committee, Work group, Advisory group, or Task Force | CMS, FDA | NINDS, NCI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NICHD, NIDDK, NIMH, OD | The Biomarkers Consortium develops, validates, and qualifies biological markers (biomarkers) to speed the development of medicines and therapies for detection, prevention, diagnosis, and treatment of disease and improve patient care. The NIH Public Private Partnership Program coordinates NIH participation in the sponsored Biomarkers Foundation for the National Institutes of Health (FNIH) consortium. The consortium is an umbrella which encompasses research projects, ongoing working groups, as well as occasional workshops and conferences. http://biomarkersconsortium.org/ |
| The Fourth Annual Trauma Spectrum Conference: Bridging The Gap Between Research and Clinical Practice of Psychological Health and Traumatic Brain Injury | Meeting/ Workshop | SAMHSA | NIMH, NIDCD, NINDS, OD | NIMH staff assisted with the planning of the Fourth Annual Trauma Spectrum Conference by examining recent research and clinical advances on psychological health and traumatic brain Injury in military personnel deployed in Iraq and Afghanistan. http://www.dcoe.health.mil/Training/TraumaSpectrumConference.aspx |
| The Genetic and Rare Diseases Information Center | Resource Development | FDA, HRSA | OD, NHGRI, NLM | Genetic and Rare Diseases Information Center (GARD) provides patients, their families, healthcare providers, researchers, and the general public with access to free, current, and reliable information in English and Spanish about rare and/or genetic diseases. GARD has worked with the FDA Office of Zorphan Products Development and HRSA to provide comprehensive information to persons with rare diseases and the public. http://rarediseases.info.nih.gov/GARD/ |
| The Health Consequences of Smoking and Involuntary Exposure to Tobacco Smoke: An Update – Workgroup on Mathematical and Statistical Modeling on the Population Impact of Smoking | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OSG | OD, NCI, NIGMS | The workgroup was convened to share relevant information and begin formulating writing plans for the 2011 update to the Surgeon General''s Report, the Health Consequences of Smoking and Involuntary Exposure to Tobacco Smoke. http://www.surgeongeneral.gov/library/secondhandsmoke/ |
| The Healthy Brain Initiative | Public Education Campaign | CDC | NIA | A call to action and a guide to assist in implementing a coordinated approach to moving cognitive health into public health practice. http://www.cdc.gov/aging/healthybrain/index.htm |
| The Healthy Communities Study: How Communities Shape Children’s Health BAA NHLBI-HC-10-15 | Research Initiative | CDC | NHLBI, NCI, NICHD, NIDA, NIDDK, OD | NHLBI led the development of BAA HL-10-15 but several NIH ICs including NIDDK, NCI, NICHD, OBSSR and CDC worked collaboratively to further refine the solicitation. The purpose of this five year, nationwide study is to identify characteristics of community programs and policies that may help reduce childhood obesity. The goal is to inform public-health practice and policy by identifying community approaches that may work best for reducing childhood obesity. The award for the BAA contract was made in mid-August 2010 and NHLBI and its NIH, CDC, and Robert Wood Johnson Foundation partners are finalizing the protocol for the study. The project contractor will evaluate 275 communities, with over 23,000 children, and will collect data on both children and communities. http://www.nhlbi.nih.gov/resources/obesity/pop-studies/hcs.htm |
| The Medical Education Partnership Initiative (MEPI) | Training Initiative | CDC, HRSA | OD/DPCPSI, FIC, NCCAM, NCI, NCATS, NHGRI, NHLBI, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, OD | The Medical Education Partnership Initiative (MEPI) awards grants to foreign institutions in Sub-Saharan African countries which receive PEPFAR support and their partners to develop or expand and enhance models of medical education in Sub-Saharan Africa. These models are intended to support PEPFAR’s goal of increasing the number of new health care workers by 140,000, strengthen medical education systems in the countries in which they exist, and build clinical and research capacity in Africa as part of a retention strategy for faculty of medical schools and clinical professors. http://www.fic.nih.gov/Programs/Pages/medical-education-africa.aspx |
| The NIH Bone Marrow Stromal Cell Transplantation Center | Research Initiative | FDA | NIDCR, CC, NCI, NHLBI, NIAID, NIAMS, NIBIB, NINDS | The mission of the NIH BMSC Transplantation is to develop clinical grade bone marrow stromal cells for use in clinical trials that utilizes the ability of these cells to exert immunomodulatory and immunosuppressive effects that are beneficial for the treatment of a number of diseases and disorders, and to provide assistance to clinical investigators in the preparation of regulator documents for IRBs and the FDA. http://sigs.nih.gov/bmsctc/Pages/default.aspx |
| The Pharmacology Research Associate (PRAT) Program | Training Initiative | FDA | NIGMS | Funding provided for the support of PRAT Associate as a second year fellow in the laboratory at the Food and Drug Administration (FDA). http://www.nigms.nih.gov/Training/PRAT.htm |
| The Science of Sex and Gender in Human Health | Other | FDA | OD | This is a Web-based course that offers a basic scientific understanding of the major physiological differences between the sexes; their influence on illness and health outcomes; and their implications for policy, medical research, and health care. http://sexandgendercourse.od.nih.gov/ |
| The Trans-NIH Rare Diseases Working Group | Committee, Work group, Advisory group, or Task Force | FDA | NIDCR, CC, CSR, FIC, NCCAM, NCI, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD | The Trans-NIH Rare Diseases Working Group was established in 2004. The working group assists ORDR to carry out its mission by working towards a set of goals that build on partnerships ORDR has developed with NIH Institutes, Centers, and Offices, HHS agencies, and other organizations that address issues in rare diseases research such as identifying research opportunities and advances in rare diseases research; promoting coordination and cooperation in joint research efforts among the NIH ICs and Offices and the research entities they support. http://dpcpsi.nih.gov/collaboration/committees.aspx |
| The United States Renal Data System (USRDS) | Resource Development | CMS, HRSA | NIDDK | The United States Renal Data System (USRDS) is a national data system that collects, analyzes, and distributes information about chronic kidney disease and end-stage renal disease (ESRD) in the United States. The missions of the USRDS are: (1) To characterize the total renal patient population and describe the distribution of patients by socio-demographic variables across treatment modalities; (2) To report on the incidence, prevalence, mortality rates, and trends over time of renal disease by primary diagnosis, treatment modality and other variables; (3) To develop and analyze data on the effect of various modalities of treatment by disease and patient group categories; (4) To identify problems and opportunities for more focused special studies of renal research issues; (5) To conduct cost effectiveness studies and other economic studies of ESRD; and (6) To make the data available to investigators, and by supporting investigator-initiated projects, to conduct biomedical and economic analyses of ESRD patients. http://www.usrds.org |
| Therapeutics for Rare and Neglected Diseases (TRND)/FDA Working Group | Committee, Work group, Advisory group, or Task Force | FDA | NHGRI, OD | A group of Therapeutics for Rare and Neglected Diseases (TRND) staff and FDA staff from the Center for Drug Evaluation and Research (CDER) meet on a semi-monthly basis to discuss pilot projects for the TRND program. The purpose of this working group is to discuss the scientific progress on each project toward the eventual goal of an Investigational New Drug Application for each project. Results of experiments are discussed, and TRND staff takes the feedback of FDA/CDER staff into consideration when developing future project plans. http://trnd.nih.gov/ |
| Tobacco Control Strategic Planning Committee | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA, IHS, OS, OSG, SAMHSA | NIDA, NCI | This committee, led by the Department of Health and Human Services, helped to develop the HHS Tobacco Control Strategic Action Plan. http://www.hhs.gov/secretary/about/prevent.html |
| Topic Refinement Panel for Peripheral Artery Disease (AHRQ) and Duke University Evidence-based Practice Center | Committee, Work group, Advisory group, or Task Force | AHRQ | NHLBI | The Duke University Evidence-Based Practice Center (EPC) is working with the Agency for Healthcare Research and Quality (AHRQ) to conduct a comparative effectiveness review on the topic of Treatment Strategies for Patients With Peripheral Artery Disease (PAD). The Technical Expert Panel (TEP) members provide expertise in the project research area to support the team of EPC investigators. TEP participation consists of attending 1-2 teleconferences over the course of roughly 12 months to discuss the protocol, key questions, analytical framework, literature search strategy, and other project-specific questions regarding report structure and data to be abstracted from the literature for inclusion in the report. |
| Tox21 Collaboration | Research Initiative | FDA | NHGRI, NIEHS | The Toxicology in the 21st Century project, or Tox21, is a collaborative effort that began in 2006 with the NIH Chemical Genomics Center (NCGC), the National Toxicology Program (NTP) based at the National Institute of Environmental Health Sciences (NIEHS), and the Environmental Protection Agency. The ambitious initiative was designed to predict the toxicity of chemicals on human health and the environment. This is accomplished by developing in vitro assays for more predictive, mechanistically-based methods than those used with current animal testing. On July 19th, 2010, the U.S. Food and Drug Administration (FDA) joined this ground-breaking collaboration. The FDA will bring human toxicity data into the project, along with other expertise, to improve upon current chemical testing methods. http://www.genome.gov/27543670 |
| Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NIAID | The presidential declaration issued at the 2009 EU-US summit called for the creation of “a transatlantic task force on urgent antimicrobial resistance issues focused on appropriate therapeutic use of antimicrobial drugs in the medical and veterinary communities, prevention of both healthcare- and community-associated drug-resistant infections, and strategies for improving the pipeline of new antimicrobial drugs, which could be better addressed by intensified cooperation between us”. The objectives of the task force are to increase the mutual understanding of US and EU activities and programs relevant to the antimicrobial resistance issues identified in the declaration to deepen the transatlantic dialogue, to provide opportunities to learn from each other, and to promote information exchange, coordination and co-operation. In September of 2011, the task force published a list of 17 recommended areas for future cooperation between the EU and the US. http://ecdc.europa.eu/en/activities/diseaseprogrammes/tatfar/pages/index.aspx?MasterPage=1 |
| Trans-NIH American Indian and Alaska Native Health Communications and Information Workgroup | Committee, Work group, Advisory group, or Task Force | IHS | NIAMS, NCI, NCATS, NEI, NHGRI, NHLBI, NIA, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIGMS, NINDS, NLM, OD | Provides a forum for health education and communications staff from across NIH to share strategies and learn effective approaches to develop and disseminate health information designed for American Indian and Alaska Native communities. http://www.niams.nih.gov/about_Us/Mission_and_Purpose/Community_Outreach/Multicultural_Outreach/AIAN_WG/ |
| Trans-NIH Nanotechnology Task Force: National Nanotechnology Initiative (NNI) Call For Trans-agency Signature Initiatives | Committee, Work group, Advisory group, or Task Force | FDA | NIDCR, NHLBI, NIBIB, NIDCD | In response to NNI’s call for Signature Initiatives, the NIH Nanotechnology Task Force (NIDCR and NIBIB representatives) together with FDA and other Federal Agencies (NIST, NSF, and DoD) have generated a draft of the Initiative entitled “Nano-Regenerative Medicine”. The overarching goals of this Initiative are to develop robust and efficient platforms for standardization, fabrication, GMP manufacturing, and regulatory approval of nanotechnology-based products that will lead to new paradigms in low-cost therapies targeting regeneration of a range of tissues in the human body affected by disease and injury. On July 24, 2009, the draft of the Initiative was submitted for review to the Office of Science and Technology Policy through NNI. In 2010, a trans-Federal Agency Working Group was formed to continue the development of this Initiative. http://www.nibib.nih.gov/research/NIHNano |
| Trans-NIH Plan for HIV-Related Research | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | OD/DPCPSI/OAR, CC, CSR, FIC, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD | Authorized by section 2353 of the Public Health Service Act, this annual collaborative planning process establishes scientific priorities for all NIH AIDS research. Broad input is solicited from scientists from NIH, other government agencies, and non-governmental organizations, as well as community representatives and other experts from the United States and abroad. http://www.oar.nih.gov/strategicplan/ |
| Transition to Fatherhood | Research Initiative | OS | NICHD | This research examines the social and economic consequences of teenage or early fatherhood. This IAA is an administrative supplement to the NICHD Transition to Fatherhood Grant-5P01HD045610-05 that assists in developing better pregnancy prevention policies for young men by improving understanding of the social and economic consequences of early and premature transitions to fatherhood. This grant supplement will undertake secondary data analysis of multiple longitudinal datasets to examine if the consequences of premature parenting are different for men than for women. This information is needed in order to inform the development of effective pregnancy prevention strategies for young men. http://fatherhood.human.cornell.edu/ttf/ |
| Translational Research to Help Older Adults Maintain their Health and Independence in the Community | Research Initiative | AoA | NIA | The National Institute on Aging (NIA) and the Administration on Aging (AoA) have partnered to solicit applications using the NIH R01 or R21 award mechanisms for translational research that moves evidence-based research findings towards the development of new interventions, programs, policies, practices, and tools that can be used by community-based organizations to help elderly individuals remain healthy and independent, and living in their own homes and communities. The goal of this initiative is to support translational research involving collaborations between academic research centers and community-based organizations with expertise serving the elderly (such as city and state health departments, city/town leadership councils, and Area Agencies on Aging) that will enhance our understanding of practical tools, techniques, programs and policies that communities across the nation can use to more effectively respond to needs of their aging populations. http://grants.nih.gov/grants/guide/pa-files/PA-11-123.html |
| Transmissible Spongiform Encephalopathies Advisory Committee (TSEAC) | Committee, Work group, Advisory group, or Task Force | FDA | NIAID | The Transmissible Spongiform Encephalopathies Advisory Committee (TSEAC) reviews and evaluates available scientific data concerning the safety of products which may be at risk for transmission of spongiform encephalopathies having an impact on the public health as determined by the Commissioner of Food and Drugs. The Committee shall consist of a core of 15 voting members, including the Chair. Members and the Chair are selected by the Commissioner or designee from among authorities knowledgeable in the fields of clinical and administrative medicine, hematology, virology, neurovirology, neurology, infectious diseases, immunology, transfusion medicine, surgery, internal medicine, biochemistry, biostatistics, epidemiology, biological and physical sciences, sociology/ethics, and other related professions. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/TransmissibleSpongiformEncephalopathiesAdvisoryCommittee/default.htm |
| Transplant Cancer Match Study | Research Initiative | HRSA | NCI | A study linking databases of U.S. transplant recipients, donors, and wait list candidates to multiple U.S. cancer registries to evaluate the spectrum of cancer risk in transplant recipients. http://transplantmatch.cancer.gov/ |
| Traumatic Brain Injury Common Data Elements Standards - Interagency Steering Committee | Committee, Work group, Advisory group, or Task Force | CDC | NINDS | The Traumatic Brain Injury (TBI) Common Data Elements (CDE) Standards – Interagency Steering Committee provides oversight to a federal scientific initiative to develop common data elements for TBI. http://www.commondataelements.ninds.nih.gov/TBI.aspx#6 |
| Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) | Research Initiative | CDC | NIDDK | TODAY is a multi-center clinical research study examining the safety and efficacy of three treatment options for type 2 diabetes in the pediatric population. TODAY was initiated due to the increase in type 2 diabetes in children and adolescents, which itself is linked to the rise in obesity. http://todaystudy.org |
| Trends in Health and Aging | Resource Development | CDC | NIA | A data archive of trend tables with health indicators displayed over time and by age, sex, and race/ethnicity. A Web-based tool developed and maintained by the National Center for Health Statistics, attempts to connect consumers of information on health and aging with suppliers of such data by providing user-friendly access to up-to-date information on the health and well-being of older Americans. |
| Trends in Hormone Concentrations in U.S. Men and Relationship to Endocrine Disrupting Chemicals in the National Health and Nutrition Examination Surveys (NHANES) Population | Research Initiative | CDC | NCI | An examination of serum hormone levels of men in the National Health and Nutrition Examination Surveys (NHANES) population to determine whether levels have declined over time and whether they correlate with serum levels of endocrine disrupting chemicals. |
| Tribal Epidemiology Centers Program | Research Initiative | IHS | NIMHD | To develop Epidemiology Centers and public health infrastructure for AI/AN communities. http://www.ihs.gov/epi/index.cfm?module=epi_tec_tecs |
| Tribal Health Research Advisory Council (HRAC) | Committee, Work group, Advisory group, or Task Force | OS | NIMHD | To support the activities of the Council, including obtaining input from tribal leaders on health research priorities and needs; and dissemination of information. http://minorityhealth.hhs.gov/hrac/ |
| U. S. Department of Education''s National Meeting on Alcohol and Other Drug Abuse and Violence (AODV) Prevention in Higher Education | Meeting/ Workshop | SAMHSA | NIAAA, NIDA | The purpose of this meeting between HHS agencies and other federal agencies was to discuss how to prevent and reduce high-risk drinking, drug use, and violence among college students. |
| U. S. Government Interagency Working Group on Nanotechnology, Environmental, and Health Implications (NEHI), of the Nanoscale Science, Engineering, and Technology Subcommittee (NSET) of the National Science and Technology Council (NSTC) | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NIBIB, NCI, NHGRI, NIEHS | The NSET Subcommittee and NEHI Working Group provide leadership in establishing the national nanotechnology environmental, health, and safety research agenda and in communicating data and information related to environmental and health aspects of nanotechnology between National Nanotechnology Initiative (NNI) agencies and with the public. NNI activities support the development of new tools and methods required for the research that will enable risk analysis and assist in regulatory decision-making. NNI agencies engage and interact with regional, state, and local groups, educational institutions, industry-supported groups, and non-governmental organizations to enhance the impact and value of NNI efforts and to provide a collaborative approach. http://www.whitehouse.gov/sites/default/files/microsites/ostp/nni_2011_ehs_research_strategy_final.pdf |
| U.S. Government Microbicides Coordinating Committee | Committee, Work group, Advisory group, or Task Force | CDC, FDA | OD/DPCPSI/OAR, FIC, NCI, NIAID, NICHD, NIDA, NIMH, NINR, OD | NIH/OAR administers and chairs committee of representatives from each side of the U.S. Government agencies involved in microbicides research. The committee provides coordination and collaboration of U.S. Government microbicides research activities. http://www.oar.nih.gov/initiatives/mrgw.asp |
| U.S.-Brazil Working Group on Public Health | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NCI, FIC, NIAID | The Brazil-US Joint Commission Meeting on Science and Technology Cooperation (JCM) established the Working Group on Public Health to address issues including: (1) renewal of the Implementing Agreement for Science and Technology Agreement in the field of Public Health and biomedical Research; (2) identification of research topics of mutual interest for possible joint support; and, (3) exchange of information and discussion of regulatory and ethical requirements for research review and implementation. The 3rd Meeting of the US-Brazil Working Group on Public Health convened February 24-25, 2011, Brasilia, Brazil. |
| U.S.-Zambia Health Research Coordination Meeting | Meeting/ Workshop | CDC, OS | NIAID, FIC, NCI, NICHD, NIMH, NINDS | The objectives of the US-Zambia Coordination Meeting include: 1) to provide an opportunity for investigators to share in scientific discussions regarding ongoing collaborative research and research training activities in Zambia, and possibly to generate additional cross-project collaborations and more joint efforts to strengthen capacity building programs in Zambia 2) to learn directly about current Zambian government research related policies and procedures from relevant officials; 3) to discuss shared challenges and respective solutions that will advance Zambian health research objectives; and 4) to explore new and current research training opportunities involving US and Zambian scientists |
| Understanding International Health Differences in High-income Countries: Patterns, Puzzles, Paradoxes, and Public Health Opportunities | Committee, Work group, Advisory group, or Task Force | OS | OD, FIC, NIA | The National Academy of Sciences in collaboration with the Institute of Medicine, is examining international differences among high-income countries in measures of health and disability over the life-cycle with special attention to public health implications for the USA. The USA compares poorly against other countries on many critical indicators of health and well-being. The examination will review available data and offer a state-of-the science assessment of underlying individual and societal causes. http://www8.nationalacademies.org/cp/projectview.aspx?key=49361 |
| Unified Medical Language System Metathesaurus (UMLS) | Other | AHRQ, CDC, CMS, FDA | NLM | NLM''s Unified Medical Language System (UMLS®) facilitates the development of computer systems that behave as if they understand the meaning of the language of biomedicine and health. To that end, NLM produces and distributes the UMLS Knowledge Sources (databases) and associated software tools (programs) for use by system developers in building or enhancing electronic information systems that create, process, retrieve, integrate, and/or aggregate biomedical and health data and information, as well as in informatics research. By design, the UMLS Knowledge Sources are multi-purpose. |
| United States Global Change Research Program, (Interagency) Climate Change and Human Health Group | Committee, Work group, Advisory group, or Task Force | CDC | NIEHS, FIC | This is a pilot crosscutting interagency working group under the GCRP focused specifically on coordinating Federal activities related to the impacts of climate change, mitigation, and adaptation on human health. http://www.globalchange.gov/ |
| US-Ireland Research & Development Partnership | Research Initiative | OS | NHLBI, NIDDK | The goal of the partnership is to stimulate collaborative research between the U.S. and Ireland in the area of cystic fibrosis, diabetes, and nanotechnology. Government agencies and non-profit organizations, including NHLBI, NIDDK, NSF, Cystic Fibrosis Foundation, R&D Office (Northern Ireland), Dept. of Enterprise, Trade, and Employment, Health Research Board, Science Foundation Ireland and Inter-Trade Ireland, participate. As an outgrowth of the U.S.-Ireland R&D Partnership, a grant proposal on the role of anaerobic bacterial infection in CF was submitted to NIH which involves U.S.-Ireland tripartite scientific collaboration. http://www.usirelandresearch.com/home.html |
| Ventilator-Associated Pneumonia | Meeting/ Workshop | CDC | CC | A series of meetings were held to develop a practical new national surveillance definition for ventilator-associated pneumonia. |
| Violence Against Women Steering Committee (DHHS VAW) | Committee, Work group, Advisory group, or Task Force | ACF, AoA, AHRQ, CDC, HRSA, IHS, OS, SAMHSA | OD, NIA, NIAAA, NICHD, NIMH, NINR, NLM | This is the committee that represents DHHS as part of the implementation of the VAW Act. This committee collaborates with the Department of Justice to implement the VAW Act. http://www.healthcare.gov/law/resources/reports/women03252011a.pdf |
| Vitamin D Standardization Program | Committee, Work group, Advisory group, or Task Force | CDC | OD | This program is directed toward standardizing the measurement of vitamin D status in national health surveys worldwide. http://ods.od.nih.gov/Research/VitaminD.aspx |
| Washington Circle Initiative | Meeting/ Workshop | SAMHSA | NIDA, NIAAA, NIMHD | Provided funding to support meeting to facilitate development of research on developing and validating performance measures for integrated treatment for substance abusers. http://www.washingtoncircle.org/ |
| We Can! (Ways to Enhance Children’s Activity and Nutrition) | Public Education Campaign | CDC, HRSA | NHLBI, NCI, NICHD, NIDDK | Through the We Can! program, the NIH and other HHS partner agencies disseminate strategies, tools, and resources to community organizations, the general public, healthcare providers, and other groups. Strategies focus on three behaviors: eating right, moving more, and reducing screen time to help prevent obesity in youth. Parents and caregivers of 8-13 year olds are the primary focus of the program''s outreach. http://www.nhlbi.nih.gov/health/public/heart/obesity/wecan/ |
| Work Group on Harmonizing Hemoglobinopathy Data Sets | Committee, Work group, Advisory group, or Task Force | CDC, HRSA | NLM, NHLBI, NICHD, NIGMS, OD | The mission of the Workgroup for Harmonizing Hemoglobinopathy Data Sets is to create a resource for federal programs and extramural communities to use in data systems which incorporate data elements in hemoglobinopathies. Specifically this entails establishing a Hemoglobinopathies Uniform Medical Language including: - Identifying specific goals and objectives for the kind of data that are required by these programs - Case definitions for electronic data systems at all levels - Consensus about conditions and data elements to be included - Differentiation between data needs for surveillance and for registries/biorepository |
| Work, Family and Health Network | Research Initiative | ACF, CDC | NICHD, NIA, OD | The Administration for Children and Families, Office of Planning, Research and Evaluation is providing NICHD funds to partially support the "Work, Family, and Health Network," a research project of NICHD. This project is examining the effects of a workplace intervention designed to reduce work-family conflict and thereby improve the health and well-being of employees and their families. There is a modification agreement and the purpose of the modification agreement is to provide continuation of research support for the Work, Family and Health Network (WFHN) "Limited Competition for Evaluating the Health Benefits of Workplace Policies and Practices." The WFHN evaluated the health benefits of workplace policies and practices aimed at ameliorating work-family conflict. http://www.kpchr.org/WORKFAMILYHEALTHNETWORK/public/default.aspx |
| Workgroup on Asian, Native Hawaiian and Pacific Islander Issues (WANHPII) | Committee, Work group, Advisory group, or Task Force | HRSA | NIDA, NIDDK | The mission of the HHS Workgroup on Asian, Native Hawaiian and Pacific Islander Issues (WANHPII) is to improve communication, coordination, agency policies, programs, and evaluations that impact the health, health care, human services and wellbeing of Asian Americans (AA), Native Hawaiians and Other Pacific Islander (NHOPI) communities. http://minorityhealth.hhs.gov/templates/browse.aspx?lvl=3&lvlid=573 |
| Workgroup on Research Related to Evidence Based Policy | Committee, Work group, Advisory group, or Task Force | ACF, CDC | NIDA | This workgroup focuses on research issues surrounding evidence-based policy. Discussions generally include cross cutting questions-- e.g., What is evidence-based? What are key lessons that have been learned as evidence-based policy has been rolled out? In addition, this group provides update on meetings and projects related to evidence-based policy. |
| Working Groups to Develop Federal HIV/AIDS Prevention and Treatment Guidelines | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA | OD/DPCPSI/OAR, CC, NIAID, NICHD, NIMH, NLM, OD | The U.S. Department of Health and Human Services issues Federal guideline documents for the prevention and medical management of HIV infection and issues surrounding HIV infection. The guidelines are written, reviewed, and updated by Working Groups of HIV experts, including physicians, pharmacists, researchers, and HIV treatment advocates. These Working Groups function under the auspices of the NIH Office of AIDS Research Advisory Council (OARAC). http://www.aidsinfo.nih.gov/Guidelines/?MenuItem=Guidelines&Search=On |
| Workshop on Computer Models of Medical Devices | Meeting/ Workshop | FDA | NHLBI | The purpose of the workshop was to assess the state-of-the-art in computer models that could be used to predict the in-vivo fate of medical implants. http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm257194.htm#agenda |
| Workshop on TB and HIV Diagnostics | Meeting/ Workshop | CDC | NIAID, NICHD | The purpose of this meeting was to focus on the critical need for the development, evaluation, and implementation of new and improved diagnostics for use in international and domestic settings and in adult and pediatric populations. This meeting was held on June 28-30, 2011 in Silver Spring, MD. http://www.blsmeetings.net/TB-HIV-Dx-Wkshop/ |
| Workshop on the Health Burden of Indoor Air Pollution on Women and Children in Developing Countries | Meeting/ Workshop | CDC | NHLBI, FIC, NCI, NEI, NIAID, NICHD, NIEHS, OD | The NIH organized a two-day workshop entitled "Health Burden of Indoor Air Pollution on Women and Children in Developing Countries," to bring together research and policy experts to develop priorities for research that could help to reduce the health risks of cook stoves to women and children. http://www.fic.nih.gov/News/GlobalHealthMatters/June2011/Pages/cookstove-workshop.aspx |
An official website of the United States government
Here's how you know
Official websites use .gov
A .gov website belongs to an official government
organization in the United States.
A .gov website belongs to an official government
organization in the United States.
Secure .gov websites use HTTPS
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.